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Abstract 
 
Foodborne diseases affect one in six members of the population every year and cause at 
least 1.5 million deaths annually. Infections acquired through food consumption are common with 
significant morbidity and mortality costs to the society. Non-typhoidal salmonellosis (NTS) is 
responsible for the significant proportion of foodborne gastroenteritis worldwide. Molecular 
identification and characterization of Salmonella with assessment of exposure and epidemiological 
analysis of outbreak-linked cases are main approaches to control the NTS. In this study we focus 
on Salmonella Typhimurium (STM) as the most common causative agent of foodborne NTS in 
Australia and a frequent cause of community outbreaks. 
The specific aim of this thesis is to examine and explain temporal dynamics of STM 
incidence, using New South Wales (NSW), Australia, as an exemplar region with good access to 
pathology services as well as an established system of public health surveillance of this notifiable 
infection. An important part of achieving this goal is the understanding of within- and between-
host variations and adaptations in STM genomes and discrimination power of rapidly evolving 
typing methods. We hypothesized (i) that the application of evolutionary approaches to the 
analysis of specific clades of STM improves the understanding of salmonellosis epidemic 
dynamics, and (ii) that polymorphism in STM genomes is a key attribute that, in conjunction with 
epidemiological evidence, can affect the recognition and investigation of STM transmission events 
and community outbreaks.  
We have examined 11,799 STM isolates recovered from human and environmental 
samples between 2009 and 2016. Our findings suggest that multi-locus variable sequence typing 
(MLST) can be successfully applied for molecular serotyping of Salmonella isolates circulating in 
NSW. However, MLST approach lacks discriminatory power to be useful for public health 
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surveillance. In contrast, multi-locus variable number tandem repeat analysis (MLVA) identified 
major clades associated with extensive epidemics over the years of this study. Only a small number 
of MLVA profiles have been associated with particular outbreaks or clusters, masking the diversity 
of profiles and reducing the potential of epidemiological investigations to elucidate transmission 
networks. Our retrospective sequencing of STM isolates, including ones associated with a large 
community outbreak, reconfirmed previously postulated high-resolution of whole genome 
sequencing (WGS) and the ultimate discriminatory power with the potential to enhance 
epidemiological investigations and elucidate transmission pathways. Our findings illustrated a 
relatively constant core genome for STM population over time, translated in stable diversity with 
predominance of endemic STM MLVA profiles. The adaptive evolution of STM in association 
within its host, particularly in the experimental model of chronic salmonellosis in mice, was one 
of the key findings. It involved a limited number of mutations, which did not compromise the 
ability of STM to maintain the infection and the excretion of STM in stools. The temporal relation 
between the incidence of STM infections in NSW and the corresponding increase of particular 
STM clades was unveiled. Our findings indicated that reduction of newly identified MLVA 
profiles of STM in winter and spring precedes the high activity of human infection in summer. 
The comparative genomic analysis performed on carefully selected representatives of 
sporadic and epidemic STM clades identified genomic polymorphisms within the successful clades 
when compared to non-successful ones. These observations emphasize the stability of accessory 
genomes, which was previously underappreciated, but require further in vivo validation. Our 
research findings provided important insights into the dynamics of community epidemics of 
Salmonella Typhimurium and identified types of genomic polymorphisms that contribute to the 
establishment of epidemic clades. Our results and analyses have also offered important evidence 
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to guide the interpretation of Salmonella Typhimurium public health laboratory surveillance and 
the translation of whole genome sequencing into more effective control of foodborne diseases. 
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Chapter 1: Introduction 
 
 1.1 Foodborne illness: an on-going public health concern 
 
Foodborne diseases affect one in six members of the population every year and cause at least 
1.5 million deaths annually (1). This impact is amplified by the globalization of food markets and 
emerging fresh produce industries. Infections acquired through food consumption can result in 
clinical complications, which can lead to hospitalization and poor clinical outcomes, usually the 
very young and the elderly. Changes associated with the spectrum of illness and the food products 
involved in transmission have taken place. Particularly in terms of current food product demand 
and supply, dramatic changes have occurred (2). Globalization of the food supply, with large 
volumes of food being imported from distant countries has facilitated widespread access to a more 
diverse food selection, resulting in food processing becoming highly industrialized (3).  
Animal production for instance, has increased to cover the population’s demand which 
translates into food production animals increasingly raised in close quarters for later slaughtering 
and processing as part of food production chains. This handling method increases the incidence 
and transmission of diseases. Developed countries have implemented surveillance systems, 
however due to limited resources, low-income countries cannot implement the same level of food 
chain surveillance (4-6). Agriculture has also been impacted by globalization of the food supply, 
particularly with production of fresh fruits and vegetables which are currently available year round, 
often transported from warmer countries contributing to the emergence of new pathogens and new 
trends in foodborne illness presentation (7-8). 
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Although foodborne diseases are clearly an important cause of morbidity and mortality 
worldwide, there remains a lack of understanding of their burden, associated risks and pathways 
of transmission, despite global awareness of foodborne diseases posing a high risk to health and 
economic development (9).  
1.2 The burden of non-typhoidal salmonellosis 
 
  Non-typhoidal salmonellosis (NTS) illness is a major cause of foodborne gastroenteritis 
worldwide. The diverse serovars of NTS are a leading bacterial cause of morbidity and mortality, 
both in children under 5 years old (10) and in the population in general (11).  Infection with NTS 
has been estimated to cause 93 million enteric infections (90% CI: 61.8–131.6 million) and 
155,000 diarrheal deaths each year (12). Despite public health efforts, it remains a growing 
challenge for both developing and developed countries. The causative agents, members of 
Salmonella spp., colonize a variety of diverse animal reservoirs and are associated with various 
routes of transmission, making control efforts extremely difficult. In developed countries however, 
the majority of infections are associated with foodborne exposures (13). 
In order to reduce the burden of foodborne salmonellosis, timely recognition of disease 
outbreaks and accurate identification of the food sources causing disease are crucial. Molecular 
subtyping of Salmonella combined with epidemiological analysis of exposures and outbreak-
linked cases are widely used to estimate the relative contribution of different food sources to NTS 
(14). However, and despite the fact that public health unit and laboratory based surveillance 
provide useful information, the true NTS burden remains underestimated (15).  In order for public 
health unit and laboratory-based surveillance systems to provide a reliable overview of the 
population incidence of NTS, an ill patient must first seek medical assistance; only by this initial 
step a specimen, usually stools, will be collected and submitted to a pathology provider. From this 
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point, the laboratory in charge of the specimen’s analysis will test for enteric pathogens and, if the 
particular organism is found, a report confirming the positive finding will be generated for the 
requesting medical practitioner and forwarded to the relevant public health authority (16-17). 
Jurisdictional Public Health Acts require mandatory reporting of all laboratory confirmed 
Salmonella infections to the relevant health departments and then to the National Notifiable 
Diseases Surveillance System (NNDSS). Due to the previously mentioned underrepresentation of 
the total number of cases of salmonellosis, it has been estimated that there are at least 7 
salmonellosis cases (95% CI 4–16) occurring in the community for every notification to health 
departments from pathology providers (18). Hence, notified cases detected by laboratory-based 
surveillance only represent a fraction of the total community cases of NTS. In terms of global 
surveillance data, the situation becomes even more difficult since a large number of countries, 
particularly developing countries, present large variations in their implemented surveillance 
standards. Several prospective and retrospective studies attempted to establish the notification 
levels associated with laboratory-based surveillance worldwide, confirming the level of sub-
notification involved with NTS cases (15-16, 9).  
An additional public health issue is the presence of antibiotic resistance in Salmonella 
serovars. Most infections with non-typhoidal Salmonella infections (NTS) are self-limiting, and 
do not require any antibiotic therapy (17-19). In animals, however, antibiotics are used for several 
purposes including therapeutics and growth promotion. It is this extensive use, or misuse, that 
drives development of resistant organisms worldwide, which is emerging as a serious public health 
threat (20). The need to monitor resistance of Salmonella in food products is a necessary safety 
strategy, as well as the necessary reduction on the use of antibiotics in food production animals 
(21-22). 
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More than 2,500 serovars of Salmonella enterica can cause NTS. While all these serovars 
can cause infection in humans, most human gastroenteritis is caused by a limited number of 
serovars. S. Enteritidis and STM, are among the most frequently identified serovars associated 
with NTS human illness, reaching around 70% of identified cases in the European Union (EU) (6-
7,9,23); however, Salmonella enterica subsp. enterica serovar Typhimurium (STM) is the 
predominant serovar in Australia (24-27). The situation with NTS in Australia is similar to the 
descriptions worldwide; approximately 72% of salmonellosis in Australia is transmitted through 
contaminated food (28-29). Common foods associated with salmonellosis in outbreak 
investigations and source attribution studies have included eggs, poultry meat, pork, beef, dairy 
products, nuts, and fresh produce (28,30-31). S. Enteritidis is the most commonly identified 
serovar after S. Typhimurium (28). This former predominates in Western Europe and North 
America, where laying contaminated hens for egg production have been confirmed as the primary 
source of human S. Enteritidis infection (6,34), S. Enteritidis is not endemic in poultry in Australia. 
According to the  OzFoodNet report (2015), most human infections with S. Enteritidis in Australia, 
have been judged as overseas acquired (35). There are several other serovars present in Australia 
associated with relatively small numbers of human cases; public health authorities have described 
them as belonging to particular ecological niches within the country, mostly related to its wide 
climatic and geographical variation (35-37).  
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1.3 STM as the main causative agent of NTS identified in New South Wales 
  
Over three thousand Salmonella isolates are received and tested every year by the New 
South Wales Enteric Reference Laboratory (ERL) based at the Pathology West-ICPMR at 
Westmead Hospital in Sydney, and around half of them have been serotyped as STM. The presence 
of such large numbers of a single serovar and historically made identification of potential 
outbreaks caused by STM extremely difficult, justifying the need for more discriminatory 
subtyping methods (38-39). The multi-locus variable number tandem repeat analysis (MLVA) was 
introduced to support public health investigations of foodborne salmonellosis outbreaks. MLVA 
measures the variable length of five STM loci and has been considered faster and more 
discriminatory than other historical typing methods (40-44). 
Representatives from several Australian reference laboratories agreed on the convention 
by which MLVA typing for STM was implemented. During 2008, the NSW ERL, in collaboration 
with the Communicable Diseases Branch of the NSW Ministry of Health and the NSW Food 
Authority, prospectively evaluated MLVA typing by comparing the results available within 
approximately 2 weeks of the receipt of isolates with epidemiological investigations of suspected 
clusters (40). Evaluation of results confirmed the higher discriminatory power of MLVA typing 
when compared to other typing methods such as serotyping and the no longer implemented phage 
typing. Since 2008, MLVA typing has been implemented in NSW to prospectively subtype STM 
and identify potential clusters (40-42). 
However, endemic MLVA profiles may cause multiple outbreaks along with sporadic 
cases and a few selected MLVA profiles may represent a large portion of isolates observed in a 
geographical location, showing that there are cases when the resolution provided by MLVA is no 
longer sufficient to generate epidemiological links (45). 
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The population of STM isolates in NSW between 2008 and 2011 remained largely stable 
in terms of main MLVA profiles dominating the STM spectrum, with almost 50% of isolates 
classified as belonging to a single phage type (i.e. PT170). Almost a third of these isolates 
possessed one of three related MLVA profiles (3-9-7-13-523, 3-9-7-12-523 and 3-9-8-12-523), 
profiles were associated with the largest numbers of STM cases until 2012, typically displaying 
seasonal peaks related to the warmer months (42). Hence, a large number of STM cases are caused 
by successful endemic MLVA profiles (34), which may cause multiple outbreaks along with 
sporadic cases, reducing the potential of epidemiological investigations to elucidate transmission 
networks (42,45).  
 
1.4 Utility of Whole Genome Sequencing in public health investigations 
 
   Whole Genome Sequencing (WGS) offers the ultimate discriminatory power with the 
potential to enhance epidemiological investigations and elucidate disease transmission pathways. 
Its advantages over other pathogen characterization methods have been proven for Salmonella and 
other organisms, offering high throughput and high-quality data which are easy to share and 
interpret between laboratories, nationally and internationally (46-50). Furthermore, it has been 
shown that WGS can complement existing epidemiological strategies by identifying previously 
undetected linked cases (51-53). 
 Recent studies have also demonstrated that sequencing of bacterial genomes can detect 
chronic carriers, predict the existence of undiagnosed cases within transmission chains, suggest 
potential routes of transmission as well as identify unrecognized risk factors associated with 
transmission events (54-56). Evidence suggests that WGS represents a paradigm shift in 
identification and characterization of foodborne pathogens, including Salmonella spp., with 
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capacity to replace some of the currently in use diagnostic techniques (57). This will require the 
development of faster result interpretation systems as well as the development of systems to 
synthesize share and store the generated genome data at a public health level (58-60). 
Nevertheless, availability of clinical and epidemiological information is required to 
confirm WGS findings regarding genetic relatedness of particular isolates. The synthesis of 
microbiological, genomic and epidemiological lines of evidence is fundamental for the 
understanding of dynamics on pathogen’s epidemics, including STM, in order to improve the 
public health surveillance and control of NTS (61-65). Whole genome sequencing has thus been 
suggested as a complementary tool to enhance traditional epidemiological and surveillance tools, 
however barriers still persist that prevent widespread global and regional adoption of this 
technology, mainly related to the acquisition of the technology and the costs involved and the 
requirement of professionals with the knowledge in bioinformatics and genomics to carry on the 
analysis (66-68).  
 
1.5 Gaps in the understanding of molecular epidemiology of STM limits our 
disease control capacity 
 
While the role of gene loss in the shaping of S. Typhi as a strict human pathogen that 
evolved from less virulent zoonotic Salmonella has been recognized (61), the genomic variation 
in bacteria causing NTS has received less attention. For NTS, genomic surveillance at the 
phylogenetic level has identified the evolution of new common ancestors of Salmonella, as well 
as identifying particular genes, which support gut colonization and faecal shedding (62). It appears 
that disease-causing strains tend to have a greater number of genes involved in replication, 
recombination and repair. This description particularly applies to STM ST313, which has been 
8 
 
reported as a multidrug resistant STM as well as a carrier of genomic modifications towards human 
host-adaptability, potentially becoming completely human adapted, changing the preventive 
approaches carried out for STM (61).  
Recent breakthroughs in genome-wide association studies have analysed the presence of 
strain-level differences in phenotypes of diverse recombining bacteria, not Salmonella, and their 
effects on bacterial population structure, and have focused on identification of multiple loci within 
genomes that collectively show a strong association with phenotype (62). However, these methods 
have not been applied to further understanding of endemic and epidemic clades of STM, which 
represents a significant gap in the collective knowledge and hence is a major focus of this thesis. 
 
1.6 Aims of the thesis and research hypothesis 
 
 The overarching aim of this thesis was to explain temporal dynamics of STM, using New 
South Wales in Australia as an exemplar region with good access to pathology services as well as 
an established system of public health surveillance of this notifiable infection. An important part 
of achieving this aim was to understand within and between-host variation and adaptation in STM 
genomes by harnessing the discriminatory power of rapidly evolving typing methods. Our 
hypotheses were that:  
 
(H1) the application of evolutionary approaches to the analysis of specific clades of STM improves 
the understanding of salmonellosis epidemic dynamics 
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(H2) polymorphism in STM genomes is a key attribute that, in conjunction with epidemiological 
evidence, can affect the recognition and investigation of STM transmission events and community 
outbreaks.  
 
1.7 Research objectives 
 
The specific objectives of this study were to: 
1. Explore the capacity of multi-locus sequence typing (MLST) to identify and differentiate the 
most common serovars of Salmonella enterica co-circulating in NSW (Chapter 5) 
2. Investigate the structure and mechanisms of seasonal epidemics of human STM disease in 
NSW (Chapter 6) 
3. Characterize attributes of STM populations that are associated with seasonal epidemics of 
human STM disease in NSW (Chapter 6) 
4. Compare the resolution power of MLST, MLVA and whole genome sequencing for public 
health laboratory surveillance (Chapters 5 and 6) 
5. Examine variations in core and accessory genomes of successful STM clades (Chapter 7) 
6. Identify within-and between-host variations and adaptations in STM genomes in acute and 
chronic infection models (Chapter 8).   
 
1.8 Thesis outline 
 
 The thesis is divided into 3 sections. The first section provides a background to the study 
and contains three chapters (Chapters 1, 2 and 3). The introductory chapter (Chapter 1) states the 
aims, research hypothesis and objectives of the thesis. Chapter 2 provides an overview of the 
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burden of foodborne salmonellosis in terms of its global significance, followed by characterization 
and taxonomy of the Salmonella spp., its pathogenic determinants and a description of challenges 
in laboratory identification as well as the public health surveillance strategies and tools applied to 
this organism.  In Chapter 3, the added value of STM genotyping describing the Salmonella genus 
was addressed, as well as describing other contemporary genotyping methodologies such as 
MLVA-5 typing, to later on fully embrace the description and applicability of WGS for pathogen 
detection and analysis of either individual non-linked cases or, with further utility, in outbreak 
investigation. 
 Section two of this thesis focuses on presentation of the strategies performed to fulfil each 
one of the research objectives. The material and methods chapter (Chapter 4) details each of the 
different approaches, methodologies and techniques applied to address the hypotheses and 
objectives of this study. 
 Section three of the thesis corresponds to the presentation of results and its corresponding 
analysis (Chapters 5, 6, 7, 8, 9). Chapter 5 focuses mainly on the utility of MLST as a tool for 
inferring Salmonella serovars as well as investigation of the general mechanisms involved in 
seasonal STM human disease in NSW. Chapter 6 approaches the main characteristics found 
within seasonal STM epidemics in NSW as well as comparing the resolution power of three 
genotype-based identification methods. The analyses presented in Chapter 7 focus on a set of 
successful epidemic STM clades, examining variations in core and accessory genomes of these 
successful STM representatives while comparing them to a set of non-successful STM clades. 
Finally, Chapter 8 describes findings generated using two separate animal models for STM 
infection, one acute and one chronic, identifying variations and adaptations in STM genomes.  
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This thesis concludes with Chapter 9, which summarizes conclusions from the previous 
chapters, explaining how the findings presented in this thesis can improve characterization of STM 
infection in NSW by harnessing the emerging field of genomic epidemiology to increase the 
understanding in terms of STM epidemic dynamics to improve public health laboratory 
surveillance. By better understanding the nature and molecular markers within successful STM 
clades, we may be able to streamline the evaluation and implementation of genomic-based 
surveillance to improve the recognition of transmission pathways and better control of foodborne 
diseases. 
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Chapter 2: The burden of foodborne salmonellosis  
2.1 Introduction 
Infection caused by foodborne pathogens is characterized by gastroenteritis with diarrhoea 
and related symptoms. There are more than 250 different foodborne diseases described worldwide. 
Campylobacter, Shiga toxin–producing Escherichia coli (STEC), nontyphoidal Salmonella, and 
Listeria are the main associated causative agents (4,7,9,11,13,69). They are an important cause of 
morbidity and mortality and a significant impediment to socioeconomic development worldwide. 
The actual assessment of this foodborne diseases burden is complex: many different pathogens can 
be transmitted by food, leading to widely different health outcomes (8-9,16,55,70). 
Many cases of foodborne illness are self-limiting, self-treated and may not be recognized 
by the health system. General practitioners and others may treat some, though few, may develop 
complications that will require extensive treatment and hospitalization beyond the year in which 
the infection occurred (3). Only a small proportion of those cases are recognized as caused by a 
hazard associated with food and therefore treated, reported to public health authorities and 
recorded as part of official statistics for each of those countries (20). 
The global community has witnessed changes within foodborne pathogens regarding type 
of illness, severity and the impact they have in the population worldwide. These changes are even 
more diverse across regions, countries and communities (2,8-10,7-74). The OzFoodNet Network 
has described the consequences of diseases potentially transmitted by food in Australia, including 
salmonellosis; absenteeism from work and the associated costs involved in the actual clinical 
condition translate into a recognizable burden on the economy (36,37). 
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This chapter examines the general burden of foodborne disease caused by Salmonella and 
its complexity, including the variety of pathogens member of this group, which can be transmitted 
through food causing a diverse array of resulting health outcomes. Its analysis would potentially 
contribute to the policy makers at the individual, population, government and industry level to be 
aware of the persistence of this situation and the need of more accurate management decisions in 
terms of control, prevention and surveillance.    
2.2 Global significance of bacterial foodborne diseases 
 
In 2007, the World Health Organization (WHO) established the Foodborne Disease Burden 
Epidemiology Reference Group (FERG), aiming to provide reliable estimates of the global impact 
of all food-borne diseases. Despite a lack of data from China, Latin America and the Middle East, 
it was reported that more than 5 billion episodes of diarrhoea were recorded annually among the 
<5 years old global population, resulting in an estimated 1.15 million deaths a year in South East 
Asia and Africa (8-9,12). But the problem was not limited to developing countries as might be 
expected due to the nature of foodborne illness: 419 million episodes of diarrhoea were recorded 
annually in Europe and 455 million in North America, with under-reporting acknowledged as a 
limitation of these estimates (8-9,12). 
This latest report included data analysis between 2007 and 2015, stating foodborne illness 
as a public health problem of major significance. Even more, it has been made clear that certain 
chronic diseases that result from contaminated food consumption can appear long after ingestion; 
as expected, the causal link is never made for these cases (9,12). 
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2.3 Global role of foodborne Salmonellosis 
 
Salmonellosis is an important public health problem cause of important morbidity, in 
addition to also having a significant economic impact worldwide (13,15,75). Although most 
infections cause mild to moderate self-limited disease, death occurs in those patients with severe 
infections. In the United States (US) it is estimated that 1.4 million non-typhoidal Salmonella 
(NTS) infections with 400 deaths occurs annually (8-9,12,15,76). The infective dose is usually 
high, but the bacteria grow well in most food. In food with a high fat content, e.g. chocolate and 
cheese, the infective dose is very low, and just a few bacteria may be sufficient to cause infection 
(77).  
The patient’s susceptibility to infection is variable. For instance in infants, elderly or 
immune-compromised hosts, the critical infective dose is lower. The onset of disease is often 
classified as acute, with an incubation period of 1 – 3 (range less than 1 – 10) days, involving 
general gastro enteric symptoms such as diarrhoea, nausea and vomiting (77). The carrier state is 
normally 4–6 weeks, but a few cases may be asymptomatic carriers for months or even years. No 
vaccine is available against non-typhoidal salmonellosis (78). Infection with NTS is generally 
limited to a specific intestinal event. However, the presence of virulence plasmids has been 
associated with non-typhoidal Salmonella spp. surviving in phagocytes and spreading from the 
small intestine to the spleen and liver (79). Salmonella species are also capable of producing a 
heat-labile enterotoxin, resulting in the loss of intestinal fluids, causing diarrhoea. This enterotoxin 
is closely related functionally, immunologically and genetically to the toxin of Vibrio cholerae 
and the heat labile toxin of pathogenic Escherichia coli (72,80).  
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According to the Food Review from the Foodborne and Diarrheal Diseases Branch at the 
USA Centres for Disease Control and Prevention (CDC), the global human health impact of non-
typhoidal Salmonella infection (NTS) can be as high as 108 cases and over 155,000 deaths yearly. 
Many of these cases could be prevented by rapidly identifying sources, which would translate into 
early public health interventions (12,15,71,74). The actual costs associated to this event are clear 
through several reports from different countries worldwide. The annual cost of foodborne illnesses 
in Sweden, according to was estimated to be 1,082 million Swedish krona (US$123 million) (81). 
Other authors also described that the Danish society saved U.S. $25.5 million by controlling 
Salmonella in 2001 (5,11,76). In Australia, the total cost of foodborne illness according to the 
Australian Government Department of Health and Ageing (2006) is estimated at $1,249 million 
per annum and for Salmonella infections in particular it costs an estimated $1,387 per notified 
infection. There is thus a global need to focus efforts on reducing transmission of Salmonella 
infection by food and other routes (24,36-27-28). 
Salmonellosis is described in the latest FERG report (WHO, 2015) as one of the most 
important causes of food-borne disease, resulting in significant economic burden affecting the 
population and health care systems. Accurate estimates of the burden of diarrheal diseases caused 
by Salmonella species and other foodborne pathogens are needed to effectively set public health 
goals and allocate resources to reduce disease burden (9,12). In general, but also applicable to the 
Salmonella related cases, laboratory-based surveillance provides useful, however only estimated 
based on confirmed cases, information.  Epidemiological surveillance alone cannot confirm cases, 
rather providing estimates of probable cases that are subsequently confirmed by laboratory testing 
(82-83).  
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For information associated with an illness to be recognized within a laboratory-based 
surveillance system, patients must seek medical assistance and submit a specimen for laboratory 
testing (83). The laboratory must test for the pathogen and report a positive finding to the relevant 
public health authorities. Taking all these steps into consideration, it is not difficult to conclude 
that cases in laboratory-based surveillance represent only a small fraction of the total community 
cases (84-86). These cases, which actually get access to testing, are usually associated only to 
specific subgroups within the general population and thus do not accurately represent the global 
burden for the condition. Regardless the region, country or population involved, reportable disease 
data are a key information source for determining the epidemiology of notifiable illnesses (87). 
Current global connections based upon travelling and migration; food production chain; 
environmental factors as well as sociocultural elements associated to each community and country 
are additional factors involved in the presented picture (85-86,88-89).  
2.4 Taxonomy of Salmonella 
 
 Salmonella are motile, non-spore forming, Gram negative, facultative anaerobic bacilli, 
usually of 0.7-1.5 x 2.5 µm in size, which belong to the family Enterobacteriaceae (105). Members 
of the genus Salmonella are described as able to grow well on simple media but almost never 
ferment lactose or sucrose. Optimum pH for growth between 6.5 – 7.5, however Salmonellae can 
proliferate in the range of pH 4.5 – 9.5 (87). They form acid and sometimes gas from glucose and 
mannose (106-107). They usually produce hydrogen sulphide (H2S) on triple sugar iron and 
decarboxylate lysine and ornithine, and able to hydrolyse indole and urea. Also, they are oxidase 
negative and catalase positive, generally able to reduce nitrate to nitrite, to grow on citrate as sole 
carbon source (107).  
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According to the literature, Salmonellae survive freezing in water for long periods of time 
and are resistant to brilliant green, sodium tetrathionate and sodium deoxycholate, which inhibit 
other enteric bacteria (108-109).  
The role of Salmonella in foodborne disease was first documented in the late 1800s when 
the bacterium was discovered by Eberth and cultured by Gaffky in 1885 (45). However, the 
association between Salmonella and human clinical disease, in the form of typhoid, dates back to 
the beginning of that century. Salmonella was originally designated Bacillus cholerae-suis and 
later isolated by an American veterinary pathologist, D.E. Salmon, from pigs suffering hog 
cholera. Similar organisms (Bacillus cholerae-suis) had previously been isolated from outbreaks 
of foodborne disease and infected animals. It was Salmon, together with Smith, a co-worker, who 
first successfully isolated the subsequently named Salmonella cholerasuis from pigs (45). In order 
to classify these organisms and in honour of D.E. Salmon, the genus Salmonella was created by 
Lignières in 1900.  
Salmonella can be serologically classified into “serovars”, also called serotypes, on the 
presence and/or absence of O (somatic) and H (flagella) antigens. The “H” antigen (the flagella) 
derives from the German word “hauch” (breath), first used to describe the swarming of highly 
motile organisms. “O” derives from the German word ‘ohne’ (without), first applied to non-
swarming (i.e., nonfagellated) bacteria, but now used as a generic term for the LPS somatic 
antigens of enteric bacteria including Salmonella. The Vi antigen was thought to be responsible 
for virulence (90). The serotyping technique is based on the serologic classification determined 
using an array of specific antisera. Historically, although “serotype” and “serovar” have both been 
frequently used, according to the Rules of the Bacteriological Code (1990) established by the 
Judicial Commission of the International Committee on the Systematics of Prokaryotes, the term 
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“serovar” is preferred to the term “serotype”. Kauffmann proposed that each serovar be considered 
a separate species (91-92).  
Salmonella serovars identified after 1966 were designated mainly by their antigenic 
formula and existence of several species within the genus Salmonella was generally accepted. 
However, some clinically relevant Salmonellae identified before 1966 had been given specific 
names either according to the disease and/or the animal from which the organism was isolated, for 
example S. Typhi and S. Typhimurium. Other Salmonellae were named for the geographical area 
where the strain was first isolated, e.g., S. London and S. Panama (93). These names had been used 
for a number of years and therefore were adopted without being amended into the new antigenic 
formula system. Kauffman and Edwards then proposed the creation of Salmonella enterica, 
including all Salmonellae (94-95). Subsequently, a similar three-species model was proposed, with 
“Salmonella enteritidis” representing all serovars other than S. Typhi and S. choleraesuis. Another 
proposal arose in 1970, which recommended that Kauffmann’s “subgenera” be considered a 
species, i.e., “S. kauffmannii” for “subgenus” I, S. salamae for “subgenus” II, S. arizonae for 
“subgenus” III, and S. houtenae for “subgenus” IV (96).  
However, in 1973, on the basis of DNA-DNA hybridization experiments, it was 
demonstrated that all Salmonella strains should belong to a single species (97). In 1982, on the 
basis of numerical taxonomy and DNA relatedness studies, the name “Salmonella choleraesuis” 
was proposed for the single Salmonella species and six subspecies were defined (98-99). In 1989, 
a single exception was described: one of the subspecies, Salmonella choleraesuis subsp. bongori, 
was separated from the other subspecies as a unique Salmonella species due to differences 
demonstrated by DNA relatedness studies (100). This classification proposal using the 
“cholerasuis” nomenclature as a name for species and serovar caused confusion, so in 1986 
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“Salmonella enterica” was again proposed against the type species of Salmonella by the 
Subcommittee of Enterobacteriaceae of the International Committee on Systematic Bacteriology 
at the XIV International Congress of Microbiology (101). 
Le Minor and Popoff of the World Health Organization (WHO) Collaborating Centre 
formally made the proposal to the Judicial Commission of the International Committee of 
Systematic Bacteriology in 1987. The word “enterica” was recommended because it had not been 
used before for a serovar nomenclature. It was also proposed that the seven subgenera of 
Salmonella be referred to as subspecies (subspecies I, II, IIIa, IIIb, IV, V, and VI). Subgenus III 
was divided into IIIa and IIIb by DNA similarity and phenotypic characteristics. The suggestion 
was accepted by the Centres for Diseases Control and Prevention (CDC) and other experts and 
laboratories but there were concerns about new nomenclature and serovar Typhi been overlooked 
(96). On this same matter, in 1999 Euzéby made an amended request to use “Salmonella enterica” 
as the type species of Salmonella and reserve the name “Salmonella Typhi” to reflect its clinical 
importance.  
Only until 2002, the real discussion took place, with a final 2005 approval: “Salmonella 
enterica” would replace “Salmonella choleraesuis” to become the type species of the genus 
Salmonella (94). Still, the names of some medically relevant serovars, such as Typhi, 
Typhimurium and Enteritidis were kept due to their frequent use. In summary and based in later 
publications, the genus Salmonella consists of three species namely: Salmonella Enterica, 
Salmonella Bongori and Salmonella Subterranean (95). A general overview of the current 
established classification for the genus Salmonella is visualised in Figure 2.1. 
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Figure 2.1. Current classification of Genus Salmonella 
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The Kauffman–White Scheme, as first published in 1929 and previously described in this 
Chapter, currently divides Salmonella based on their serological reactions to somatic 
lipopolysaccharide (O), flagellar (H) and capsular (Vi) antigens (79). These Salmonella serovars 
can also be subdivided into the three following host range types that also influence clinical 
manifestations/presentations (98):  
(i) host generalist (ubiquitous serovars) include Salmonella enterica serovar Typhimurium 
(S. Typhimurium) and S. Enteritidis that cause infections in diverse human and animal 
hosts; they produce a range of clinical symptoms but mainly acute and self-limiting 
gastroenteritis (102). 
(ii) host-adapted Salmonella (confined to a small number of hosts) such as S. Dublin in 
bovine animals and S. Choleraesuis in swine results in systemic infections, but these 
serovars can also infect humans and a limited number of other species (103). 
(iii)  host-restricted Salmonella are associated with severe systemic infections in a single 
host: S. Typhi and S. Paratyphi cause enteric fever exclusively in man while S. 
Typhisuis causes paratyphoid in swine, S. Gallinarum causes typhoid in fowl and S. 
Abortusovis causes abortions in sheep (104). 
Of clinical relevance in human infection is Salmonella enterica, which is divided into six 
subspecies: S. enterica subspecies enterica (subsp. I), S. enterica subspecies salamae (subsp.II), S. 
enterica subspecies arizonae (subsp. IIIa), S. enterica subspecies arizonae (subsp IIIb), S. enterica 
subspecies houtenae (subsp. IV), and S. enterica subspecies indica (subsp. VI). Table 2.1 
represents a summary of current nomenclature and taxonomic position of Salmonella (110). 
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Table 2.1. Taxonomic classification (writing format) and nomenclature for Salmonella spp. 
Genus 
(capitalize, 
italic) 
Species (italic) Subspecie 
(italic) 
Serovar (or 
serotype)  
No. of serovars 
is each species 
or subspecies 
Salmonella Enterica enterica 
(subspecies I) 
Cholerasuis, 
Enteritidis, 
Paratyphi, Typhi, 
Typhimurium 
1504 
  salamae 
(subspecies II) 
9,46:z:z39 502 
arizonae 
(subspecies IIIa) 
43:z29:- 95 
diarizonae 
(subspecies IIIb) 
6,7:l,v:1,5,7 333 
houtenae 
(subspecies IV) 
21:m,t:- 72 
indica 
(subspecies VI) 
59:z36:- 13 
Bongori subspecies V 13,22:z39:- 22 
Subterranean    
 
Within these subspecies, the various existing serovars used today to further classify each 
Salmonella, are based on the use of the antigenic classification system. The WHO Collaborating 
Centre for Reference and Research on Salmonella at the Pasteur Institute, Paris, France is 
responsible for updating the scheme. Every year newly recognized serovars are reported in the 
journal Research in Microbiology. In the latest report, there were a total of 2,541 serovars in the 
genus Salmonella (111). Serotypes may be said to be ‘host adapted’ if they are prevalent in one 
particular host, and also able to colonize and perhaps cause disease in other hosts. Serotypes 
adapted to man, such as Salmonella Typhi and Salmonella Paratyphi, usually generate severe 
septic typhoid syndrome (enteric fever) in humans and these serotypes are not usually pathogenic 
to animals (112-113). Ubiquitous serotypes, such as S. Enteritidis or S. Typhimurium, affect both 
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man and animals. Salmonella subspecies enterica include S. enterica serovar Typhi that causes 
typhoid fever, however, non-typhoidal salmonellosis (NTS) is caused by Salmonella species other 
than S. Typhi and S. Paratyphi (114). For a small number of serotypes, biochemical reactions or 
reactions against capsule proteins (Vi antigens) are also included. According to the established 
annotation, the antigenic formula is written with numbers and letters, with antigenic groups 
separated by colons. Each antigenically distinguishable Salmonella possesses a specific O (cell 
wall) and H (flagellar) antigen; many express alternate phase flagella of two antigenic types (H1 
and H2) and a few produce Vi (capsular) antigen (47).  
Each Salmonella serovar is therefore recognized by its unique combination of antigens (its 
antigenic formula), and each serotype was accorded species status. For example, the antigenic 
formula for the serotype Typhimurium is 1,4,5,12:i:1,2 because it carries an LPS protein reacting 
against the 1,4,5, and 12 antisera and the i phase I H antigen and the 1,2, phase II H antigen (71). 
Currently there are 67 O-antigens and 117 H-antigens that have been identified (47,95-96). The 
addition of the antigenic formula by national and international reference laboratories imparts more 
precise information about the isolates. Table 2.2 summarizes some of the most common 
Salmonella serovars and their antigenic formula. 
 
 
 
 
 
24 
 
Table 2.2 Some of the most common Salmonella serovars and their antigenic formula 
 
O 
Group 
                       
                      Serovar 
 
 
O 
somatic 
antigen 
 
Vi 
antigen 
 (if 
present) 
 
H  
flagellar 
antigen 
(phase 1) 
 
H 
flagellar 
antigen 
(phase 2, 
if 
present) 
        
    
Antigenic      
formula* 
 
 
D 
 
Salmonella 
Typhi 
 
  9,12     Vi     D -     9, 12 (Vi): d: 
- 
 
A 
 
Salmonella 
ParaTyphi A 
 
1,2,12       -     A         -     1, 2, 12: a: – 
 
 C1 
 
Salmonella 
Cholerasuis 
 
 
6,7                      
    
-
 
    c         
 
      1,5 
     
     6, 7:c: 1,5 
 
B 
 
Salmonella 
Typhimurium 
 
 
1,4,5,12                 
 
-
 
    I 
 
      1,2 
    
1, 4, 5, 12: i: 1, 
2 
 D Salmonella 
Enteritidis 
 
1,9,12       -   g,m         -    1, 9, 12: g, m: 
- 
 
  *O antigens: boldface numerals 
 (Vi): Vi antigen, if present 
 H antigen (Phase 1): lower case letter 
 H antigen (Phase 2, if present): numeral 
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2.5 Challenges of laboratory identification of Salmonella 
 
When requested by a clinician, the specimen is plated on selective media such as 
Salmonella-Shigella (SS) agar, Hektoen enteric agar, xyloselysine desoxycholate (XLD) agar or 
desoxycholate-citrate agar, which favour growth of Salmonellae and shigellae over other 
Enterobacteriaceae. Chromogenic agars specifically for Salmonella recovery are also available 
(97). The specimens are also often inoculated into the selenite F or tetrathionate broth, both of 
which inhibit replication of normal intestinal bacteria and permit multiplication of Salmonellae. 
After incubation for 1 – 2 days, the cultured isolate plated on differential and selective media for 
proper identification and classification. In order to ensure an adequate and accurate identification 
of each organism, a maximal recovery of Salmonella from faecal specimens must be obtained by 
using an enrichment broth. However, sensitivity of stool culture for recovery of Salmonella spp. 
is estimated to be only 70 % (114).  
For the past 25 years, there has been an urgent need to develop faster methods to detect, 
identify and subtype Salmonella, specifically in clinical, food and environmental samples. For 
clinicians and clinical laboratories, the ideal test should be fast and accurate. Public health 
associated practitioners on the other hand, value tests that are fast and accurate, generally 
emphasize on accuracy more than speed, often needing more detailed information regarding 
isolates than clinicians do in order to epidemiologically link cases (4). For decades, the mainstream 
of diagnostics for enteric pathogens such as Salmonella has been through the use of culture. Most 
surveillance systems define a case as a culture-confirmed infection. Often isolates are submitted 
from clinical diagnostic laboratories to public health laboratories where further characterization is 
performed (115). 
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Despite traditional serotyping widespread use, it does have a number of drawbacks. 
Serotyping of Salmonella takes around 3 days to complete, is labour intensive, requires the 
maintenance of over 250 typing sera and 350 different antigens, and is unable to type rough or 
mucoid strains. Rough strains are incapable of expressing the O antigen, whereas in mucoid strains, 
it is common to observe the presence of a capsule that prevents the immunologic detection of the 
O antigen. These strains are known as variants of serotypes that don’t express all the general 
antigenic characteristics, and could be classified as variants among serovars, due to the absence of 
the recognized antigens which are characteristic for particular serovars. 
Furthermore, traditional serotyping is often not sensitive enough to provide the level of 
discrimination needed for food-borne illness outbreak investigations, and it cannot be used to infer 
phylogenetic relationships (116). Although traditional culture based methods detect “viable” 
bacterial cells, they do not detect potentially infectious non-culturable cells, and these techniques 
are time consuming, labour intensive, and not specific enough to detect and characterize 
Salmonella at the strain level, particularly when a large number of samples are involved (106). 
 Current testing of food and environmental samples for the presence of Salmonella can be 
divided into three stages: (i) detection of the pathogen; (ii) identification of the isolate as 
Salmonella and its specific serovar designation; and (iii) subtyping of the isolate for association 
with any clinical cases of salmonellosis (117-118). Confirmation relies on traditional biochemical 
testing of sugar and nutrient utilization media, which can take days to complete. Even with newer 
automated technologies that permit simultaneous testing of multiple samples, at least 24 hours are 
needed for a confirmation of Salmonella (117). The largest advance towards faster detection of 
Salmonella has been associated with molecular biology, where PCR and real-time, quantitative 
PCR (qPCR) are predominantly being applied as the methods of choice for the detection stage of 
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this process. Many different protocols targeting different genes or gene regions specific to 
Salmonella have been published (118-119).  
 Most laboratories have adopted culture-independent methods; this decision has been based 
mostly on the speed factor and also, in some cases, considering that these methods can provide 
more types of information than were previously available (120-121). However, specimens 
collected for culture independent testing may, in some cases, be incompatible with culture. In 
addition, performance characteristics of culture independent tests are variable and different from 
those of culture (122-123). Culture-independent tests for bacterial enteric pathogens include 
nucleic acid amplification tests such as PCR and antigen-based methods such as enzyme 
immunoassays and lateral flow assays. Culture often requires multiple days, whereas some culture-
independent methods yield results in approximately one day. Although culture-independent test 
materials may be more expensive, they often yield cost savings by reducing the need for highly 
trained microbiologists. It also has the potential for ease of use and lower cost, therefore its 
adoption may increase the number of tests performed and, hence, the number of cases ascertained. 
Some tests might also detect pathogens that are not detectable using culture (120). Additionally, 
many targets have been investigated for the specific and sensitive detection of all Salmonellae in 
food and environmental samples. Though speed is the main advantage for PCR/qPCR assays, there 
are disadvantages to consider (Table 2.3). Advanced molecular and immunological methods 
require only a few hours on average to detect the target pathogen from food samples compared to 
3 - 4 days using conventional culture-based methods (123). 
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Table 2.3 Comparison of traditional methods to molecular methods for Salmonella detection, 
identification and subtyping. (From: Bell et al, 2016. Recent and emerging innovations in 
Salmonella detection: a food and environmental perspective. Microbial Biotechnology (2016) 
9(3), 279–292). 
Technical competency 
Method Resolving 
power 
Accuracy Performance Analysis Time to resolve 
PFGE Sub-serotype 100%d Highly 
trained/must be 
certified 
Highly 
trained/must be 
certified 
1 – 3 days 
Traditional 
serology 
Serotype Approx. 80%e Highly 
trained/must be 
certified 
Highly 
trained/must be 
certified 
Up to 3 days 
Phage typinga Sub-serotype Approx. 80%f Highly 
trained/must be 
certified 
Highly 
trained/must be 
certified 
1 – 2 days 
PCR/qPCR Genus to 
serotypeb 
Varies with 
protocol and 
matrixg 
Moderately 
trained 
Moderately 
trained 
4 – 6 hours 
MALDI-TOF Species >98% at species 
levelh 
Easy for clinical 
workflow 
Easy for clinical 
workflow 
< 5 minutes 
LC-MS Serotype to sub-
serotype level 
98% at serotype 
level 
Moderately 
trained 
Highly trained < 1 day 
WGS Strain 100% Easy to perform Highly trained 3 – 4 daysj 
Metagenomics Genus to strainc Approx. 11%i Easy  to perform Highly trained 3 – 4 daysj 
a Only used for S. Typhi, ParaTyphi A, Typhimurium and Enteritidis 
b Depends on primers and matrix set used; some only detect genus, some serotypes 
c Depends on sequencing depth, analysis pipeline and available database to query against 
d If performed with Pulse Net certification standards 
e Due to rough, mucoid and non-motile strains  
f Due to ambiguous  lysis reaction 
g Must have a minimum of 102 genomes in the reaction in order to get a positive detection 
h Based on single lab evaluation studies 
I Based on current pipelines and databases in naturally contaminated cilantro (Jarvis et al, 2015) 
j Depending on analysis time 
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2.6. Clinical and public health relevance of Salmonella serovars 
 
Worldwide Salmonella infections, excluding those caused by S. Typhi and S. Paratyphi, 
were estimated in 2010 to cause 93.8 cases of gastroenteritis per year million (90% credible 
interval 61.8–131.6 million), 80.3 million of which are considered foodborne (9,12). According to 
FERG’s 2015 report, NTS infections, when translated into global burden and its numerical location 
regarding association with foodborne illness, are located in the area associated with relatively low 
individual impact (DALYs per foodborne case) but having a high impact on a global spectrum (9). 
In the USA, over 1,000 different Salmonella serotypes were reported from 2002 to 2006, however 
the 100 most common serotypes accounted for about 98 % of the isolates (12). NTS have never 
been only present on developing countries. In fact, Salmonella causes approximately 1.4 million 
human infections each year in the United States, resulting in 116,000 hospitalizations and 600 
deaths (2-3,15). Additionally, to commonly being associated with gastrointestinal illness, 
Salmonella can cause extra-intestinal infections. S. Typhi, S. Paratyphi, S. Choleraesuis and S. 
Dublin are the major serotypes, which cause invasive salmonellosis in humans (15). These invasive 
Salmonella infections may be life threatening. However, secondary bacteraemia and meningitis 
have been described appearing in less than 10% of cases. Antibiotic therapy would be needed in 
these severe situations (124). S. Typhimurium, S. Enteritidis and S. Heidelberg, are associated with 
a relatively low proportion of invasive infections; however, the total number of invasive cases 
caused by these serotypes appears to be high because they are relatively prevalent among the whole 
Salmonella population (125). 
Despite the improvement in sanitation and hygiene, NTS illness continues to impose a 
significant burden on the population’s health in industrialized and underdeveloped countries. It is 
estimated that 93.8 million cases of gastroenteritis due Salmonella spp. occur worldwide leading 
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to 155,000 deaths each year (9,12). The referred as “extreme age patients”, as well as those with 
immune suppression or accompanying severe infections such as meningitis, septic arthritis and 
osteomyelitis, would be at higher risk of developing extra intestinal salmonellosis complications 
(1). FERG latest report describes the ubiquitous presence of NTS through different regions across 
the globe. These regions include all different continents, involving cases from countries originally 
from developing as well as developed regions. It is interesting how the proportion of illness 
associated with NTS is higher among the regions of Europe, America and the Western Pacific 
Regions (9,12).  
Although children <5 years of age represent only 9% of the global population, 43% of the 
disease burden from contaminated food occur in this group. Foodborne illnesses from diarrheal 
and invasive NTS resulted in the largest disease burden, reflecting the ubiquitous nature of 
Salmonella, the severe nature of illness, and the fact that young children are commonly infected 
(1,2). In these patients, the duration of diarrhoea was estimated to be 4.9 days (minimum of 4.3 – 
maximum of 8.4 days). In patients over 5 years old, the duration of NTS diarrhoea was 2.8 days 
(1). Mortality rates vary through regions, as it has been stated earlier on this revision.  
WHO classifies countries/regions as medium to high-risk mortality countries and also low 
mortality countries, which could also reflect the availability and access to adequate health care. 
Low mortality countries and/or regions include Europe (i.e France, Netherlands), Australia, New 
Zealand and the United States of America. Medium to high-risk mortality countries/regions 
include Africa, Asia and Latin America, with no particular gender distribution in any 
epidemiologically related aspect, though there are differences in terms of dietary habits in some 
populations according to gender (9,11,12). Case fatality rates have been associated with several 
and very different risk factors. These are distributed in different levels according to the country 
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and the population involved in the analysis and include those strictly related to the patient’s 
immune status, the presence of other gastrointestinal pathologies such as diarrhoea and 
malnutrition as well as cultural habits in terms of food consumption. 
Additionally, different Salmonella serovars may differ in their invasiveness and risks of 
mortality. Also, the reports of unsafe food handling, mostly in terms of food preparation and lack 
of cross-contamination prevention, are some of the other confounding factors which have helped 
maintaining the presence of Salmonella serovars through different regions across the world. 
Serovars Enteritidis and Typhimurium are the most common in the UK (http://www.hpa.org.uk). 
Their distribution and presence globally is associated to numerous factors (11). In Africa according 
to public health statistics, S. Enteritidis and S. Typhimurium represent 26% and 25% of the isolates 
respectively. In Asia, Europe and Latin America/Caribbean, S. Enteritidis is the most frequent 
isolate (38%, 87% and 31%, respectively). 
In North America, S. Typhimurium is the most frequented reported (29%) followed by S. 
Enteritidis (21%) and other Salmonella spp. (21%) (6,17). This statistics contrast with information 
belonging to other regions such as Asia, where NTS invasive disease is quite rare, with the 
exception of patients suffering from severe immunosuppression (19,22). In Australia, the most 
common serovar is S. Typhimurium, which is also the most commonly identified etiological agent 
associated with NTS outbreaks (27,32-33-36). Other serovars which are highly incidental in other 
reasons, such as S. Enteritidis, are not endemic in Australian poultry layer flocks and most human 
infections with S. Enteritidis are acquired overseas (25-27,30). Many other serovars occupy 
particular ecological niches and epidemiological foci in Australia, mostly due to the fact that it is 
a large country with wide climatic and geo-physical variation across all its regions/states (7). 
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 In general, and according to annual reports, Salmonellosis is highly seasonal in Australia 
with October being the start of the high season for its presentation. It is also tracking towards a 
record number of notifications in 2016, with 3,011 notifications over the last quarter which is 1.3 
times the quarterly rolling five year mean of 2,352.4. Since 2000, the Australian Government 
established OzFoodNet, a foodborne disease surveillance system, to improve national surveillance 
and conduct applied research into the causes of foodborne illness. This entity analyses national-
level information on the incidence of diseases caused by pathogens commonly transmitted by food, 
Salmonella included, as well as investigating foodborne disease outbreaks across the country (35-
37,126-128). Organizations such as the Public Health Laboratory Network (PHLN), Food 
Standards Australia New Zealand (FSANZ), the Department of Agriculture, Fisheries and Forestry 
as well as the National Centre for Epidemiology and Population Health at the Australian National 
University, are part of the OzFoodNet network. Its role, collaborating on the presentation of 
surveillance data, allows the characterization and comparison of the foodborne disease problem in 
Australia  (1,9,28).  
 STM is the most common Salmonella serotype in New South Wales (NSW). According to 
OZFoodNet yearly reports, it regularly accounts for over 50% of all NSW Salmonella notifications 
and also a large number of Australian foodborne outbreaks. The NSW Salmonella surveillance 
system involves a complex network of local and interstate laboratories and notification processes. 
Local primary laboratories identify Salmonella species (spp.), while serovar confirmation as well 
as subtyping occurs at the closest reference laboratory. STM-induced salmonellosis follows a 
typical seasonal pattern with an increase in cases during warmer months. There is a decrease on 
notifications during winter months, which is also applicable to STM (37).  
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 According to the NSW Public Health Bulletin, the majority of cases of human 
salmonellosis are caused by a small number of serovars (40-41). The 10 most common serovars 
identified by the NSW Enteric Reference Laboratory between 2010 and 2015 are listed in Table 
2.4. These 10 most common serovars across NSW account for a range of 64.2 – 79% of all 
identified isolates. 
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Table 2.4 Ten most common Salmonella serovars isolated from humans and identified in the NSW 
between 2010 and 2015 
Ranking 2010 
(n = 3,744) 
2011 
(n = 3,473) 
2012 
(n= 2,945) 
2013 
(n= 3,420) 
2014 
(n= 4,300) 
2015 
(n= 4,052) 
1 STM 
untyped 
(19.4%) 
STM 
(56.8%) 
STM 
(53.3%) 
STM 
(52.8%) 
STM 
(59.2%) 
STM 
(42%) 
2 STM – PT 
170 
(14.6%) 
S. Enteritidis 
(5%) 
S.Enteritidis 
(5.2%) 
 
S.Enteritidis 
(4.4%) 
S.Enteritidis 
(3.6%) 
S.Enteritidis 
(4%) 
3 S. enterica – 
unknown 
serovar 
(8%) 
S. Virchow 
(4.6%) 
Monophasic 
(ser. 
4,5,12:i-)# 
(3.5%) 
S. Virchow 
(3.3%) 
S. Virchow 
(2.8%) 
S. Saint Paul 
(3.3%) 
4 STM 
(untypable) 
(6.4%) 
S. Wangata 
(2.6%) 
S. Virchow 
(2.9%) 
S. ParaTyphi B 
bv Java 
(2.3%) 
S. ParaTyphi 
B bv Java 
(2.3%) 
S. Java 
(3%) 
5 STM – PT 9 
(5%) 
S. Infantis 
(2.1%) 
S. ParaTyphi 
B bv Java 
(2.8%) 
S. Infantis 
(2.2%) 
S. Wangata 
(2%) 
S. Virchow 
(2.5%) 
6 S. Infantis 
(3.9%) 
S. ParaTyphi B 
bv Java 
(2.1%) 
S. 
Birkenhead 
(2%) 
S. Wangata 
(2.2%) 
S. Infantis 
(1.9%) 
S. Birkenhead 
(2.3%) 
7 S. 
Birkenhead 
(2.8%) 
S. Birkenhead 
(2%) 
S. Singapore 
(1.9%) 
S. Birkenhead 
(2.1%) 
S. Birkenhead 
(1.8%) 
S. Wangata 
(2%) 
8 STM – PT 
135 
(2.1%) 
S. Saint Paul 
(1.4%) 
S. Wangata 
(1.8%) 
S. Saint Paul 
(1.4%) 
S. Saint Paul 
(1.1%) 
S. Infantis 
(2%) 
9 S. 
Singapore 
(1.5%) 
S. 
Bovimorbificans 
(1.3%) 
S. Infantis 
(1.4%) 
S. 
Bovimorbificans 
(1.2%) 
S. Stanley 
(0.9%) 
S. 
Bovimorbifican
s 
(1.8%) 
10 S. 
Enteritidis- 
untyped 
(1.4%) 
S. Newport 
(1.1%) 
S. Saint Paul 
(1.2%) 
S. Stanley 
(1.2%) 
S. Chester 
(0.8%) 
S. Stanley 
(1.3%) 
(n = number of records for that year. The percentage of each Salmonella serovar for the year is 
given in brackets. This information was obtained from OzFoodNet-Enhancing Foodborne Disease 
Surveillance across Australia. NSW OzFoodNet Annual Report 2010, 2011, 2012, 2013, 2014 and 
2015.)            
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Since it is a heterogeneous serovar, additional molecular subtyping methods are needed in 
order to identify and relate specific strains to specific outbreaks. Within the different subtyping 
techniques available, MLVA (Multilocus variable-number tandem-repeat) typing appeared as a 
rapid alternative to successfully differentiate strains. In fact, in 2006 and 2007, routine STM 
MLVA subtyping was implemented in Queensland and NSW respectively and though is about to 
be superseded by newest tests and methods, it is still the performed typing method for STM (26).  
2.7 Current characterization of Salmonella for public health surveillance 
 
 Emerging technologies such as Next Generation Sequencing (NGS) offer big opportunities 
providing even more rapid and accurate detection and genetic characterization of various 
Salmonella (118). Costs will remain relatively higher than currently available rapid methods until 
further technological and commercialization development occurs and may still require skilled 
technical and computer support to conduct analysis of the massive data sets (129). Currently, WGS 
requires a pure culture for the generation of a complete genome sequence, making the pathogen 
detection directly from food or another samples a challenge (130).  
 Several approaches for molecular detection and characterisation of Salmonella have 
emerged, including PCR-based, from the current genomics era. All of these methods propose to 
generate more efficient automation and data management, with an eventual final goal of a fully 
automated laboratory diagnostics workflow, with outputs from one approach strengthening other 
approaches, being directly or indirectly related (131-132). In Australia, all laboratory-confirmed 
Salmonella infections are reported to state and territory health departments, and subsequently to 
the National Notifiable Diseases Surveillance System (NNDSS).  
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 In Australia, the Public Health Laboratory Network (PHLN) has developed a standard case 
definition for the diagnosis of diseases, which are notifiable in Australia. In this particular case, 
the “confirmed laboratory case definition” for Salmonella distinct two distinct syndromes: enteric 
fevers (typhoid and paratyphoid fevers) and gastroenteritis/salmonellosis, where the other over 
2,500 serovars are classified. It requires of laboratory confirmation testing to be performed before 
notifying the public health authorities (40). This confirmation includes preliminary serology at 
public or private clinical laboratories, followed by confirm/biochemical identification, complete 
serological identification, and any other specific subtyping method to narrow down the 
identification step. Particularly in New South Wales (NSW), primary laboratory diagnosis of 
salmonellosis is usually made through the culture of stools and protocols stay close to the general 
previously made description (29,40-42).    
 The most common subtyping methods currently in use are the pulse-field gel 
electrophoresis (PFGE) and multiple loci sequencing typing (MLST) (52,133). PFGE is based on 
the separation of chromosomal DNA fragments after restriction enzymatic digestion. MLST is 
based on sequencing analysis of particular house-keeping genes and it has higher discriminatory 
power, excellent data analysis capability and, in contrast to PFGE, it has higher reproducibility 
between laboratories (134-143). Public as well as private diagnostic laboratories submit 
Salmonella cultures for serotyping to the NSW Enteric Reference Laboratory (ERL) at the Centre 
for Infectious Diseases and Microbiology Laboratory Service (CIDMLS), NSW Health Pathology. 
All isolates are tested to confirm their identity. The traditional tube methods of biochemical testing 
are the gold standard for reference laboratories (40-41). Though serovar identification within 
Salmonella is not relevant for patient’s management, it is an important piece of information for 
epidemiological and outbreak investigation. For those common and successful serovars further 
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subtyping including the use of molecular based techniques such as multilocus variable-number 
tandem-repeats analysis (MLVA) are needed and have been implemented, becoming the method 
of choice in several laboratories worldwide till date (37,40-41, 127).  
 In Australia, the Public Health Laboratory Network (PHLN) has developed a standard case 
definition for the diagnosis of diseases, which are notifiable in Australia. In this particular case, 
the “confirmed laboratory case definition” for Salmonella distinct two distinct syndromes: enteric 
fevers (typhoid and paratyphoid fevers) and gastroenteritis/salmonellosis, where the other over 
2,500 serovars are classified. It requires of laboratory confirmation testing to be performed before 
notifying the public health authorities (41). Laboratory confirmation includes preliminary serology 
at public or private clinical laboratories, followed by confirm/biochemical identification, complete 
serological identification, and any other specific subtyping method to narrow down the 
identification step. Particularly in New South Wales (NSW), primary laboratory diagnosis of 
salmonellosis is usually made through the culture of stools and protocols stay close to the general 
previously made description (37,41).  
 The traditional tube methods of biochemical testing are the gold standard for reference 
laboratories (42,45). Though serovar identification within Salmonella is not relevant for patient’s 
management, it is an important piece of information for epidemiological and outbreak 
investigation. For those common and successful serovars further subtyping including the use of 
molecular based techniques such as multilocus variable-number tandem-repeats analysis (MLVA) 
are needed and have been implemented, becoming the method of choice in several laboratories 
worldwide (43,44,144-146). Public Health England, the USA CDC, MDU in Victoria and NSW 
ERL all routinely perform Salmonella WGS. In NSW, this is a complementary analysis to the still 
up to date implemented MLVA typing (147). 
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2.8 Public health relevance of reservoirs of salmonellosis 
 
The vast majority of Salmonellae are primarily pathogenic in animals that constitute the 
reservoir for human infection; these include poultry, pigs, rodents, cattle and domestic pets (148-
150). The organism almost always enters via the oral route through contaminated food or drink. 
Its main niche is the gastrointestinal tract of humans and animals (151-152). Many animals 
including cattle, rodents and fowl are naturally infected with a variety of Salmonellae, having the 
bacteria in their tissues (meat), excretions or even eggs (150).  
Salmonella can be transmitted through the entire food chain from animal feed, primary 
production, and all the way to households or food-service establishments and institutions. In 
humans, salmonellosis is generally contracted through the consumption of contaminated food of 
animal origin (mainly eggs, meat, poultry and milk), although other foods including green 
vegetables contaminated by manure, have been implicated in its transmission under “cross 
contamination” (153-155). Salmonella spp. have a variety of animal reservoirs and routes of 
transmission that can result in human infection, including domestic or wild animal contact, human 
to human contact, water and soil (156). 
In Australia, approximately 72% of salmonellosis cases are estimated to be transmitted 
through contaminated food (157-158). Common foods associated with salmonellosis in outbreak 
investigations and source attribution studies include eggs, poultry meat, pork, beef, dairy products, 
nuts, and fresh produce (157,159). Salmonellae are difficult to eradicate from the environment. 
However, because the major reservoir for human infection is poultry and livestock, reducing the 
number of Salmonellae harboured in these animals would significantly reduce human exposure 
(160). For example, in Denmark, all animal feeds are treated to kill Salmonellae before 
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distribution, resulting in a marked reduction in salmonellosis. Other helpful measures include 
changing animal slaughtering practices to reduce cross-contamination of animal carcasses as well 
as vaccination of food production animals such as chickens (121). To control salmonellosis, 
education and communication must target not only food producers, but those who prepare and 
provide food products. Protecting processed foods from contamination, providing training in 
hygienic practices for all food-handling personnel in slaughterhouses, food processing plants, and 
restaurants, cooking and refrigerating foods adequately in food processing plants, restaurants and 
homes are some of the areas where action must be taken in order to achieve control over the risk 
of infection (83,84,121). 
2.9 Pathogenic determinants of Salmonella 
 
Most of the serovars with exception of Salmonella enterica serovars Gallinarum and 
Pullorum, present a peritrichous flagella (the ‘H’ antigen). This multiprotein complex grants the 
bacteria the necessary structures for swimming and swarming motility (159). Salmonella strains 
will typically express either of two sets of genes encoding the flagellar antigens, and two distinct 
H-antigen ‘phases’ are therefore said to exist, and both need to be expressed in order for the 
serotyping to be performed (89). The mean infective dose to produce clinical or subclinical 
infection in human is 105 – 108 Salmonellae. Host factors such as gastric acidity, normal intestinal 
microbiota and local intestinal immunity certainly contribute to resistance to Salmonella infections 
(115-116). Once ingested, Salmonella spp. must survive the low pH of the stomach, adhere to the 
small intestine epithelial cells and overcome host defence mechanisms to enable infection. 
Salmonella spp. possesses a number of structural and physiological virulence factors, enabling 
them to cause acute and chronic disease in humans (160).  
40 
 
The virulence of Salmonella spp. varies with the length and structure of the O side chains 
of lipopolysaccharide molecules located on the bacterial cell surface. Resistance of Salmonella 
spp. to the lytic action of complement (part of the immune response) is directly related to the length 
of the O side chain (161). Other important virulence factors include the presence and type of 
fimbriae, which determines the ability of Salmonella spp. to attach to host epithelium cells (148), 
as well as the expression of genes responsible for invasion of host cells (162-163). As shown in 
Figure 2.2, Salmonella will successfully invade non-phagocytic cells by inducing their own uptake.  
Virulence genes involved in invasion and those required for intracellular survival are 
clustered in large chromosomal DNA regions designated Salmonella pathogenicity islands (SPIs), 
which are defined as large gene cassettes within the Salmonella chromosome that encode 
determinants responsible for establishing specific interactions with the host, particularly associated 
with bacterial virulence (164-168). SPIs contribute to host cell invasion and intracellular 
pathogenesis. Currently, 12 SPI have been described, and though Salmonella subspecies and 
serovars may present differences in terms of SPIs size, structure, function and distribution, there 
are also several SPIs conserved throughout the genus (168). For example, SPI-1 is distributed 
among Salmonella spp. and required for bacterial invasion into the intestinal epithelial cells, while 
systemic infections and intracellular accumulation of Salmonella spp. are dependent on the 
function of SPI-2 (164-165). 
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Figure 2.2 Pathogenesis model of Salmonella enterica serovar Typhimurium. 1: Salmonellae 
attach to the intestinal epithelium using adhesins encoded within SPI-3 and SPI-4. 2 and 3: 
Invasion and engulfment of bacteria, mediated by virulence factors encoded within SPI-1 and SPI-
5. 4: alternatively, dendritic cells can directly take up bacteria from the sub mucosa layer. 5: Once 
inside the cytoplasm, Salmonella is located within the Salmonella containing vacuoles SCVs 
where it replicates. 6: The SCV releases the internal cells to the sub mucosa. 7: Bacteria are 
internalized within phagocytes and located again within a SCV. Finally, these phagocytes can 
disseminate through the lymph and blood stream. Figure from Salmonella enterica serovar 
Typhimurium skills to succeed in the host: virulence and regulation. (From: Fabrega A and Vila J. 
Salmonella enterica serovar Typhimurium skills to succeed in the host: virulence and regulation. 
Clin. Microbiol. Rev. April 2013; 26(2):308-341). 
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SPI-1 and SPI-2 encode type III secretion systems, consisting of multiprotein complexes 
in charge of building channels across the bacterial and epithelial cell membranes. These structures 
result in the efficient translocation of bacterial effectors directly into the epithelial cell cytoplasm, 
which after interaction with the cell’s own structures, are capable of altering the host cellular 
functions, resulting in intracellular bacterial survival and posterior colonization (168). Following 
invasion, Salmonella stays within a membrane compartment known as the Salmonella-containing 
vacuole (SCV; Figure 2.2), where the bacteria actively remodels this compartment and establishes 
itself, becoming capable of survival and replication (164-166). 
In other aspects, multiple antibiotic resistant strains of Salmonella have also emerged; one 
example is S. Typhimurium definitive phage type 104 (DT104). Multi-resistant S. Typhimurium 
ST 104 infects both humans and animals, such as cattle and sheep (169). To date, this organism is 
not endemic in Australia, although it is a significant health problem in European countries, North 
America, the Middle East, South Africa and South-East Asia. Similar situation applies to ST 34 
and its multiple antibiotic resistant profile (44). Salmonella spp. is one of the most commonly 
identified pathogens worldwide, able to cause a variety of infections in humans and animals (3).  
Due to the over 2,500 different serovars within the species S. enterica, typing methods for 
discriminating bacterial isolates from the same species, which used to be essential epidemiological 
tools, became insufficient due to their limited ability to examine the relatedness of isolates. 
Methods exploring at the molecular level became revolutionary, adding new tools for enhanced 
surveillance and outbreak detection. Depending on the setting, one or more genotyping methods 
might need to be considered. The following chapter describes the implementation and use of 
particular genotyping technologies for STM.   
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Chapter 3: Added value of genotyping of STM in disease control 
3.1 Introduction 
 
In Chapter 2, the taxonomy of Salmonella was discussed in detail, showing the complex 
classification and diversity involved within these organisms. The focus of this Chapter is 
Salmonella genotyping and the importance of it for public health control of salmonellosis. 
Traditional serotyping remains widely used, and the identification of Salmonella serovars remains 
an important public health diagnostic need (147). However, this technique presents several 
obstacles discussed in detail in Chapter 2 (subchapters 2.4 and 2.5) that include the time frame 
involved to generate accurate identification results, labour, training and the maintenance of a large 
number of antisera to actually serotype each Salmonella isolate (79). 
Hence, there is a proclivity to test, implement and even some day replace traditional typing 
techniques with genomic based methods completely, which could potentially save time and mostly 
labour involved in the characterisation of pathogens such as Salmonella enterica serovar 
Typhimurium (STM). Nevertheless, genomic methods also require bioinformatics skills in 
addition to the time needed to analyse this data (148).  
3.2 Genome of Salmonella 
 
The first analysis of a Salmonella genome was through the construction of linkage maps, 
where the genes were located along a map. Individual genes were points representing particularly 
defined mutations, without any additional information regarding size or even nucleotide sequence 
of the gene. Salmonella enterica serovar Typhimurium strain LT2 (STM-LT2), the principal strain 
for cellular and molecular biology, was isolated in the 1940s, going through several changes in 
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term of the descriptive approach. The circular map that was originally created had no physical 
length of the chromosome. This was later on redefined by predicting the length of the chromosome 
in kilobases (kbs) of DNA, based on the analysis of joint transduction of genes (149). The 
publication of the first completely sequenced Salmonella genome happened in 2001, particularly 
for Salmonella Typhimurium LT2 (150). They sequenced the 4,857-kb chromosome and 94-kb 
virulence plasmid of S. Typhimurium strain LT2 and compared it against 8 other enterobacteria 
(Figure 3.1). STM-LT2 genome presents a size of 4,857,432 base pairs (bp), with a G+C content 
of 53%. The general characteristics of the STM-LT2 genome are summarized in Table 3.1. 
Table 3.1 STM LT2 genome main characteristics 
Parameter Chromosome Plasmid pSLT 
Size (bp) 4,857,432 93,939 
G + C content 53% 53% 
rRNA clusters 7 0 
tRNAs 85 0 
tRNA pseudo gene 1 0 
Structural RNAs 11 1 
CDS (including pseudo genes) 4,489 108 
CDS pseudo genes 39 6 
 
Genomic comparisons between sequenced enterobacterial genomes including other 
Salmonella serovars and other enteric pathogens such as Escherichia coli K12 and O157:H7 have 
been performed (150). These two species can be considered related phylogenetically in the distant 
past since they share this large amount of genetic material, which typically varies between 2,500 
and 3,100 orthologous genes (between 50% and 70% of the whole genome. As expected, there is 
also large homology between Salmonella spp. (>98%), for DNA and also amino acids. 
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Figure 3.1 The Salmonella enterica serovar Typhimurium LT2 genome. a: STM LT2 
chromosome compared to 8 related enterobacteria. Base pair numbering is indicated outside the 
outer circle. The outer two circles represent the coding orientation, with the forward strand on the 
outside and the reverse strand on the inside. Red indicates close homologues in all eight genomes. 
Green indicates genes with a close homologue in at least one other Salmonella (S. Typhi, S. 
paratyphi A, S. paratyphi B, S. arizonae or S. bongori) but not in E. coli K12, E. coli O157:H7 and 
K. pneumoniae. Blue indicates genes present only in STM LT2. Grey indicates other combinations. 
The black inner circle is the G+C content; the purple/yellow innermost circle is the GC bias. The 
positions of the origin of replication (ORI) and terminus (TER) are shown. b: The plasmid pSLT. 
Base pair numbering is indicated outside the outer circle. The plasmid is not to scale. The colour 
scheme is the same as for A. (From McClelland et al, 2001. Complete genome sequence of 
Salmonella enterica serovar Typhimurium LT2. Letters to Nature, Vol 413, 25 October 2001). 
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Callister et al (2008) described that, at the sequence level, the genes that belong to 
the core genome are highly similar, but it is uncertain whether they have maintained similar 
function in both species since they inhabit different ecological niches and are not 
functionally independent of the specie-specific genes. Kaushik et al (2017) reviewed the 
diversity of gene cassettes which gene expression is known to be optimized throughout 
evolution toward the changes in an organism’s lifestyle and the niche that it occupies, 
which would explain the prevalence of these organisms worldwide and through time.  
 For other enterobacterias, homology is from 80% minimum for DNA and >88% for amino 
acid sequences. Distinct phenotypic characteristics have been observed amongst the 2,500 
Salmonella known lineages, the genetic basis of which has been determined using genomic 
sequence analysis. These characteristics have been used as a way to identify distinct differences 
between organisms from similar species (151). As an example, a comparison of Salmonella serovar 
subspecies I genomes which infect both animals and humans, demonstrated that these pathogens 
share around 90% of their genes. This large portion within the genome has been named “core 
genome”.  
The core genome includes mainly genes that are essential for the bacterial cell in terms of 
growth and survival, and are often related to code for enzymes involved on the biosynthetic 
pathway. Core genes, are not only highly conserved in terms of sequence identity but also in terms 
of their position within the genome (152). The remaining 10% of genes has been described as 
unique to each of the different lineages and has been labelled as “accessory genome”. This 
accessory genome, contains mostly genes of prophages and genes of unknown function which 
have contributed to the genetic diversity of Salmonella spp., for example, the Salmonella 
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Typhimurium serovar (153). The accessory genes are those related to pathogenesis. 
Chromosomes of enteric bacteria consist in collinear regions intermixed with so-called islands, 
which could be unique to certain species. These islands, also known as Salmonella pathogenicity 
islands (SPIs), are main components of the accessory genome together with prophages, which 
sometimes encode pathogenic functions. The acquisition of SPIs can occur horizontally, enabling 
bacteria to rapidly gain complex virulence functions from other species (139). There are 23 
different SPIs, which have been described so far within the accessory genome (154).  Five SPIs 
(SPI-1 to SPI-5) are common to all serovars of S. enterica while the rest is distributed among 
different serovars and/or strains. Laing et al (2017) showed a concordant relationship within S. 
enterica, between the core and accessory genomes. Their results indicate that the accessory 
genome is a specific selection within particular niches, establishing a complement of genes and 
regulatory elements that enable as well as increase the survival of the S. enterica strains.  
The definition of core and accessory genome is not absolute. It has been stated that genes 
could be defined to be part of the core genome taking into consideration the actual strains being 
compared. For example, when performing comparison between 2 strains, core genome would be 
defined as those genes that are common to the 2 members of the comparative pair (153).  However, 
there will be a high proportion (approximately 90%) of genes shared between different members 
of the genus, and the majority of differences that exist between Salmonella serovars under analysis 
would be primarily due to differences localized in the accessory genome. This was described by 
comparing genomes from Salmonella paraTyphi C strain RKS4594 and Salmonella cholerasuis 
strain SC-B67. They shared 4,346 genes, equivalent to 96.66% of the S. paratyphi C strain 
RKS4594 and 98.2% of the cholerasuis strain SC-B67 (155).  
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In terms of the clinical response generated by Salmonella pathogens, they may not have as 
many genes in common. This was demonstrated when comparing the human typhoid agents S. 
Paratyphi A and S. Typhi. These only have 89.8% and 90.2% common genes at core genome level, 
which was equal to 4,008 genes only (156). These mentioned genomic differences might imply 
the influence that independent adaptation processes associated with the host are taking place. Host- 
pathogen interactions would be then responsible of the gene modifications taking place in the 
described comparison, despite the expected closeness of these two infectious agents. 
3.3 STM MLVA for laboratory surveillance  
 
Pulse-field gel electrophoresis (PFGE) has been used worldwide for many years to subtype 
Salmonella enterica serovar Typhimurium within phage types (157). Unfortunately, phage typing 
often makes differentiation of epidemiologically closely-related isolates difficult, which can 
interfere with epidemiological investigations of outbreaks. Furthermore, PFGE can be relatively 
slow in terms of performance and results as well as subjective in terms of interpretation (158). 
Combined, these factors can lead to delays in identifying outbreaks and their sources in order to 
prevent further spread. The development of MLVA typing has offered a solution to this situation: 
a shorter turnaround time combined with high discriminatory power enables the characterization 
of subspecies during epidemics from a single serovar or a phage type (159). 
Several MLVA schemes have been developed for Salmonella, including a general scheme 
for S. enterica subspecies enterica, one for S. Typhi and for S. Typhimurium (119). This particular 
typing method became widespread among many public health laboratories for the investigation of 
Salmonella and other foodborne organisms. Although there are several other methods still 
available, MLVA generates reproducible and comparable results, by using the same standardized 
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techniques, can be easily shared between different laboratories (160). The technique of MLVA is 
based on the polymerase chain reaction (PCR) and involves amplification of targeted DNA 
fragments using fluorescently-labelled (161). The generated products (amplified DNA segments 
or amplicons) contain variable copies of tandem repeats which are then measured in terms of 
length, either by gel or capillary electrophoresis. This method provides reproducible and accurate 
sizing of fragments (within 1 base + or -) and can be performed more rapidly than other molecular-
based methods. It has several additional advantages over other molecular methods including 
reduced cost, minimum equipment required, speed, reliability as well as high reproducibility. 
The chromatogram representation (Figure 3.2) provides the approximate lengths for each 
locus. The sizes of the genotyped fragments as determined by the analysis program are relative 
due to slight differences in DNA migration through the capillary matrix. These differences depend 
on the DNA sequence, which affects the secondary structure of the single strand, DNA as well as 
the type of fluorescent marker associated to the primer. 
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Figure 3.2 An example of a S. Typhimurium MLVA chromatogram. Generated by ABI capillary 
genotyping of fluorescently-labelled multiplex PCR products. Each peak corresponds to a specific 
MLVA locus. Source: New South Wales Enteric Reference Laboratory at the Centre for Infectious 
Diseases and Microbiology, ICPMR, NSW Health Pathology, Westmead. 
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The raw genotyping data is then compared to a standard curve prepared by sequencing a 
number of different sized fragments from each locus and comparing the actual fragment length to 
the sizes provided by genotyping. This may also be confirmed by comparing the nucleotide 
sequence of the fragment with the genomic sequence of type strain STM- LT2 in the NCBI 
Genbank. The number of repeats for each locus is inferred by subtracting the known length of the 
flanking sequence from the total amplicon length, and dividing the result by the known length of 
each repeat sequence. In recent years MLVA has almost completely replaced PFGE as the method 
of choice for genetically separating closely related Salmonella strains. STM was one of the first 
serovars of S. enterica to be analysed using the MLVA system (161-162). This MLVA typing 
scheme was first proposed for the analysis of S. Typhimurium in 2004 (162), with later on 
development of the assay targeting five more variable loci. The five involved loci are – STTR9, 
STTR5, STTR6, STTR10pl (‘pl’ referring to the fact that this locus – STTR10pl – is on a plasmid 
while the other loci are on the chromosome) and STTR3. These five loci are summarized in Table 
3.2. 
The MLVA profile is usually expressed as a series of numbers of particular length, each of 
which represents the number of copies of repeated sequences at each one of the loci under analysis 
in a standard and particular order (163). This method does not make any assumptions on the nature 
of the sequence. For STM, loci are designated as STTR – (Salmonella Typhimurium tandem 
repeat), plus an arbitrary number.  
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Table 3.2 Designated loci, size and sequences for S. Typhimurium MLVA. (i) as described in 
http://www.pasteur.fr  
Locus Length (bp) Tandem repeat sequence 
STTR-9 9 Gtctgcgat 
STTR-5 6 Accacg 
STTR-6 6 Gcaagg 
STTR-10 6 Cctgtt 
STRR-3 27, 33* Cgatgtgaccccgcccgatgatagcggcgatga 
* The length of repeat sequences at locus STTR-3 corresponds to a combination of 27 and 33 base 
pair repeats. 
 
After all five loci of an isolate are assigned a particular fragment length, a profile (or string) 
is prepared. One way of expressing the profile is providing the actual fragment lengths in base 
pairs. Another subtyping method, proposed by Lindstedt et al (2004), which is the method used 
throughout Australia, is assigning numbers that reflect the number of tandem repeats contained 
within a particular fragment. Table 3.3 relates particular fragment lengths to the Australian MLVA 
coding system. 
Table 3.3 Fragments relationship to the Australian MLVA coding system 
Locus STTR-9 STTR-5 STTR-6 STTR-10 STTR-3 
Fragment length (bp) 162 313 324 371 523 
Australian code 03 24 11 11 523 
 
As shown in Table 3.3, the profile 3-24-11-11-523 indicates 3 repeat copies at locus 1, 24 
repeat copies at locus 2, and so on. Where repeat copies differ in length, allele codes can be 
assigned to distinguish specific types of repeat combinations (132). Since repeat lengths in STTR3 
can differ, this particular locus is sometimes expressed as the total size in base pairs (163). This 
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one in particular has been described as a complicated locus to analyse. The 5-locus STM multiplex 
scheme has been widely adopted in Europe, Australia and other countries (34,164-165). Some 
countries, such as Norway and Denmark, have been able to successfully harmonize the performed 
analysis (166). Whilst there are various possible formats in which the MLVA profile could be 
expressed, so far, none has been globally adopted (167). 
In 2008, representatives from Australian reference laboratories agreed that for all loci 
except STTR3, the result will be expressed as 0 if there is no amplicon (i.e. the locus is absent); 1 
if the size of the amplicon corresponds with that of the flanking region (i.e. the locus is present, 
but no repeat sequences are present); 2 if the amplicon length corresponds with the sum of the 
flanking region and one repeat, and so on. For the STTR3 locus, which is complicated by the 
potential presence of variable numbers of repeats of two different lengths, it was agreed that the 
actual amplicon length would be given. The agreement on displaying information is represented 
in Figure 3.3; this provided a method by which Australian laboratories can compare results (32). 
Genetic relatedness of isolates can be established by analysis of their MLVA profiles. In NSW, 
MLVA fragment lengths data from each STM screened isolate are entered in the NSW STM-
MLVA Database together with any relevant epidemiological details such as date, source and 
location. Using this, data dendrograms can be generated providing a summary of the 
epidemiological scenario behind the appearance of particular MLVA profiles. 
In general, loci STTR-9 and STTR-3 are considered stable loci as there is slight or no allelic 
variation between isolates that are closely related based on phage type and epidemiological data 
(119). Consequently, any differences observed at either of these two loci for any given isolates are, 
regardless of the data for the remaining three loci, considered sufficient to call the isolates 
unrelated (distinct), conclusion which should be supported providing necessary epidemiological 
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data (165). Allelic variation in loci STTR-5, STTR-6 and STTR-10, has been found to be frequent 
since any of these three loci may undergo one or more tandem repeat changes with relative ease. 
For these particular loci, confirmation of relationships between isolates may need supplementary 
information based on additional pieces of information. 
An example of genetic relatedness based on MLVA profiles is shown in Table 3.4. 
 
Table 3.4 Examples of genetic relatedness between STM isolates based on MLVA profile 
MLVA-5 locus: tandem repeat numbers 
Profile STRR-9 STRR-5 STRR-6 STRR-10 STRR-6 
Genetically 
related to 
profile 1* 
1 2 23 10 10 523 N/A 
2 2 23 10 9 523 Probable 
3 2 24 12 10 523 Possible 
4 2 24 12 11 523 Distinct 
*  The presented categories for genetically related to profile 1 corresponds to a proposal by the 
Rural Industries Research and Development Corporation, Australian Government, 2013. 
 
The MLVA method has shown a high discriminatory power between isolates belonging to 
the same serovar, whether obtained from human, food or animal sources. It is also a method that 
has proven to be suitable for identifying links between potential outbreak cases and sources (168). 
However, common or endemic MLVA profiles may cause multiple outbreaks along with sporadic 
cases and a few selected MLVA profiles may represent a large portion of isolates observed in a 
geographical location (34). In terms of MLVA profiles analysis, it typically relies on distance-
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based methods to infer relationships between isolates and their different profiles based on 
dendograms or phylogenetic tree constructs, as proposed by PulseNet MLVA protocols 
(http://www.pulsenetinternational.org).  
Dendograms are usually based on the number of differed loci, which is a rather basic 
approach that could implicate some problems including the linking of profiles which share loci 
instead of actually inferring relationships beyond the loci based profile (168). So, high genetic 
diversity outside the five typing loci within particular MLVA profiles may need additional analysis 
beyond MLVA typing in order to accurately identify links between cases and to resolve outbreaks 
of salmonellosis. In such instances, Whole Genome Sequencing (WGS) has presented itself as the 
ultimate discriminatory power tool, with the potential to improve epidemiological investigations 
and determine transmission pathways (Section 3.4) (169). 
As concluding remarks for this subchapter, MLVA typing has proven to have enough 
discriminatory power to, in general, effectively differentiate STM isolates. Its discriminatory 
power is even superior to other typing methods. It is also technically simple, inexpensive to 
perform and has been used as a helpful method for epidemiological investigation. Hence, common 
MLVA profiles may represent a large portion of isolates observed in a geographical location, 
without possibility of accurately differentiating them. WGS has offered highest discriminatory 
power when compared with MLVA typing, improving epidemiological investigations and 
transmission pathways analysis. 
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3.4 WGS for pathogen detection and analysis 
 
Advances in genomics are transforming public health laboratory surveillance (148). The 
term “genomics” came into sight around 1986 by Dr. Thomas Roderick, a US geneticist, who was 
mostly focussed on the study and comparison of genomes of diverse species, including concepts 
of evolution and relationships (170). It was actually the Human Genome Project the instance that 
encouraged the actual revolution in terms of sequencing technologies. Through its initiatives, high-
throughput WGS was established as an important tool involved in the study of human and 
microbial organisms at a deeper, modified and improved level based on the methods previously 
published (171). The first aim was to search for more efficient and richer in information sequencing 
methods, including sequencing of longer segments of DNA and/ or whole chromosomes. 
Advances in software and computer science helped producing large amounts of sequence data 
across the genome that was then assembled using newer computation technology (172). 
As WGS continually becomes quicker and more cost effective, it is likely to be used as a 
routine epidemiological typing tool due to its ability to discriminate between sporadic and outbreak 
related cases, which may be indistinguishable using traditional molecular subtyping methods 
including MLVA (173). The development of high-throughput next generation sequencing 
technology has focused on the establishment of increasingly simple bench top technology (148). 
These have improved the capacity to perform efficient and lower-cost WGS, enabling its 
implementation as a tool to be used in clinical diagnostics and public health microbiology almost 
in real-time (174). Generally, WGS technology follows a mostly standardized workflow, 
beginning with extraction of homogenous microbial DNA, which in the case of STM, is usually 
from a single colony selected from a pure culture. WGS requires high-quality, intact, non-degraded 
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DNA (175). The extracted DNA is then subjected to library preparation (176), which involves 
preparation of a double-stranded DNA library consisting of cleaved DNA fragments ligated to 
‘adapters’ which are known sequence fragments, specific to the particular sequencing platform.  
Preparation of a DNA library is a crucial step, required to generate material suitable for 
sequencing (177), and there are several library preparation methods specific for the various 
sequencing platforms. However, they all have in common that the DNA fragments must always 
be linked with particular adapters. These adapters will enable multiple samples to be pooled in a 
single run and subsequently de-identified and assembled for analysis. Prior to adapter attachment, 
normalization and clean-up of the samples must be performed; that way a standardized amount of 
each sample is loaded into the sequencer. Once the DNA fragments have been loaded into the 
sequencer and sequencing data have been generated, the output is referred to as reads, which are 
short or long base pair sequences which have been inferred from the DNA template by the 
sequencing process. Figure 3.3 summarizes the steps involved in one of the library preparation 
procedures available. 
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Figure 3.3 General library workflow for WGS. Simple overview from input DNA, DNA 
tagmentation and sequencer (Source: Illumina Nextera DNA reference guide, 2016).    
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Read length has bioinformatics implications in terms of analysis; authors have referred to 
short sequencing reads at lengths below 500 bp and long reads above this length (178). Once the 
output is revealed from sequencer, the options are either read mapping to a reference genome or 
reads can also be assembled by using de novo assembly into longer contiguous sequences. 
Mapping is a term used to describe the alignment of short sequence reads to a longer 
specific reference sequence; de novo assembly refers to the reconstruction of contiguous sequences 
without making use of any reference sequence (179). There are several quality metrics such as 
coverage (or sequencing depth), Q30 scores and cluster density which enable the determination of 
data quality post sequencing; among these, Q scores are defined as a property that is 
logarithmically related to error among the base calling process performed by the sequencer. A 
Phred quality score (Q30) is equivalent to the probability of an incorrect base call in 1,000 times, 
providing a base call accuracy of 99.9%. Q30 is considered a benchmark for quality in WGS (180). 
Sequence coverage refers to the average number of reads per locus that the sequencer has been 
able to analyse in order to achieve confident base calling. It is expressed as an average or median 
of all the coverage values per base. Sequencing at high levels of coverage provides the generation 
of high quality and accurate sequences, reliable in terms of accurate detection of variants within 
particular genomes. Human WGS studies are usually performed at least at 40x coverage (181). 
Cluster density is another term to consider when analysing sequencing results. It is an important 
metric that influences the total data output. 
“Clonal clusters” are the amplification product from the library preparation and should be 
around 170-200 raw density (K/mm2). The density of these clusters impact in terms of data quality 
and total data output. Under clustering may result in high data quality but lower data output 
whereas over clustering leads to lower data quality in general (182).  
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Different factors may contribute to under and over clustering; insufficient library clean-up, 
inaccurate library quantification and nucleotide diversity within the library are the main general 
ones. There are other several elements, particularly involved on the quality of the sequencing data, 
which must be taken into consideration: overall GC content, duplicate reads and necessary amount 
of reads to be able to interpret results are among them. Different tools provide summarized 
statistics in relation with quality control (176). Trimming low quality data and reads can be 
performed with the help of several software and scripts. Failure to remove sequences that are not 
within expectations can disrupt the final conclusions based upon the sequencer resulting output 
information (178). Figure 3.4 summarizes the steps involved in data analysis of WGS sequencing.    
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Figure 3.4 General overview of WGS data analysis workflow. 1) Sequencing starts with good 
quality DNA extract. 2) This is loaded into any of the available next-generation sequencers, which 
will be able to produce either short genome reads or long genome reads . 3 & 4) Analysis may be 
performed by either mapping reads against a specific reference genome or by assembling these 
reads into longer contiguous sequences (de novo assembly). 5) If mapping to a reference genome 
is used, this can lead to epidemiological comparisons and outbreak investigation. The resulting de 
novo assemblies can be used for further analysis including antibiotic resistance detection. (Figure 
from Kwong J, Mccallum N, Sintchenko V, Howden B. Whole genome sequencing in clinical and 
public health microbiology. Pathology. 2015; 47(3): 199–210. 
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 Worldwide, there are numerous sequencing platforms available and hence several 
considerations must be taken into account when determining which platform should be used for a 
particular clinical microbiology application (148). Currently the market offers several next-
generation sequencing methods, all of which have advantages and disadvantages (178). Table 3.5 
summarizes some of the most popular sequencing technologies and their main characteristics. 
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Table 3.5 Summary of the currently most used sequencing platforms 
Traditional sequencing 
Sanger sequencing Still widely used of short DNA segments sequencing. 
Shotgun sequencing Involved fragmentation of long strands of DNA into 
numerous smaller segments for Sanger sequencing, 
therefore higher price. 
Next-generation sequencing technologies (NGS) 
Pyrosequencing (Roche 454) One of the earlier NGS technologies. Currently not 
much in use. 
SOLiD sequencing (Life Technologies) Less popular than Ion Torrent, likely to be over 
shadowed by newer technologies. 
Ion semiconductor sequencing (Life Technologies Ion 
Torrent) 
Popular due to lower cost and speed of sequencing for 
short read sequences. Higher error rates and poor 
coverage for high A-T or G-C regions. 
Illumina sequencing Current market leader. High sequencing throughput; 
low error rate and low cost. Limitation of short read 
sequences. 
Single molecule real-time sequencing (Pacific 
Biosciences) 
Novel method. High raw errors. Overlapping reads can 
produce accurate consensus sequences. 
Emerging technologies 
Nanopore sequencing (Oxford Nanopore) Benchtop sequencing technologies leader. Portability. 
Capable of generating long-sequence reads. Still being 
refined. 
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Following, is a list of the main aspects that should be taking into consideration when 
considering the use of sequencing technology: 
i) Cost: 10 years ago the sequencing costs of a million base pairs sequenced were 
approximately US$1000; the costs are now below US$0.10 (183). Despite the decrease 
in price, there remain large expenses involved on the implementation of this kind of 
equipment, including set up, sequencing reagents cost and also bioinformatics 
processing costs. 
ii) In-house sequencing or service provider purchasing: The main consideration on this 
particular mater is the investment associated with the purchase of sequencing 
technology. If this can be handled, turnaround times for analysis and data generation 
can improve dramatically. External service providers may involve longer times related 
to analysis and data. 
iii) Sequencing contents: There are differences regarding the available sequencing 
technologies. Some of them can sequence less than 10 bacterial genomes within hours; 
others can sequence up to 100 in a single run, which may take around 3 days. This will 
certainly impact on the costs implicated on the sequencing run. 
iv) Versatility: Considering that sequencing technology is explosively evolving, the 
platform’s capability to upgrade and modify its sequencing practices is a relevant 
factor. 
v) Data quality: This factor, in practical terms, might be one of the most relevant ones. 
Without good quality of sequencing results, there would be not much information to 
report. Each sequencing platform is equipped with a tool that will be able to provide 
information about the quality of the sequencing reads. 
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There are some limitations that should be taken into account when evaluating NGS 
technologies. Primarily, most of the analyses are carried out through the use of single nucleotide 
variants (SNPs), which are identified from comparative analysis against a reference genome (175). 
This implicates that the analysis is dependent on the quality and the appropriate selection of the 
reference genome, which could jeopardize the resolution and accuracy needed in order to carry out 
adequate public health and/or clinical decisions. 
 
3.5 Added value of whole genome sequencing in public health microbiology 
 
The development of microbial genomics has provided access to large amounts of 
information; genome analysis is currently an important part of the clinical microbiology field, 
particularly thanks to the availability of large number of available human/animal bacterial 
pathogens supporting the fields of diagnostics, epidemiology, pathophysiology and treatments 
(184). Microbial genomics enable identification and analysis of particular markers such as 
antibiotic resistance genes, virulence genes and genes transference that may be important to 
consider when making decisions regarding to treatment and prognosis of the current infection 
under study. The four major applications of WGS in the context of pathogen characterization are: 
identification, typing, resistance detection and virulence gene detection (185). Initially, genome 
sequences were mainly generated to answer research questions, mostly related to evolution 
concepts (144). Currently, WGS plays a key role particularly for those organisms that are unable 
to be identified based on the routine established screening methods and where culture preparation 
for further identification is not a possibility (148). 
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Metagenomics, the culture-independent analysis of all nucleic acids from a sample, has the 
potential to improve the detection of both known and novel microorganisms. Laboratories can rely 
in a single sequencing based test, which would allow identification of most microorganisms in a 
sample without the need of a traditional culture (186-187). This relatively new approach to 
infectious disease investigations has become increasingly common in public health laboratories 
worldwide, being performed directly from clinical samples belonging to outbreak investigation or 
complex diseases (188). 
The technology of WGS is rapidly becoming routine and shared between diagnostic fields. 
The potential of accurate pathogen detection tests by metagenomic sequencing has been 
demonstrated in numerous studies and clinical contexts, holding great hopes as an improvement 
tool for infectious disease diagnostics (189). On the typing field, there’s hardly any question 
regarding the explicit association/application between typing bacterial pathogens using WGS in 
terms of infection control, surveillance and/or outbreak investigation. There are a number of 
traditional typing methods, described in detail in Chapter 3/Subchapter 3.3, which are often 
performed in centralized reference laboratories and not in routine diagnostic ones. This case is well 
represented with the surveillance of Listeria monocytogenes, for which established typing methods 
include serotyping, binary typing, ribotyping, MLVA typing, PFGE and MLST typing. With this 
diversity of diagnostic methods, as mentioned earlier, comparison of results becomes difficult and 
challenging. Sequencing technology provides an opportunity to perform analysis at a widely 
comparative as well as highly discriminatory level (190). 
The resistance detection related application for WGS is based on the fact that previous 
research has showed the capability of this science to assist with antimicrobial resistance detection. 
Analysis using WGS generated data can detect particularly acquired resistance by detecting 
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particular gene expression profiles (191). In terms of its relationship with the treatment field, WGS 
could reduce diagnosis time and therefore reducing the potential risk of exposing a patient to 
ineffective drugs increasing the risk of generating additional or new resistance profiles for 
particular cases (192). The ability to detect virulence genes is an important use of the WGS 
generated data. Research related to the ability of WGS to detect presence of particular virulence 
genetic markers that increase its pathogenicity has been published in organisms such as 
Staphylococcus aureus and Escherichia coli and its Shiga toxin (193).  
Evidence suggests that WGS is most likely to be used in reference laboratories, tertiary 
hospital laboratories and research-associated laboratories (194-195).   Costs are certainly one of 
the main significances preventing the general use of NGS in clinical and public health 
microbiology worldwide.  It also highlights the perception of the utility associated to this 
technology in clinical and public health microbiology, facilitating national and international 
collaborations (185).   
3.6 Genomics and its use in STM-related outbreak investigation 
 
Data generated using WGS complements existing epidemiological tools by enabling 
reassembly of transmission networks and identification of possibly undetected epidemiological 
links. WGS has been used to identify outbreak isolates from non-outbreak isolates of some 
Salmonella serovars, including STM (196). From a public health and epidemiologic perspective, 
robust and higher resolution genomic analysis provided by WGS has turned out to provide details 
into transmission pathways for several significant pathogens. Although the majority of these 
published investigations have been conducted retrospectively, the findings in all of them agree to 
highlight the potential of WGS as a real-time infection control tool (43).  
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Salmonella associated outbreaks have been involved in diverse scenarios worldwide, with 
identified sources including agricultural produce such as tomatoes (197); poultry and poultry 
related products (198); ready –to-eat food suppliers such as dine-in or take away restaurants (199); 
kitchen utensils and appliances (200); livestock production (201) and also related to cases 
involving wildlife (202). Considering that an outbreak will always involve at least 2 cases, with a 
high risk of increasing these numbers in a short period of time, prompt subtyping of Salmonella 
and synthesis of laboratory findings into public health actions are critical in reducing delays in 
outbreak investigation (203). WGS has proven to have the potential to discriminate between 
sporadic and outbreak isolates that would not be able to be differentiated by currently implemented 
subtyping methods (24). Even more relevant, the technology has taken outbreak investigations to 
near real-time (196). 
It has been proven that, while carrying out analysis based on a common STM-MLVA 
profile known to have been associated with two food-borne outbreaks along with sporadic cases 
in NSW, by sequencing these STM isolates associated with acute gastroenteritis can highlight 
distinct foodborne community outbreaks within groups of isolates sharing the same MLVA profile. 
Genomic analysis itself can also further differentiate sporadic cases from outbreak cases and 
cluster sporadic isolates within endemic MLVA profiles of STM, which can significantly improve 
the resolution of public health laboratory surveillance (35). The current technology involving 
genomic sciences and its applicability to the public health and microbiology field are numerous 
and are currently being approached worldwide. NSW Health is taking advantage of it by 
combining the information provided by traditional typing methods and the added value that data 
generated by WGS technology can provide to STM surveillance. Its use is becoming more massive 
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every year across Australia due to accessibility and understanding of the technology and its 
required analysis. 
Aims 2 and 3 from this thesis intend to confirm the real utility this technology presents in 
different scenarios such as the genomic variability within already identified successful STM 
MLVA clades and the genomic variability present when acute and chronic STM infection in 
animals takes place, in the hope that some findings will contribute to increase the knowledge 
surrounding this infection and therefore also contributing in decision making processes against 
this organism.   
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Chapter 4: Material and Methods  
4.1 Introduction 
In order to carry out a full description and analysis of the mentioned aims of this research 
work and therefore to test the hypothesis considered throughout the investigation process, different 
approaches have been considered. There are 3 different aims of the project requiring different 
methods that are to be addressed in this thesis.  
The examination of the temporal dynamics of STM infections, which were characterized 
by specific MLVA profiles tested in the STM isolates and observed through the years, has been 
presented as a quantitative analysis by summarizing the isolate MLVA profile dynamics obtained 
from the cases taking place across the mentioned time period within NSW population (objective 
1). Also, a small section is presented aiming to test the ability of MLST to infer serotypes using  
100 randomly selected Salmonella enterica isolates that were previously serotyped by the 
conventional method. The top 10 most common Salmonella serovars in NSW were included  and 
evaluated. 
Whole Genome Sequencing (WGS) was applied to STM isolates belonging to objective 2. 
These isolates were classified as successful and non-successful clades based on the yearly 
presentation numbers associated to non-typhoidal Salmonella (NTS)-STM human cases with some 
particular MLVA profiles. NSW Health has identified these particular MLVA types as associated 
with large numbers of STM cases each year. By using WGS technology, we aimed to explore the 
genomic differences in a set of STM isolates with certain specific MLVA profiles. This would 
help to explain the mechanism of diversity by the presentation of successfulness and non-
successfulness population clades that have been persistent t in NSW over a five years’ time period.  
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In the animal experiment section (objective 3), WGS was performed on a serial of STM 
isolates obtained through a mouse passage experiment. This section was aiming to explore the 
within- and between host genomic changes of STM developed through oral inoculations of STM 
for five generations in mice. This was aimed to exam the transmission mechanism of the pathogen 
pathogenicity by an animal model and to potentially emulate transmission pathways present in 
human infections.      
4.2 Clinical and environmental isolates included in the study 
 
All Salmonella isolates from clinical and environmental sources included in this study were 
obtained from the NSW Enteric Reference Laboratory (ERL), Institute of Clinical Pathology and 
Medical Research (ICPMR)-Pathology West. The conventional serotyping based on Kauffman–
White Scheme (available on line at: 
http://www.pasteur.fr/sante/clre/cadrecnr/salmoms/WKLM_En.pdf) were performed for all of the 
isolates and MLVA detection and profile assigning for STM isolates were conducted previously 
by this laboratory. The detailed information of the isolates and the particular analyses performed 
on the isolates within the aims of research will be presented throughout the materials and methods 
chapter. 
The study was approved by the Western Sydney Local Health District Human Research 
Ethics Committee (WSLHD HREC Reference Number LNR/16/WMEAD/405). 
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4.3 Multi-locus sequencing typing (MLST) 
 
4.3.1 Bacterial isolate preparation 
A set of 126 randomly selected and previously serotyped Salmonella enterica isolates 
collected between 2010-2012 were subjected to MLST typing following the scheme published 
previously (205).  Frozen cultures stored at -80oC were revived on the selective media xylose 
lysine desoxycholate (XLD) agar plate overnight at 37oC. A single colony from the overnight XLD 
plate was sub cultured on the Blood Agar (BA) media overnight at 37o C.  A single colony was 
picked up from the BA plate and re-suspended in 200 µL water.  
4.3.2 DNA extraction and PCR amplification 
DNA was extracted from the 200 µL suspension by boiling for 10 minutes. The suspension 
was then centrifuged at 14,000xg for one minute and the supernatant was used for PCR. The PCR 
amplification for Salmonella MLST was performed by using the HotStarTaq Master Mix Kit ® 
(Qiagen, Germany). The sequences of seven primer sets according to the published MLST scheme 
for Salmonella (Kidgell et al, 2002) and the seven housekeeping genes involved in the MLST 
typing were given in Table 4.3.2.   
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Table 4.3.1 The primer sequences and genes for Salmonella MLST typing (Kidgell et al, 2002):  
 
Primer Sequence Housekeeping gene  PCR product size (bp) 
thrAF 5'-GTCACGGTGATCGATCCGGT-3' thrA (aspartokinase+homoserine dehydrogenase) 852 bp 
thrAR 5'-CACGATATTGATATTAGCCCG-3'  852 bp 
purEF 5'-GACACCTCAAAAGCAGCGT'-3' purE (phhohoribosylaminoimidazole carboxylase) 510  bp 
purER 5'-AGACGGCGATACCCAGCGG-3'  510 bp 
sucAF 5'-CGCGCTCAAACAGACCTAC-3' sucA (alpha ketoglutarate dehydrogenase ehydrogenase) 643 bp 
sucAR 5'-GACGTGGAAAATCGGCGCC-3'  643 bp 
hisDF 5'-GAAACGTTCCATTCCGCGC-3' hisD (histidinol dehydrogenase) 894 bp 
hisDR 5-GCGGATTCCGGCGACCAG-3'  894 bp 
aroCF 5'-CCTGGCACCTCGCGCTATAC-3' aroC (chorismate synthase) 826 bp 
aroCR 5'-CCACACACGGATCGTGGCG-3'  826 bp 
hemDF 5'-GAAGCGTTAGTGAGCCGTCTGCG-3' hemD (uroporphyrinogen III cosynthase) 666 bp 
hemDR 5'-ATCAGCGACCTTAATATCTTGCCA-
3' 3'ATCAGCGACCTTAATATCTTGCCA-
3' 
 666 bp 
dnaNF 5'-ATGAAATTTACCGTTGAACGTGA-3' dnaN (DNA polymerase III beta subunit) 833 bp 
dnaNR 5'-A TTCTC TTCG GAGGA -3'  833 bp 
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The PCR reaction was prepared in a total volume of 25 µL reaction mix including 12. 5 uL 
of 2X Hot Star master mix, 0.12 µL of each of the forward and reverse primers at 0.2 µM 
concentration, 10.26 uL of the molecular grade and 2 lug DNA extract. The thermocycler profile 
used was as follows: 95o C for 15 minutes (1 cycle), 95o C for 30 seconds; 55o C for 60 seconds; 
72o C for 60 seconds (30 cycles), 72o C for 10 minutes; hold 22o C (1 cycle). All PCR products 
were visualized on a 2% Agarose gel. Once successful PCR amplification was confirmed, a PCR 
clean-up was performed by adding 2 µL of ExoproStar ® enzyme (GE Healthcare, USA) in 9ul of 
PCR product and incubated at 37o C for 30 minutes, followed by a 80oC inactivation step for 30 
minutes. 1 µL of the primer, either forward or reverse, at a concentration of 9 µM was then added 
to the mix and ready to be sequenced by an external service provider.   
4.3.3 Sequence result analysis 
The sequence data was visually checked and analysed using software Chromas® 
(Technelysium, Australia) by trimming of low quality nucleotides at the beginning and the end of 
the sequence. The trimmed forward and reverse sequencing reads were then assembled into a 
contig. Once the contigs were obtained from all of the seven genes for each isolate, the contig 
sequences were then submitted to a website based MLST Databases at The University of Warwick 
(http://mlst.warwick.ac.uk/mlst/mlst/dbs/Senterica) for the allele number and the sequence type 
assignments. The sequence type (ST) was then compared to the corresponding serotyping result 
previously identified by the NSW ERL.  
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4.4 Multilocus variable-number tandem repeat typing (MLVA) 
MLVA typing has been performed on all STM isolates at the NSW ERL as part of the 
NSW state Public Health Salmonella enterica serovar Typhimurium Surveillance program, using 
a national harmonized method based on a previously published method (41). The existing MLVA 
results were analysed for Aim 1 intending to explore the temporal dynamics and diversity of STM 
isolates over a time period based on MLVA profiles. 
4.4.1 PCR amplification for MLVA typing 
MLVA typing was performed through a multiplex PCR reaction by amplifications of five 
loci including STTR9, STTR5, STTR6, STTR10pl and STTR3 on the STM genome using five 
sets of primers labelled with fluorescent dyes NAD, HEX and FAM, respectively. The reaction 
was achieved in a 30µl reaction mix prepared using Qiagen HotStar Taq PCR Mix (Qiagen, 
Germany) with the mix components as described in Wang et al, (2008).  The PCR amplification 
conditions were as follows: an initial denaturation at 95°C for 15 minutes, followed by 25 cycles 
of 94°C for 30 seconds, 60° for 1.5 minutes and 72° for 1.5 minutes. A final 72°C extension for 
10 minutes was performed. The standard gel electrophoresis was performed to visualize the 
amplification products before the detailed fragment length analysis by capillary gel electrophoresis 
(CGE). 
4.4.2 Fragment length analysis by CGE 
The lengths of PCR products amplified on the five loci were measured by CGE using an 
ABI 3130xl Genetic Analyser (Applied Biosystems) by a service provider. The CGE result was 
presented as chromatogram data, which was analysed using the Peak Scanner software (Applied 
BioSystems) to determine the size length of each amplicon. The size length of each sequence was 
converted to a repeat number determined based on the S. Typhimurium LT2 complete genome 
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sequence (Genbank Accession Number NC_003197). The MLVA result was reported as a string 
of five numbers in an order of STTR9-STTR5-STTR6-STTR10pl-STTR3. The first four digits 
represent the number of repeats and the fifth is the actual length of the sequence. In the cases of 
no amplicon was generated, “0” was assigned.  
4.4.3 Study of bacterial population dynamics and cluster definition  
 
All STM isolates serotyped and MLVA typed by NSW ERL during 2010 and 2015 were 
included in this study (N=11,799). All duplicate isolates and environmental/food samples were 
removed from the dataset. Epidemiological approaches applied to this investigation include the 
definition of cluster, which included the following criteria: the identification of five or more 
isolates with the same MLVA profile over a period of 4 weeks within a particular geographical 
location (e.g., neighbouring residential postcodes). These clusters have been related to what the 
NSW Health Department investigated; and the descriptive epidemiological analyses of cluster 
demographics, including distributions of age groups and gender. MLVA profiles were used in the 
classification of clusters as endemic/new patterns, successful clades. The divergence observed 
through time was the main focus of the analysis of the MLVA profiles. Simpson’s diversity (D), 
Richness of species (St) and Population velocity (Pvi) indexes/time scale were also calculated, 
based on ecological diversity concepts (Magurran, 1988).  
Simpson’s diversity (D) formula corresponds to: 
                                                                    D = 1 - ∑ n (n-1) 
                                                                                  N (N-1) 
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where n = number of individuals of each species in time (number of MLVA profiles),            
N = total number of individuals of all species in time (total number of STM). 
All temporal changes in STM population were represented by quarter and yearly figures. 
Minimum spanning trees were generated using BioNumerics v.6.5 (Applied Maths, Sint-Martens-
Latem, Belgium) to measure the genetic distance between the successful MLVA clades from all 
typed isolates in NSW using the categorical coefficient and no priority rules for the algorithm. 
4.5 Whole Genome Sequencing (WGS) 
For objective 2, sixteen isolates from three different MLVA profiles that were regarded as 
successful clades by their presentations of high incidence rates across NSW throughout the years, 
were selected for WGS. These isolates had a known association with human STM clinical 
infections with three MLVA profiles identified as STM-clade 3-9-7-12-523, STM-clade 3-10-13-
12-496 and STM-clade 3-17-9-11-523. For the first two profiles, six isolates from each were 
selected. These made up of a single isolate collected and identified each year between 2010 and 
2015.   For STM-clade 3-17-9-11-523, due to its appearance since mid-2012, only four 
representatives from each year between 2012 and 2016 were included.   
In addition, three extra isolates of different MLVA profiles were also selected for 
comparison by WGS. These MLVA types were regarded as sporadic or non-successful MLVA 
profiles based on their presentations at   low rates of incidence and association to STM human 
infections in NSW.  Two of these, STM-clade 3-9-7-15-523 and STM-clade 3-16-11-11-523, not 
only presented low rates of STM human infections compared to the successful clades, but also, 
these MLVA profiles were very similar to that of the successful clades by presentations of less 
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than two tandem-repeat differences at one or maximum two loci (Table 4.5), which may suggest a 
major genetic variation manifested by the repeat differences.   
 
Table 4.5 Details of selected STM isolates from successful and sporadic MLVA profiles for WGS 
 
 
 
 
 
 
 
Isolate  Year 
collected 
MLVA profile 
STM-01_S46 (STM1) 2010 3-9-7-12-523 
STM-2_S27 (STM2) 2010 3-10-13-12-496 
STM-3_S58 (STM3) 2011 3-9-7-12-523 
STM-4_S48 (STM4) 2011 3-10-13-12-496 
STM-5_S13 (STM5) 2012 3-9-7-12-523 
STM-6_S16 (STM6) 2012 3-17-9-11-523 
STM-7_S35 (STM7) 2012 3-10-13-12-496 
STM-8_S31 (STM8) 2013 
 
3-9-7-12-523 
 
STM-9_S8 (STM9) 2013 3-17-9-11-523 
STM-10_26 (STM10) 2013 
 
3-10-13-12-496 
 
STM-11_50 (STM11) 2014 
 
2014 
3-9-7-12-523 
 
 
STM-12_S23 (STM12) 2014 
 
3-17-9-11-523 
 
STM-13_S52 (STM13) 2014 3-10-13-12-496 
STM-14_S19 (STM14) 2015 3-9-7-12-523 
STM-15_S30 (STM15) 2015 3-17-9-11-523 
STM-16_S7 (STM16) 2015 3-10-13-12-496 
SRR2538292 (STM17) 2010 5-10-12-9-490 
SRR2538293 (STM18) 2012 3-16-11-11-523 
SRR2538304 (STM19) 2012 3-9-7-15-523 
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Comparative analysis of these set of isolates was performed focusing on allele difference 
between successful and non-successful isolates as well as differences for the successful MLVA 
profiles through time.   
For objective 3, transmission pathways of STM in animal model, analysis was focused on 
the identification of MLVA allele differences and the single nucleotide polymorphism (SNP) by 
WGS. SNP analysis was performed by using CLC Genomic Workbench 
(https://www.qiagenbioinformatics.com/products/clc-genomics-workbench/).  Detailed 
bioinformatics analyses are described  in subchapter 4.6.    
4.5.1 DNA extraction for WGS 
The DNA from isolates was extracted using an automated DNA extraction instrument of 
Chemagic Prepito-D ® (PerkinElmer, USA). This equipment allowed us to extract DNA from 12 
samples within 80 minutes utilizing the Prepito NA Body Fluid Kit ® (PerkinElmer, USA) and 
the Plasma protocol following the manufacturer instructions. The procedure is based on magnetic 
particle separation by usage of beads, which are magnetized by an external magnet, and enables 
isolation of high quality DNA. This involves: 1) Preparation of a input sample of 200 lug fresh 
culture colony suspension in  Phosphate Buffered Saline (PBS) buffer at ~4 McFarland (~x108/mL 
CFU); 2) Addition of the 200 lug culture suspension with 450 µL Lysis buffer containing 10 µL 
Proteinase K in a deep-well plate (DWP) and uploading to the Chemagic Prepito-D instrument; 3) 
Preparation of 150 lug of the magnetic beads and 100 lug  DNA elution buffer in the chemagic Tip 
& Tube Rack and uploading to the instrument; 4) Proceed to the extraction operation following 
the onscreen protocol. Once the extraction protocol finished, the extracted DNA was treated by 
adding 1 µL RNase A® (Qiagen, Germany) to degrade single-stranded RNA in the extracts. 
Additional DNA purification was performed according to the following procedures if required:  
80 
 
45 µL of each DNA extract was transferred to a 96-deep-well plate. Then, after vortexing AMPure 
XP® (Beckman Coulter, USA) magnetic beads for 1 minute, 81 µL were added to the 45 µL 
extract. This is a highly efficient purification system to increase DNA quality with no salt 
carryover. 
i) The plate was placed on an OrbiShaker MP® micro plate shaker/vortexer (Benchmark 
Scientific, USA) for 2 minutes at 1500 rpm followed by 10-minute incubation at room 
temperature. The plate was then pulse centrifuged for 5 seconds using the PlateFuge 
Microplate Centrifuge® (Benchmark Scientific, USA). 
ii)  The plate was placed on Invitrogen™ Ambion™ Magnetic Stand-96 magnetic holder 
(Invitrogen, ThermoFisher Scientific, USA) for 3 minutes in order to remove 
supernatant by pipetting without disturbing the beads.  
iii) Leaving the plate on the magnetic holder, 200 µL of freshly prepared 80% EtOH was 
added to each well and incubated for 30 seconds before aspiration using a multi-channel 
pipette. This wash step was performed twice.  
iv) The plate was then span down for 5 seconds and again placed on the magnetic holder 
in order to remove any EtOH leftover. The remaining beads after EtOH removal were 
air dried at room temperature for 10 minutes while still on the magnet. 
v)  Once dry, 30 µL of 10mM Tris-HCl pH 8.0 was added as elution buffer and pipetted 
up and down 30 times until beads were completely re suspended. Then plate was taken 
into the shaker for 2 minutes at 1500 rpm, followed by a 5 second spin. 
vi) Plate was placed on the magnetic holder again, this time for 3 minutes, allowing 
transference of the 30 µL of supernatant without the beads into new Lo bind collection 
tubes.  
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The DNA extracts were then analysed using a NanoDrop® spectrophotometer (NanoDrop™ 
ThermoFisher Scientific, USA) to determine the DNA quality by measuring absorbance ratios at 
A260:A230 and A280:A260. The ratios for the acceptable DNA quality were between 1.8 to 2.0 
for both absorbances. A Qubit® assay (Qubit® ThermoFisher Scientific, USA) was also used to 
determine the final DNA concentration of the extract. The Qubit® working solution was prepared 
by diluting the Qubit® dsDNA BR Reagent 200-fold in Qubit® dsDNA BR buffer.  
Subsequently, 190μL of the Qubit® working solution was placed into two 0.5mL tubes for 
standards 1 and 2, and 198μL of the working solution in 0.5mL tubes for the samples. Afterwards, 
10μL of each Qubit® standard was added to the appropriate tubes and mixed by vortexing for 2-3 
seconds. After that, 2μL of DNA extract was added to 198μL of the working solution. The tubes 
were then allowed to incubate at room temperature for 2 minutes. The selection of DNA and 
dsDNA Broad Range mode on the Qubit® 2.0 fluorometer (Qubit® ThermoFisher Scientific, 
USA), was made, based on the assay type to be used for measurement as well as expected DNA 
concentration.  
4.5.2 Library preparation for (WGS) 
The Illumina Nextera XT Library preparation kit was used for the genome library 
preparation. The procedures are outlined below.   
Quantitation of DNA by Picogreen measurement:  the input DNA for library preparation was 1 ng 
as required by the Illumina specification. The quantitation of DNA was performed by using Quant-
iT™ PicoGreen® dsDNA Assay Kit (ThermoFisher Scientific, USA). A 20X TE buffer (10mM 
Tris-HCl and 1mM EDTA) was diluted with sterile, distilled, DNase-free water to generate a 1 X 
Tris EDTA (TE) buffer with a pH of 7.5. The DNA samples were diluted 50-fold in 1X TE buffer 
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in a 96-well plate to a final volume of 100μL. A 2μg/mL working solution of dsDNA was made 
by diluting a 500μg/mL Lambda DNA standard stock 250-fold to make a 2μg/mL working 
solution. A second dilution of the 2μg/mL working solution was made to achieve a concentration 
of 1ng/mL for the high range standard curve. This was the reference standard for the assay. The 
standards were added to the 96-well plate with the samples. The Quant-iT™ PicoGreen® reagent 
(ThermoFisher Scientific, USA) was prepared by a 200-fold dilution of the concentrated reagent 
with 1XTE buffer. To each sample, 100μL of the Quant-iT™ Picogreen working solution was 
added, and incubated for 2-5 minutes at room temperature in the dark. Fluorescence was measured 
using the Victor X Plate Reader (Perkin Elmer Inc. USA) with wavelengths at 485 nm for 
excitation and 528 nm for emission. The DNA concentration was calculated based on standards of 
known concentrations referred to the standard fluorescence curve. Samples were then diluted to 
0.2 ng/μL with 10mM Tris buffer pH 8.0 using the JANUS® NGS Express Automated Liquid 
Handling Workstation (PerkinElmer Inc., USA). 
Tagmentation of the sample DNA: 5 μL of the sample DNA at 0.2 ng/μL was added to each well 
of a 96-well hard shell TCY Nextera XT Tagment Amplicon (NTA) plate. Following that, 10μL 
of Tagment DNA (TD) buffer (Illumina, USA) was added to each well, and mixed with sample 
DNA by pipetting up and down. 5μL of Amplicon Tagment Mix (ATM) (Illumina, USA) was 
added to the wells and mixed by pipetting up and down.  The NTA plate was then sealed with a 
MicroSeal® ‘B’ adhesive seal (Bio-Rad, USA), and centrifuged at 1500 rpm at 20°C for 1 minute. 
The NTA plate was then placed in a thermocycler at 55°C for 5 minutes to instigate tagmentation. 
The tagmentation reaction is neutralized through the addition of 5μL of Neutralise Tagment (NT) 
buffer (Illumina, USA). The NTA plate is sealed again with the MicroSeal® ‘B’ adhesive seal 
83 
 
(Bio-Rad, USA) and centrifuged at 1500 rpm for one minute and incubated at room temperature 
for 5 minutes. 
Index PCR amplification: The NTA plate was placed on a TruSeq Index Plate Fixture (Illumina, 
USA) and 15 μL of the Nextera PCR Master mix (NPM) (Illumina, USA) was added to each well. 
With a multichannel pipette, 5μL of index 2 primers was added to each column of the NTA plate, 
and 5μL of index 1 primers was added to each row of the NTA plate.  The NTA plate was then 
sealed with a MicroSeal® ‘A’ adhesive seal and centrifuged at 1500 rpm at 20°C for one minute. 
The plate was placed in a thermocycler at 72°C for 3 minutes, 95°C for 30 seconds, followed by 
12 cycles of 95°C for 10 seconds, 55°C for 30 seconds, and 72°C for 30 seconds, then 72°C for 5 
minutes and held at 10°C. 
Post-PCR clean up: The NTA plate was centrifuged at 1500 rpm for 1 minute. A multi-channel 
pipette was used to transfer 50 μL of each PCR product and 30 μL of AMPure XP magnetic beads 
(Beckman Coulters, USA) into a 96-well MIDI labelled as CAA (Clean Amplified Plate).  The 
CAA plate was then shaken on a microplate shaker at 1800 rpm for 2 minutes, and incubated 
without shaking for 5 minutes. The supernatant was carefully removed and discarded while the 
CAA plate was on a magnetic stand. The magnetic beads were then washed with 200 μL fresh 
80% ethanol and the plate was incubated on the stand for 30 seconds. The supernatant was once 
again removed and discarded. The ethanol wash step was repeated once, removing all remaining 
ethanol. The plate was kept on the magnetic stand and allowed to air-dry for 15 minutes. The CAA 
plate was then removed from the magnetic stand, and 52.5 μL of resuspension buffer (RSB) 
(Illumina, USA) was added to each well. The CAA plate was then shaken on a microplate shaker 
at 1800rpm for 2 minutes, and further incubated at room temperature for 2 minutes without 
shaking. The CAA plate was once again placed on the magnetic stand for 2 minutes. 50 μL of the 
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supernatant in the CAA plate was transferred to a new clean 96-well TCY plate (CAN) ready for 
normalization. 
Library normalization: 20 μL of the supernatant from the CAN plate was transferred to a MIDI 
plate labelled as Library Normalization Plate (LNP). A mixture of 4.4 ml library normalizations 
additives (LNA1) and 800μl library normalization Beads (LNB1) was prepared for the 
normalization of about 96 samples. 45 μL of the combined LNA1/LNB1 was added to each well 
of the LNP plate containing libraries. The LNP plate was sealed with a MicroSeal® ‘B’ adhesive 
seal and shaken on a microplate shaker at 1800rpm for 30 minutes.  The LNP plate was then placed 
on a magnetic stand for 2 minutes and 80 μL of the supernatant was removed and discarded. The 
LNP plate was removed from the magnetic stand and the beads are washed twice with 45 μL 
Library Normalization Wash (LNW1) in each well. The supernatant was then removed and 
discard. 30μL of 0.1N NaOH was added to each well, the plate was re-sealed and shaken at 
1800rpm for 5 minutes. During those 5 minutes, a new 96-well plate was prepared by   adding 
30μL of library storage buffer (LNS1) to each well (Storage plate SGP).  The LNP plate was placed 
on the magnetic stand for 2 minutes then 30μL of the supernatant from the LNP plate was 
transferred to the SGP plate. The SGP plate was sealed with MicroSeal ‘B’ adhesive seal and then 
centrifuged at 1000 g for 1 minute. The plate was store at 4oC ready for library quantitation and 
sequencing. 
Kapa library quantification qPCR: The Kapa Library Quantification Complete Kit (KAPA 
Biosystems) was used to determine if the library preparation worked and the quantity of the library.  
Firstly, the libraries were diluted by 1 in 8000 in a DNA dilution buffer (10 mM Tris-HCl, pH 8.0). 
The Kapa q PCR master mix was prepared from the kit and then 16 μL of the mix was dispensed 
into each well of a LightCycler® 480 96-well plate. 4 lug of diluted DNA samples and Kapa 
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standards provided with the kit were dispensed into the wells to make up a 20 μL reaction mix. 
Molecular-grade PCR water was added to negative control wells instead of DNA. The PCR was 
performed in a LightCycler® 480 machine and the thermal profile for amplification consisted of 
a denaturation step of 95°C for 5 minutes, followed by 35 cycles of amplification, involving 95°C 
for 30 seconds and 60°C for 45 seconds. All samples and standards were tested in duplicates. The 
sample quantitation was referred from the Ct values generated by standards.  A Ct value between 
13 and 18 was to be considered sufficient concentration for sequencing. Samples that did not 
generate a Ct value may indicate the failure of indexing the sample needs to be re-indexed. Samples 
with a Ct value >18 may be of very low concentration. 
Library pooling: The SGP plate was centrifuged at 1000g for 1 minute before the library pooling. 
5 μL of each library from SGP plate was pooled together into a LoBind tube (Eppendorf, Germany) 
labelled as pooled amplicon library (PAL). A 30 μL of the PAL aliquot was mixed with 30 μL of 
freshly prepared 0.2 N NaOH in a separate LoBind tube to denature double-stranded DNA libraries 
into single strands. The denatured library was then combined with 30 μL of 200mM Tris-HCl at 
pH 7.0 to neutralize denatured library. The library was then diluted with a pre-chilled 
Hybridization buffer (HT1) by taking a volume between 30 to 70 μL of the library solution in 870 
to 830 μL of HT1 buffer depending on the cluster density. A PhiX genome provided by Illumina 
was used as a 1% spike-in sequencing control as recommended by the Illumina. The final library 
to be ready for sequencing was prepared by mixture of 195 lug of the denatured and diluted library, 
1.3 lug of denatured and diluted PhiX control at 20pM, and 1103.7 lug of the pre-chilled HT1 (1.3 
ml in total).  
NextSeq 500 sequencing setup and loading: The WGS was performed using Illumina NextSeq 500 
platform. Following the Ilumina’s instruction, the Flow Cell, NextSeq reagent and buffer 
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cartridges were removed from the freezer and thawed at room temperature for 30 minutes before 
loading the library and upload to the machine. The entire 1.3 ml of the pooled denatured and diluted 
library was transferred into the designated reservoir on the reagent cartridge. Following the 
onscreen step by step instructions on the sequencing machine, the flow cell, the reagent cartridge 
and buffer cartridge were upload to the machine and lot numbers of all item were checked and 
proceed to sequencing once the run was set up on the BaseSpace Cloud Server-Sequence Hub ® 
(Illumina Inc, USA) following the procedure instructions. 
4.6 Bioinformatics applied for STM genome analysis  
Various bioinformatic approaches were employed through this research for aims related to 
genomic variation in the animal model as well as the comparative genomics for successful and 
non-successful STM clades. They have been separated into different method description sections 
in order to make it clearer to the reader.  
4.6.1 Identification and analysis of Single Nucleotide Polymorphisms (SNPs) 
SNPs were determined using, first, raw reads mapping against a reference genome and 
secondly by de novo assembled sequences mapped against the reference. FastQ files were 
imported into CLC Genomics Workbench v 7.0 (CLC bio, Aarhus, Denmark) and reads were 
trimmed to remove Nextera transposase adapter sequences then mapped to the reference genome 
of S. Typhimurium LT2 (NCBI GenBank Accession No. NC_003197). Quality-based variant 
detection was performed using settings of a minimum neighbourhood quality of 15 and minimum 
central quality of 20. Variant detection thresholds were set for a minimum coverage of 10 reads 
and minimum variant frequency of 75 %. De novo assembling was performed using the CLC 
Genomic Workbench by default setting except the contig length was set at great than 500 bp. 
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All predicted SNPs were visually/manually checked by locating the SNP positions in the 
read-mapping files and comparing the consensus calls to the reference genome. Gene and amino 
acid changes associated with each SNP were determined from the annotated reference genome. 
All identified SNPs were concatenate and made the alignment against the reference genome LT2 
using Snippy (https://github.com/tseemann/snippy). The resulting alignment was then performed 
phylogeny analysis using MEGA 7, which generate a SNP tree using maximum likelihood method. 
4.6.2 Analysis of core and accessory genomes  
Sequencing data was de novo assembly using SPAdes assembler using accurate parameter.  
The genome assemblies were than annotated using Prokka ®. The output GFF3 file from Prokka 
was used as input file for the pan genome analysis using Roary ® (220). The output files from 
Roary were generated either as a .csv file for a list of annotated genome with the presence and 
absence of core and accessory genes, or a core gene alignment phylogeny tree and  a pangenome 
matrix.    
4.7 Animal model for STM transmission pathways 
In order to analyse the presence of these potential variations across the genome and the 
description of genomically related changes, potentially associated with transmission events, is that 
an animal model causing STM infection was used, to resemble potential changes occurring on the 
human to human transmission events.  
4.7.1 Selection of a STM isolate for the animal model 
A human isolate of STM with a MLVA profile of 3-9-7-12-523 was selected as the initial 
inoculum in the mouse passage experiment. The isolate was collected from a human stool sample 
in 2010 and was revived from the culture collection at NSW ERL. The MLVA profile of this 
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isolate was selected since it had been identified as extremely successful, with its presence 
associated with numerous salmonellosis cases in NSW and also linked in particularly large 
outbreaks in terms of number of cases involved, not only in NSW but also in other states across 
Australia (34). The isolate was sub-cultured on the XLD culture media overnight at 37oC. A single 
colony from the XLD plate was subculture on a BA plate at 37o C overnight, from which the 
inoculum sample was prepared for mice experiment.  
The inoculum for mice experiment was prepared in PBS buffer as a suspension containing 
x105/mL colony-forming units (CFU) of bacterial cells. A volume of 200 µL was inoculated to a 
randomly selected mouse by oral gavage. To check the actual live cells inoculated into the mouse, 
a serial dilution of the original inoculum was prepared in PBS by 1 in 104, 103 and 102 dilutions 
and a triplicate sample of 10 µL from each dilution was inoculated on a BA plate and incubated at 
37oC overnight. The colonies from each dilution were visually counted and the average colony 
numbers from the triplicate samples were used to calculate the live cells inoculated in to the mouse. 
. 
4.7.2 Selection of experimental animals  
For the acute infection model, an albino, laboratory bred BALB/c mouse strain was 
selected. In total, 29 female BALB/c strains at age of 6 weeks old, weighing 16 – 18 grams were 
selected for the acute infection experiment. In the subsequent chronical infection experiment, the 
mouse strain 129X1/SvJ was selected. This strain has been reported that it presents clinical 
symptoms of non-typhoidal salmonellosis in a more similar way to that present in human STM 
cases (Sondberg and Jelsbak, 2016). A total of 10 mice at age of 6 weeks old, weighing 16 – 18 
grams, were selected. All experimental mice were kept at the Animal House facilities at Westmead 
Hospital to establish Salmonella infection. Upon arrival, mice were randomly distributed into 
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pairs. A week of adjustment and settling in was given and they were not deprived of either water 
or food during settling time. Cages were supplied with bedding for environmental enrichment. 
All animal experiments described were approved by the Western Sydney Local Health 
District Animal Research Ethics Committee (Protocol Number 5126.06.14). 
4.7.3 Animal Data Collection 
For individual identification purposes, all mice were marked using permanent ink and 
distinctive colours. During settlement week, and also later after infection, daily clinical 
examinations took place including daily recording of the following parameters: weight, activity 
level (categorized as normal, reduced activity and no activity), feeding habits (categorized as 
normal, reduced feeding, no feeding); appearance of fur (categorized as normal, ruffled, over 
ruffled); hunched position (categorized as normal, partial round and complete round), 
ataxia/tremor (categorized as normal, mild and over). After the first week of settling and if clinical 
examinations wouldn’t provide any signs of potential immune system alterations (weight loss or 
any other abnormal clinical finding), inoculation took place. 
4.7.4 Animal inoculation 
Infections were performed using the oral gavage technique by administrating 200 µL of 
inoculum at an infective dose of 105 cfu/mL. Appropriate manual restraint methods as well as 
technique skills were needed in order to minimize the risk of oesophageal trauma as well as 
avoiding dosage into the lungs, which usually results in the animal showing immediate signs of 
respiratory distress. If this was to be observed, then the animal should have been humanely killed. 
Negative controls consisted of healthy, 200 µL saline inoculated mice. 
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4.7.5 Stool sample collection 
 
Mice were manually and visually inspected after inoculation took place. Initial stool 
collection took place 72 – 96 hours post inoculation; later on, twice a week stool collections were 
performed for every inoculated animal. These were collected using a vial containing nutrient broth, 
incubated at 36o C overnight, vortexed vigorously and then plated on XLD agar plates for another 
overnight incubation. Enumerated and labelled positive plates were stored in STGG broth if later 
needed. Positive stool samples were collected for at least 4 days post-inoculation. If the clinical 
condition of the animal allowed, stools were collected up to 4 weeks post- inoculation. The last 
one of these stool collection series was used to prepare the subsequent passage inoculum. This one 
was prepared and treated following the same previously described method of inoculum preparation 
in subsection 5.7.2. In cases where no positive stool collection was detected, re inoculation of the 
mice took place under the exact same inoculum preparation. 
4.7.6 Tissue collection 
Tissues were collected after a minimum of 10 days after the initial positive stool cultures 
were obtained. Infected animals were culled based on clinical symptoms following the animal 
ethics guidelines for researches affiliated with The University of Sydney. Use of a carbon dioxide 
(CO2) gas chamber was the preferred culling method. For the second stage of the animal 
experiment, where mice strain modifications occurred, and no CO2 gas chamber was available. In 
these circumstances, dislocation of cervical vertebrae was performed. Once the appropriate 
euthanasia was confirmed, the tissue collection was performed by placing the mouse on adequate 
surface against the animal’s back. Anterior and posterior limbs were held by needles, so the 
abdomen and skin was not folded and ready to be disinfected with sterile 70% isopropyl alcohol 
pads.  
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A longitudinal incision from the sternum’s xiphoid process was performed. This allowed 
abdomen cavity completely exposed for tissue collection.  The collected tissues included the liver, 
spleen and intestine. Both liver and intestine tissue was collected by dissection of the organ and a 
collecting sample of approximately 1 cm in length. The spleen was collected as total organ. 
All tissues were enriched in nutrient media broth and plated on selective XLD agar plates 
and incubated overnight at 36o C. Once the Salmonella positive tissue cultures were obtained on 
the XLD plate, a single colony was sub-cultured on BA plates and incubated overnight at 37o C. 
The DNA was extracted from the BA culture following the DNA extraction procedure described 
in subchapter 4.5 for WGS. In the chronical animal experiment, stool isolate-based inoculation 
was also performed. Negative controls were established by an inoculation of 200 µL saline in the 
mice. 
4.8 Statistical analysis 
Statistical methods for the data belonging to aim number 1, including Spearman’s rank 
correlation coefficient and uni-variable linear regression were performed to investigate the 
correlation between observed and expected cases of STM; 95% confidence intervals and p-values 
were calculated. A value of p<0.05 was considered statistically significant when Chi square test 
was performed. For objectives 2 and 3, level of significance for comparative results were also 
calculated with Chi square test. All statistical analysis was performed by using IBM SPSS 
software® (International Business Machines Corp., US).  
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Chapter 5: Discriminatory power of MLST and MLVA subtyping methods 
for STM characterization 
 
5.1 Introduction 
The notion that circulating clades of Salmonella that cause human disease can significantly 
evolve over time is explored in this chapter. The results presented directly address the following 
research objectives: (I) To explore the capacity of MOST to identify and differentiate between the 
most common Salmonella enteric servers co-circulating in NSW, and (ii) to capture and 
characterize STEM population diversity in New South Wales by use of MOVE typing results. The 
results presented herein describe the molecular epidemiology of STEM in NSW between 2010 and 
2015, and propose a testable framework for monitoring circulating STEM clades. The MLST 
typing results were presented and defended as oral presentation by the candidate at the Australian 
Society for Microbiology Annual Scientific Meeting in Melbourne in 2014.  
 
5.2 Utility of MLST for inferring prevalent Salmonella enterica serotypes 
 
 
In order to confirm the ability of MLST to infer serovars as well as including serovars, 
which were prevalent for NSW and had not been previously reported by others, we randomly 
selected 126 Salmonella enterica isolates serotyped by the NSW Enteric Reference Laboratory 
between 2010 and 2012. These isolates represented the nine most common serovars associated 
with human disease in NSW in 2013. The proportion of isolates representing each serovar selected 
for inclusion in this study correlated with the prevalence of each serovar within the NSW 
population in 2013 (Table 5.1). In 2013, the majority of human NTS cases in NSW were caused 
by STM (71.7%; n= 91) followed by S. Enteritidis (7.9%; n=10) and S. SaintPaul (4.7%; n= 6).  
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Table 5.1 The S. enterica isolates included in this study. The selected serovars followed the 
respective proportions displayed by Salmonella in NSW during year 2013. 
Serovars Proportion within sample set (%) No of isolates selected 
for testing (n) S. Birkenhead 0.8 1 
S. Bovimorbificans 3.4 4 
S. Enteritidis 7.9 10 
S. Infantis 2.5 3 
S. Montevideo 2.5 3 
S. SaintPaul 4.7 6 
S. Stanley 1.7 2 
S. Typhimurium 71.7 91 
S. Virchow 4.7 6 
          Total 100 126 
   
Once MLST typing was performed and trimmed sequences submitted to the NSW ERL 
Salmonella database as described in Chapter 4 (Subchapter 4.3.3) a specific Sequence type (ST) 
was identified for each isolate. All STM isolates belonged to ST19 (n=86). Similarly, all isolates 
of SaintPaul serovar were assigned to ST50 (n= 6), S. Virchow strains were classified as ST16 (n= 
6), S. Infantis was associated with ST32 (n= 3) and serovars Birkenhead and Stanley were 
classified as ST424 (n= 1) and ST29 (n= 2), respectively. Thus, serovars could be distinguished 
based on MLST STs, differences between the profiles within serovars were observed. The 
sequence type and MLST profiles for each serovar are detailed in Table 5.2. For those isolates 
belonging to particular serovars where different ST types were inferred, the MLST allelic profile 
could differ by up to 5 alleles. This is the case of the isolates within the serovar Montevideo. 
Two distinct ST types were assigned, ST138 (n= 2) and ST316 (n=1).  When comparing 
these two allelic profiles, only the genes dnaN and hisD generated the same profile. All the 
remaining loci, when compared between each other, have a different assigned allele number. 
Differences within STM monophasic isolates were also observed; 3 different ST types were 
assigned including ST85, ST19 and ST34. Comparison within their allelic profiles was performed 
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finding differences within all 7 genes for ST85.  Differences between ST19 and ST34 were present 
only at dnaN.  Allelic profiles from STM and one of the STM monophasic isolates (ST34) were 
close, only differing in profile belonging to gene dnaN. Serovars can still be distinguished based 
on the last position of the profile.  
 
Table 5.2 ST designation for serovars of S. enterica and individual allelic profiles 
 
 
 
The distribution of the ST types and the relationships between them was visualized using 
minimum spanning trees. The size of the nodes represented the number of isolates included within 
that particular node, therefore the larger the node, the larger number the isolates within it. Also, 
linkage between nodes, expressed by the coloured shading between the ST19 and ST34 nodes, the 
95 
 
ST377 and ST499 nodes and the ST11, ST183 and ST180 nodes, represents a close relationship 
and genetic distance between sequence types within the same Salmonella serovar (Figure 5.1). The 
results suggest 100% concordance between serovars obtained by serotyping of somatic and H 
antigens and those inferred from MLST results. Our findings confirmed the ability of MLST-7 
scheme to predict S. enterica serovars that dominate ecological niches in the NSW. 
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Figure 5.1 Minimum spanning tree containing Salmonella enterica ST types (n=126). The red, green and blue shading refers to ST type 
relatedness based on allele profile within same serovars. The nodes are assigned different colours based on the proportion of isolates 
contained in each one of them. Red = > 80 isolates, dark blue = between 5 – 10 isolates, light blue = between 3 – 4 isolates, purple = < 
2 isolates.   
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5.3 Frequency distribution of STM infections based on MLVA profiles  
 
We then reviewed MLVA profiles associated with individual sequence types in order to 
compare the discriminatory power of two typing methods. The previous subchapter aimed to the 
capacity of MLST to identify and differentiate between the most common Salmonella enterica 
serovars co-circulating in NSW, which was accomplished, however, there were several distinct 
MLVA profiles within individual STM STs. Within the 86 isolates serotyped as STM and further 
classified as ST 19, there were 23 different MLVA profiles identified within these isolates (Table 
5.3). These findings reflect the need of a superior resolution tool to accurately investigate the 
distribution of STM infection in NSW. In order to accomplish this, a total of 11,799 STM isolates 
were genotyped using MLVA-5 between the 1st of January 2010 and 31st of December 2015. All 
duplicate isolates and environmental/food samples were removed from the dataset.  The number 
of MLVA typed isolates ranged from 1571 in 2012 to 2547 in 2014; year 2014 represents the 
highest number of typed isolates during the study period.  
The majority of isolates (96.5%) were recovered from stool samples; the remaining isolates 
were obtained from blood cultures, urine or other tissue samples and aspirates. The number of 
MLVA profiles present every year varied, with an average of 372 different types (range: 295 – 
398). Specifically, 436 MLVA profiles were documented in 2010, 398 in 2011, 295 in 2012, 360 
in 2013, 353 in 2014 and 390 in 2015, respectively. The number of yearly STM typed isolates 
according to particular MLVA profiles is detailed in Table 5.4. 
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Table 5.3 MLVA profile distribution within STM serovar, STM monophasic and ST types.  
 
NA= (no applicable). Corresponds to 2 MLVA profiles which at the time of isolates analysis and 
selection were not available as part of the NSW ERL Salmonella database. 
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Table 5.4 Total STM isolates and number of different MLVA profile identified each year, NSW 2010 – 2015 
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Mean age of patients regardless of gender was 30.09 ±23.81 years, with 41.1% of cases 
aged less than 14 years. In terms of the presence of the new cases of Salmonella evaluated through 
time and a potential association to demographic factors, no statistically significant differences 
among either gender or age group were found, the proportion of female (48%) and male (52%) 
cases was similar (p>0.05). Younger age groups, such as children between 0 – 4 years old, were 
over-represented in terms of new cases, but again, no statistical significance was found for this 
association. A gradual increase in the number of STM cases was observed during the study period, 
with some successful endemic STM activity identified. Among the MLVA patterns, six closely 
related clades, based on the 1 tandem repeat difference present within locus STRR10 and STRR6, 
were predominant: 3-9-7-13-523; 3-9-8-13-523; 3-9-7-14-523; 3-9-7-12-523; 3-9-7-15-523 and 3-
9-8-12-523. These clades represented almost 25% of all STM isolates analysed during the study 
period and could be clustered as part of one identifiable complex (STM Complex 1).  
STM Complex 1 has been present constantly in NSW, being involved in a large number of 
outbreaks and sporadic cases since the implementation of MLVA typing in 2007. MLVA profile 
3-9-7-13-523 was regularly identified and was established as one of the most successful endemic 
clades through the state. This finding was confirmed by reviewing the whole MLVA dataset for 
years 2010 – 2015. However, from 2012 the incidence of infections with MLVA profile 3-9-7-13-
523 isolates decreased, from 546 during 2010 to 30 in 2015.  
One repeat difference clade, MLVA profile 3-9-8-13-523, which was also regularly 
identified since earlier years also decreased, from 121 isolates in 2011 to only 4 during 2015. A 
similar decrease was evident for almost all members of STM complex 1 from mid-2012 until late 
2016. Profile 3-9-7-14-523 was successful between 2010 and 2011, before decreasing to 
undetectable levels during 2015. Another significant complex (STM Complex 2) present in NSW 
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included MLVA profiles 3-16-9-11-523, 3-16-9-12-523, 3-17-10-11-523, 3-17-9-11-523 and 3-
17-9-12-523. Though some of them were not detected in NSW earlier than mid 2012 - early 2013, 
there has been a slight increase in the number of outbreaks caused by STM Complex 2 from 2015. 
The number of isolates involved in STM infection and clustered within complex 2 remains less 
than the ones presented within STM complex 1. STM complex 2 exhibit a larger variety of related 
clades with one tandem repeat difference either in loci 3 or 4. This complex emerged strongly in 
2012, being identified in over 150 cases of disease. Even though the incidence of complex 2 
infections decreased during 2016 and early 2017, it’s still observed yearly, with numbers of new 
cases of approximately 45.  
When the incidence of a particular complex 2 MLVA profile decreased presentation during 
a particular year i.e. profile 3-17-9-12-523 between years 2013 and 2014, profiles with a one 
tandem repeat difference, i.e. 3-17-9-11-523, became associated with a large number of STM cases 
(refer to Table 5.5 to review this relationship). Distribution of the most common MLVA profiles 
identified during the study period was also represented using minimum spanning trees (MST) 
(Figure 5.2). Even though MLVA profile members of STM complex 1 have been present in NSW 
for longer period of time, when reviewing the total number of clades per complex between 2012 
and 2015, it becomes evident that this complex has not been the most successful one in years, 
hence STM Complex 2 has become highly successful in terms of STM cases presentation as 
presented in Table 5.5.  
During 2010, a large number of isolates were part of STM Complex 1. Following years, 
2011-2012, exhibited the same complex distribution: majority of STM cases still attributed to 
endemic profiles including 3-9-7-13-523 and 3-9-8-13-523; since 2012 though, the appearance of 
new successful patterns, displayed as large nodes challenging those linked to complex 1 became 
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evident. Several large nodes were evident in year including patterns belonging to both described 
complexes, 1 and 2, as well as additional new MLVA profiles (3-10-14-12-496 and 3-10-13-12-
496), which were linked to particularly large outbreaks (Table 5.6). The location of theses nodes 
within the whole spanning tree create a separate branch that was not present between 2010 and 
2012 (Figure 5.2). Year 2014 presented the largest number of STM isolates through the 6 years 
studied. Presentation of complex 1 and 2 remained, but complex 1 is represented by smaller nodes, 
being replaced by complex 2 isolates as well as novel MLVA profiles causing specific outbreaks 
(Table 5.6). The characterization presented during year 2014 is similar for year 2015 in terms of 
the predominant presence complex 1, in addition to previously define as sporadic MLVA profiles.  
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Table 5.5 The most prevalent MLVA clades over the period of this study (total counts and percentages shown).  
 
MLVA profile  Complex 2010  2011  2012  2013  2014  2015  Total 
3-9-7-13-523 1 546 (51.8%) 264 (25%) 106 (10%) 90 (8.5%) 19 (1.9%) 30 (2.8%) 1055 
3-9-7-12-523 1 61 (23.5%) 24 (9.2%) 14 (5.4%) 19 (7.3%) 102 (39.2%) 40 (15.4%) 260 
3-9-7-14-523 1 130 (42.2%) 106 (34.4%) 10 (3.3%) 49 (15.9%) 13 (4.2%) 0 308 
3-9-8-13-523 1 82 (18.7%) 121 (27.6%) 130 (29.7%) 89 (20.4%) 12 (2.7%) 4 (0.9%) 438 
3-16-9-11-523 2 ND ND ND 26 (16.1%) 91 (56.1%) 45 (27.8%) 162 
3-16-9-12-523 2 ND ND 63 (41.7%) 37 (24.5%) 49 (32.5%) 2 (1.3%) 151 
3-17-10-11-523 2 ND ND ND 5 (4.5%) 93 (84.5%) 12 (11%) 110 
3-17-9-11-523 2 ND ND 5 (1.5%) 40 (11.6%) 213 (61.7%) 87 (25.2%) 345 
3-17-9-12-523 2 ND ND 151 (46.6%) 163 (50.3%) 8 (2.5%) 2 (0.6%) 324 
Total clades per 
complex 
Complex 1 
Complex 2 
819 
 
515 260 
219 
247 
271 
146 
454 
74 
148 
2061 
1092 
ND = non-detected 
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Figure 5.2 Minimum spanning tree for main MLVA profiles through 2010-2015. Numbers 1 – 5, 
15 -16 within nodes correspond to profiles belonging to STM complex 1. Numbers 17 – 18, 22- 
25 within nodes correspond to profiles belonging to STM complex 2. 
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In order to further explore the distribution of STM, we then analysed the seasonal trends 
of the most common MLVA profiles associated with STM cases followed the expected STM 
seasonal pattern as displayed in Figure 5.3, with an increased number of cases during the warmer 
months. Two seasonal peaks, concentrating the larger number of cases based on “month of sample 
for culture collection”, have been usually observed: during Quarter 1 (January – March) and 
Quarter 4 (late September - December). The peaks in terms of increased number of cases during 
warmer months seem to be expanding to include cooler months such as May. For this month, 
current presentation of STM cases has shifted from an average of 6.4% of cases between 2010–
2012 to an almost 12% between 2013 – 2016. Regarding MLVA profile distribution across the 
whole period, Figure 5.3 displayed the dominance of particular profiles belonging to clonal 
complexes through identifiable years.   
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Figure 5.3 Temporal trends of successful STM MLVA profiles, NSW 2008 – 2016. The bars show the individual count for each of the 
considered MLVA profiles. Bars are coloured to represent the individual MLVA patterns specified. The bar height represents number 
of cases of each profile/month, etc. 
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5.4 MLVA profiles associated with community outbreaks 
 
 
Over the 5-year study period, there was no significant change regarding clustering of typed 
STM isolates as shown in Figure 5.2. However, these clusters present a particular trend in NSW: 
majority of them are small in size (less than 25 confirmed cases) and often within a limited 
geographical area (based on patient’s residential postcode), therefore usually demonstrate close 
geo-spatial distribution. In occasions, there are not always environmental samples clearly 
identified along the epidemiological investigation which test positive during outbreak 
investigation; however, based on epidemiological surveillance, a majority of these clusters were 
linked to a common source. Between 2010 and 2015, 113 confirmed outbreaks associated with 
STM were identified. The majority of the outbreaks occurred within Q4-Q1. When analysed over 
time, annual differences in the predominant PT of outbreak-associated isolates were observed. 
Table 5.6 describes the presentation of outbreaks yearly. In 2010, the MLVA profiles 
commonly identified as the source of 18 outbreaks belonged to PT170 corresponded to 3-9-7-13-
523, 3-9-7-12-523 and 3-9-7-15-523, all of them presenting 1 repeat difference within STTR10.  
From year 2011, PT170 organisms were still present associated to outbreaks but also un-related 
novel profiles emerged, such as 3-10-7-13-523. Rare MLVA types such as 3-11-11-9-523 and 3-
14-8-12-523 belonging to PT135 and PT6 were associated with a limited number of outbreaks. 
2011 presented less number of outbreaks than the previous year (n=13); 84.6% of them were linked 
to a particular food vehicle, predominantly raw eggs. 
Profiles 3-17-9-12-523 and 3-10-8-9-523, belonging to PT153 were highlights among the 
endemic PT170 organisms identified during 2012. This year was characterized by the largest 
number of outbreaks of salmonellosis (n=27), 85% of them were associated with STM. In 2013 
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the number of STM outbreaks decreased (n=9), and these were mostly associated with PT135 
profiles 3-17-9-12-523, 3-13-11-9-523, as well as the endemic PT170. 2014 displayed an increase 
in number of outbreaks (n=26), however trend continued as described earlier in terms of a decrease 
in association of them to endemic PT170 clades; PT170 was still represented but mostly related to 
other MLVA profiles. An increase on PT135 representatives, including uncommon MLVA 
profiles was also observed. Regarding PT 9 related patterns such as 3-10-7-12-523, 3-10-13-11-
496, and their respective clades, confirmed association to several outbreaks during 2015 was 
observed, manifesting a diversification of MLVA patterns associated with STM outbreaks through 
time (Table 5.6). 
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Table 5.6 Significant STM associated foodborne outbreaks in NSW during 2010 – 2015 
 
Year PT MLVA profile No. of outbreaks Cases within outbreak 
2010 170 3-9-7-13-523 9 82 
  170 3-9-7-15-523 3 19 
  170 3-9-7-12-523 2 25 
  170 3-10-7-15-523 2 5 
  170 3-9-7-14-523 1 16 
  170a 3-14-8-14-523 1 7 
  9 3-10-13-12-496 1 4 
  9 3-21-12-13-523 1 9 
  9 3-27-16-12-526 1 168 
  135a 3-11-11-9-523 1 7 
  204 3-11-10-9-523 1 4 
  6 3-14-8-12-523 1 10 
2011 170 3-9-7-13-523 1 6 
  170 3-9-7-14-523 1 6 
  170 3-9-8-13-523 1 17 
  170 3-9-8-14-523 1 13 
  44 3-10-8-9-523 2 93 
  135 3-12-9-10-550 1 9 
  135 3-13-11-9-523 1 4 
2012 170 3-9-7-13-523 3 27 
  170 3-9-9-12-523 5 65 
  170 3-10-7-15-523 1 15 
  170 3-9-8-13-523 4 19 
  170 3-10-7-13-523 1 14 
  135a 3-10-8-9-523 1 11 
  135a 
3-15/16-10/11-
523 1 8 
  135 3-13-9-11-550 1 4 
  44 3-9-8-14-523 1 14 
    3-27-8-21-496 1 9 
    3-14-9-14-523 1 10 
   3-17-9-12-523 3 23 
 2013  170 3-9-7-14-523 1 7 
   170 3-9-8-9-523 1 5 
   135a 3-10-7-14-523 1 49 
    3-23-23-11-523 1 17 
    3-27-8-21-496 1 8 
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Year PT MLVA profile No. of outbreaks Cases within outbreak 
2014 
 
 
2014 
135 3-12-12-9-523 3 26 
  
 
 
 135a 3-10-7-12-523 3 45 
    3-12-11-14-523 3 93 
   170 3-9-7-12-523 3 21 
    3-17-10-11-523 2 57 
  
 
  3-24-12-10-523 2 17 
    3-17-9-11-523 1 19 
    3-16-9-12-523 1 26 
    3-25-13-10-523 1 6 
    3-26-13-8-523 1 13 
    3-26-7-20-496 1 11 
   170 3-9-8-11-523 1 4 
    3-9-8-12-523 1 16 
    3-13-10-11-523 1 4 
   3-26-13-8-523 1 7 
 2015  170 3-9-7-12-523 1 5 
    3-26-17-10-523 1 5 
    3-16-9-11-523 1 8 
    3-12-11-14-523 2 16 
    3-12-12-9-523 1 11 
    3-14-9-13-523 1 5 
    3-10-9-9-523 1 5 
    3-26-13-8-523 1 4 
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5.5. Using WGS to distinguish outbreaks caused by a particular MLVA profile 
 
Analysis based on the use of WGS was performed in order to examine its utility in 
discriminating sporadic and outbreak linked STM infections within the same endemic MLVA 
profile. To accomplish this, two epidemiologically independent outbreaks (outbreak A and 
outbreak M) of a single MLVA profile belonging to STM complex 2, MLVA profile 3-17-10-11-
523, in NSW between January and May 2014, along with interspersed sporadic cases were 
analysed. Outbreak A was linked by NSW Health Authorities to chicken liver pate produced 
weekly from fresh ingredients at a Sydney café (Food Authority NSW, personal communication, 
14 August 2014). Outbreak M appeared to be caused by contamination of a number of foods and 
environmental surfaces at a Sydney hot bread shop (Food Authority NSW, personal 
communication, 14 August 2014). All sporadic cases occurred within two months of one or both 
outbreaks as shown by Figure 5.4. 
Of the 85 isolates of MLVA 3-17-10-11-523 recovered from human cases diagnosed 
between January and May 2014, 56 isolates were epidemiologically classified as belonging to 
either outbreak from the available data and therefore sequenced for this analysis. A breakdown of 
the 56 isolates regarding outbreak and type of isolate can be reviewed in detail in Appendix A.   
Following WGS, two case isolates from Outbreak A and two from Outbreak M were excluded 
from the analysis due to the poor quality of sequences. The total number of case isolates included 
in the study was 52.  
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Figure 5.4 Distribution of outbreak related isolates by date of collection. Outbreak isolates are labelled “C” (case), “E” (environmental) 
and “SC” (secondary case). 
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Outbreak isolates clustered into two groups consistent with their known epidemiological 
sources on the basis of SNP differences (Figure 5.4). All case isolates from outbreak M had a 
unique non-synonymous SNP (C to T) at position 723663 (reference STM LT2 base position), 
which was also present in the environmental and food isolates obtained from outbreak M. All of 
the isolates from outbreak M also had a single nucleotide insertion (A) at position (A) at position 
1789781.In addition, two isolates from outbreak M carried unique genomic variations, a deletion 
at position 2162287 and a synonymous SNP at position 3983630. Along with SNP differences 
described above, a seven base-pair deletion at position 2332558 was identified. This deletion was 
present in all isolates from Outbreak M but not those from Outbreak A. (see supplementary 
material for a complete SNPs table). All case and environmental isolates from outbreak A shared 
a unique single nucleotide insertion (A) at position 7408. In outbreak A, all of the case and 
environmental isolates from outbreak shared a unique single nucleotide insertion; only 1 of the 
case isolates also had a unique SNP at position 185058 and clustered separately from major 
outbreak A (Figure 5.4). Sporadic case isolates showed distinct SNP profiles compared to the 
isolates from Outbreak A and M, which are displayed independently in the MST as miniclusters 
detected by WGS.  Most sporadic cases were more than two SNPs away from the outbreaks and 
from each other, with only a few exceptions (Figure 5.5).  
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Figure 5.5 Minimum spanning tree of SNPs identified from the 52 STM isolates. Each circle 
represents isolates with indistinguishable genome; the size of circles corresponds to the number of 
isolates. The grey colour indicates the proportion of environmental isolates included in the 
analysis. The black corresponds to the isolate from the secondary case. Numbers above or on the 
left of the connecting lines between circles are the number of SNPs. SNPs as numbered and named 
accordingly in supplementary material.  
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5.6 Discussion 
 
Our findings have illustrated how molecular typing adds important evolutionary 
perspective to contemporary serotyping of Salmonella enterica. The congruence between observed 
and expected results of MLST-7 indicates that MLST scheme should perform well when applied 
to Salmonella strains circulating in NSW and Australia and can be reliably employed for molecular 
serotyping of them, minimizing the considerable challenges of serotyping, which include low 
throughput and high cost (205). We note that our experience has been limited to a relatively small 
set of 100 isolates and should be verified on a larger set, however, we have been encouraged by 
recent findings described by Bale et al (2016), who reported excellent molecular serotyping ability 
of MSLT-7 after analysing 29 Salmonella isolates with uncommon antigenic formulae, referred to 
Public Health England (PHE) between 1994 and 2004 (206). A Danish group headed by Litrup et 
al (2010), also established an association between Salmonella enterica serovars by means of MLST 
typing. Though the main aim of their research was to assess the concordance between virulence 
gene content and MLST data, the assignment of ST types agrees with the ones found in our study 
for serovars Enteritidis in 10 evaluated strains (ST 11) (207).  
Serovar Typhimurium (21 strains), which we identified mostly associated to ST19, ST34 
and ST85 in the monophasic Typhimurium isolates, presented a larger diversity of ST types in the 
Danish study. Still, ST19 remained the most common one, with the addition of ST34, 35 and 376 
for 3 individual isolates respectively. From these more uncommon ST types related to serovar 
Typhimurium, the only one present within our set of isolates was ST34 (n=1). 
Our MLST results are similar to the ones described by Achtman et al (2012) in terms of relation 
ST type to designated serovars (205). For instance, within serovar Typhimurium, majority of 
isolates were grouped within ST19. This complex is the central one, with the largest proportion of 
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isolates. Soyer et al (2009) described STM monophasic variants, identifying independent genetic 
events, containing distinct variants grouped within ST34 (208). This last ST type appeared to be 
associated with antibiotic resistance in China (209). There have been 26 different ST types reported 
by Achtman et al (2012) for the Typhimurium serovar, which differs from the 4 found within our 
group of Typhimurium isolates (205). This can be explained by the difference in isolates number 
that each project considered. Our project included 91 different Typhimurium previously serotyped 
human isolates, whereas the mentioned research published in 2012 describes the analysis of 482 
Typhimurium isolates. Our isolates corresponded to patients belonging only to Australia, 
particularly the state of NSW, much smaller when compared to the mentioned study, which 
included representatives from all continents. Also, our study did not consider other host than 
human, neither environmental isolates. 
Australia differs from many other developed countries, where serovar Enteritidis is the 
dominant cause of sporadic cases as well as outbreaks, mostly due to sociocultural profiles and 
dietary habits (210). Isolates from our study belonging to Serovar Enteritidis, were mostly 
classified as ST11, the most common ST for this particular serovar according to literature that 
focused on analysing isolates belonging to serovar Enteritidis from Greece (211). Similarly to 
Typhimurium, our study grouped Enteritidis isolates in one primary complex, which consists of 
two closely related ST types, which differ by less than 2 loci. These limited loci difference findings 
correspond to other published results (212). MLST approach can provide discriminatory power 
when compared to traditional serotyping methods, reproducibility, reliability and portability.  In 
addition, the increasing availability of MLST data in the public domain facilitates method 
harmonization between different laboratories and enables MLST to be used as a tool to accurately 
infer ancestral lineages. However, our experience also demonstrated the limits of MLST in 
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distinguishing between closely related outbreak isolates. In fact the seven-gene approach tends to 
cluster all Typhimurium isolates into a single sequence type, reason why the application of 
emergent technologies such as WGS can be used in a far more efficient way in the context of 
outbreak investigation. Currently, the Public Health England (PHE) is in the process of replacing 
the conventional MLST methodology with MOST, a method based on short read sequence data 
derived WGS (213). Since MLST can be inferred by WGS it is clear that the sequencing data 
generated by this platform is capable of providing more accurate results than the conventional 
MLST method. 
There were differences regarding the serovars included in our study when compared to the 
ones included by previously published research, which referred to the analysis of the top 20 
serovars among US human sources, other 20 among non-clinical non-human sources and an 
additional 20 human source isolates from other parts of the world (158). Australia’s, particularly 
NSW, top 10 incident serovars differ from other areas worldwide, therefore we were only able to 
develop comparisons between serovars Typhimurium, including monophasic strains, and 
Enteritidis. England presents serovars such as S. Stanley, S. Kentucky and S. Virchow within its 
most recurrent ones whereas for NSW serovar Virchow and Stanley are present but distant apart 
from the top 10 incident.     
Our results have demonstrated the superior resolution of whole genome sequencing. Using 
an example of one community outbreak, our study demonstrated unique genomic variations in 
each of the outbreak clusters, with one or two specific nucleotide variations in each outbreak group. 
This is consistent with a recent report examining 57 isolates of STM across five outbreaks, where 
within-outbreak isolates were genetically indistinguishable or differed by one or two SNPs (39). 
The findings also independently confirmed those of another recent study that analysed genomes 
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of 12 STM isolates and similarly demonstrated the presence of unique SNPs within outbreaks. In 
this research, isolates from distinct outbreaks differed from each other by more than 10 SNPs 
whereas in our study, isolates were more genetically similar, as it has been shown in other 
publications (196). Other studies have also found highly similar isolates within individual 
outbreaks, along with greater variability between outbreaks, where eggs from the same source 
were implicated (214, 131). 
The MLVA method has been implemented and employed to distinguish variants of S. 
Typhimurium worldwide, providing a discriminatory power exceeding that of the MLST method 
(131, 93). Furthermore, the clustering of STM isolates using MLVA approach has been correlated 
well with epidemiological data adding value to public health investigations. This utility is 
especially important STM was responsible for over 76% of outbreaks in NSW, whereas United 
States describes an average of 64% of egg-associated outbreaks (215). The analysis of STM 
infections distribution based on MLVA profiles in NSW, with an average of over 350 different 
profiles individualized through MLVA typing, is likely to be explained by a relative stability of 
‘endemic’ MLVA profiles grouped within PT170, associated with majority of confirmed outbreaks 
in NSW until 2012 (22, 27, 30,113-114). This magnitude of MLVA profiles seems not to be unique 
to Australian settings: the average of 372 distinct MLVA profiles identified through our study is 
similar to findings described in 2007 (119) in Denmark during a period of 2 years, and to some 
degree under the 414 distinct patterns described in Belgium (165). These studies including ours 
confirm the concept of stability of the MLVA loci in terms of reiterative presence of particularly 
endemic profiles involved in the majority of outbreaks present in different populations.  
Just as we observed locally, seasonal peaks are broadly described by Wuyts et al (2013), 
associated to Belgium warmer months (165). Similar trend was previously reported for Australia, 
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particularly in NSW by Sintchenko et al (2012) and by Lal et al (2016) for New Zealand; the first 
one detailed the presence of three seasonal peaks between August 2007 and August 2010, rising 
from November until March, where high temperatures take place (34). The second authors found 
relatively high temperatures to be positively associated with risk of infection in Auckland and 
Christchurch (216). While analysing the presentation frequency of particularly successful MLVA 
profiles, our study identified endemic and therefore successful profiles, often accompanied by 
related isolates with minimum allelic variations. Niemann et al (2015) described similar 
conclusions, with loci variation within a particular set of isolates mostly observed at STTR5 and/or 
STTR6, rarely at STTR3 (217). Additional reports by Chiou et al (2010) also labelled loci STTR5 
and STTR6 as hyper variable whereas STTR3 was considered as moderately variable (168). Our 
results highlight that locus STTR10pl has the greatest number of different alleles, followed by 
STTR5 and STTR6, suggesting a close genomic relatedness as well as the constant appearance of 
related MLVA profiles associated with outbreaks or large number of cases associated with STM 
infection. 
Our observations that STTR3 and STTR9 are less variable among chosen loci are 
congruent with reports by Dyet et al (2010) (218) and Prendergast et al (2011) (219). Hopkins et 
al (2007) have argued that these single-locus variations detected in MLVA profiles can occur 
worldwide (220), and proposed to consider isolates with single locus differences as related, 
similarly to what Larsson et al (2009) described (163). The uniform descriptions of predominant 
variants of main persistent clonal lineages could lead to the assumption of them as potential 
parental clades, as described for clonal complexes 1 and 2 through our findings. Earlier research 
involving animal and human isolates by Best et al (2007) also identified major clusters including 
large numbers of MLVA profiles (215). 
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Kurosawa et al (2012) from Japan, demonstrated 3 major and 3 minor clusters based on 
MLVA typing for isolates from bovine Salmonellosis (221). Also, research from Finland by 
Lienemann (2015), supports the identification of “clonal clusters” based on the isolates MLVA 
profile, with over 80% of the isolates being identified as clustered, based on MLVA typing (222). 
Our data and previous findings could suggest that the rarely isolated variants might represent 
mutant off-springs which could potentially spread out through the community, enhancing a 
possible accumulation of them in the environment in particular and make contributions to the 
permanent circulation and persistence of Salmonella. 
In conclusion, this chapter has examined the capacity of MLST to accurately identify and 
differentiate the most common serovars of Salmonella enterica co-circulating in NSW. Also, it 
has characterized the profile and temporal changes in STM populations in NSW based on the 
resolution power of MLVA typing for public health laboratory surveillance, highlighting existence 
of epidemic clades within specific seasons. We illustrated how WGS of STM associated with acute 
gastroenteritis can illuminate distinct foodborne community outbreaks amongst groups of isolates 
sharing the same MLVA profile. Genomic analyses can also further differentiate sporadic from 
outbreak cases and cluster sporadic isolates within endemic MLVA types of STM, which can 
significantly improve the resolution of public health laboratory surveillance. 
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Chapter 6: Temporal dynamics of STM in NSW 
6.1 Introduction   
In Chapters 5 and 6, results generated using the MLVA typing method has enabled 
temporal changes in STM populations to be identified. However, several important questions 
remain unanswered in terms of appearance of changes in STM population related to the increase 
or decrease in the severity of seasonal epidemics. Also, inquiries related to the real impact of 
established and new STM clades on the temporal dynamics of STM epidemics are relevant topics 
of discussion to provide the reader with a panoramic view in terms of temporal-dynamic events 
involved in STM infection presentation in NSW.  
In this Chapter, we further examine seasonal epidemics of STM previously described in 
Chapter 5 intending to unveil why the severity of annual epidemics in NSW varies and whether 
there is an association between emergence, increase or decrease of particular STM clades and 
changes in seasonal severity, generating new insights about the key attributes of STM populations 
associated with seasonal increases of human STM disease in the most populous state of Australia 
(Chapter 1, research objective 3).  
6.2 Seasonality of Salmonella Typhimurium (STM) infections  
Seasonal trend of cases followed the expected STM seasonal pattern, presenting an increase 
of cases during warmer months. Two seasonal peaks were usually found: one around summer 
(Quarter 1, January – March) and a final one related to late spring –early summer (Quarter 4, late 
September - December). Refer to Chapter 5 for figures. While analysing the total STM cases in 
NSW during all years listed in Table 6.1 and correlating them with clustered cases (Chapter 4), 
seasonality is observed with high incidence peak of total number of cases as well as clustering 
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present between summer and early autumn months across the whole period. A decrease in cases 
and clustering occurred around winter and early spring 2011, decreasing the total number of cases 
as well as clusters by about 50% (Figure 6.1). To investigate changes in the magnitude of annual 
STM epidemics, Summer-Autumn seasons were divided into ‘high’ and ‘low’ based on the 
incidence of STM cases. We calculated the average number of cases for summer-autumn season 
in NSW, which equals 1,300 cases and defined a season as ‘high’ if more than 1,300 cases were 
reported, whereas “low season” was defined by a total number of cases less than 1,300. For details 
regarding the STM isolates considered in this section of the thesis, total number of STM isolates 
serotyped and then genotyped as well as the number of MLVA profiles presented every year, refer 
to Chapter 5. The increase of STM cases during summer months was reflected in increases in the 
number of MLVA types detected in the community, as showed in Table 6.1. 
The proportions of STM isolates included in clusters showed seasonal fluctuations 
corresponding to changes in STM incidence. There was no significant change in the number of 
clusters or their average size over the period of this study (Figure 6.1). Regarding phage type (PT), 
this typing method was applied in NSW until year 2010 officially. For later years, it has been 
mostly inferred based on previous results and association to particularly common MLVA profiles. 
Year 2012 presents some isolates officially phage typed for research purposes (0.7%).  
For the remaining years, STM spectrum in NSW, based only on PT inference, was 
dominated by a small number of phage types, particularly PT170 which was the most common in 
NSW through the period of our study and through the analysed set of isolates (99.1%). The arrival 
of PT 135 has been inferred based on recent appearance of other MLVA profiles since 2012.  In 
2014 we noted the arrival and gradually increasing activity of PT9 with characteristic MLVA 
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profiles. PTs exit as well as its relationship with particularly successful MLVA profiles can be 
review in figure 6.2.   
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Table 6.1 Total STM and MLVA profile count, NSW 2010 – 2015 
 
 
 
 
 
 
 
Figure 6.1 Counts of STM cases and clustered cases in NSW between December 2008 and March 2016 
 
Year No. isolates (% of total) Number of MLVA profiles 
2010 2,054 (17.4) 436 
2011 1,972 (16.7) 398 
2012 1,571 (13.3) 295 
2013 1,807 (15.3) 360 
2014 2,547 (21.6) 353 
2015 1,848 (15.7) 390 
Total 11,799 (100) Average MLVA types: 372 
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Figure 6.2 Temporal trends of MLVA clades and associated phage types, NSW 2010 – 2015. Each bar colour corresponds to specific 
MLVA clades. The red arrow represents the exit of PT170; blue dotted arrow represents the arrival of PT135 and the green dotted arrow 
represents arrival of PT9  
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6.3. Rise and replacement of successful MLVA clades 
Focusing on the main representatives from STM clonal complex 1 and 2, previously 
described in Chapter 5 (subchapter 5.3) and their general distribution between mid-2008 and mid-
2016, Figure 6.3 shows the seasonal epidemics of human STM disease in NSW associated with 
STM clonal complex 1, which were the predominant cause of STM infections until 2012. 
During 2012 there was an evident change in terms of MLVA profiles causing STM 
infections; the MLVA profile 3-17-9-11-523 and its respective clades emerged and rapidly became 
the predominant cause of illness (Figure 6.3). MLVA clades belonging to STM clonal complex 2, 
presented a discrete initial appearance during 2012 (refer to Chapter 5, Table 5.5) and replacement 
of clades members of the initially endemic STM clonal complex 1. Neither of the individual 
MLVA profile members of complex 2 has presented the high number of identifications associated 
with STM infection that a single MLVA profile from STM clonal complex 1 displayed in 2010 
and 2011 (Table 5.5, year 2010 and 2011).    
From STM complex 2, MLVA profile 3-17-9-12-523 and its one repeat difference clade 3-
17-9-11-523, were the ones with the highest association to STM infection cases. When STM 
complex 2 has dominated the STM population in terms of new cases, STM clonal complex 1 and 
its members, appeared less common, but it was still identified until mid-2016 (Figure 6.3). There 
was no apparent association between particular successful MLVA profiles and a specific epidemic 
season during the study period. All successful profiles fluctuated accordingly to the previously 
described high and low seasons. The majority of STM infections associated with these successful 
clades, regardless if they belonged to STM complex 1 or 2, occurred during warmer seasons, 
regardless of whether it was a high or low season in terms of number of cases as shown in Figure 
6.4.  
127 
 
 
 
Figure 6.3 Temporal dynamics of a set of successful clades associated with STM infection cases in NSW, 2008 – 2016. The different 
colours represent proportion of presence for a set of successful MLVA profiles through time.   
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* High seasons (Summer 2010, 2011, 2014 and 2015) display a blue bracket; Low seasons (Summer 2009, 2012 and  2013 display a green bracket.  
 
Figure 6.4 Seasonal peaks involving successful MLVA profiles and STM infection cases, NSW 2008 – 2016. Series 1 (light blue) 
corresponds to MLVA profiles 3-16-9-11 (12)-523; Series 2 (orange) corresponds to MLVA profile 3-17-10-11-523; Series 3 (grey) 
corresponds to MLVA profiles 3-17-9-11(12)-523; Series 4 (yellow) corresponds to MLVA profiles 3-9-7-12 (13;14;15)-523 and 
Series 4 (dark blue) corresponds to MLVA profile 3-9-8-13(12;14)-523. 
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By calculating a linear regression of the observed number of incident cases every summer, 
plotted against the expected number of incident cases related to new MLVA profiles seen in the 
preceding winter, we estimated that for each incident case associated with a new pattern during 
Q2-Q3 (autumn - winter season), 4.4 more incident cases are to be expected in the following Q4-
Q1 period, (p= 0.032) for the 5 years studied. Though there was no association between particular 
MLVA profiles and high or low season, the diversity of infections in the preceding winter was a 
good predictor for a subsequent high season. 
  
6.4 MLVA profile uniqueness 
 
The concept of ‘profile uniqueness’ considers any MLVA profile present among a 
particular time period that causes less than 10 cases to be unique. Our results showed that close to 
2% of all typed isolates are related to more than 50 STM cases in NSW, however 90% of all MLVA 
profiles produce less than 10 cases per year, (Table 6.2). Demonstrating the relatively large 
diversity of “unique” MLVA profiles across NSW, which are associated with yearly STM 
infections. When correlating the seasonality of the STM cases during summer and winter season, 
referring to the number of STM infection cases presented (see subchapter 6.2) and the presence of 
unique MLVA profiles, warmer seasons always displayed a higher proportion of unique MLVA 
profiles (Usp) present when compared to the number of profiles present during colder seasons (Uwi) 
(Figure 6.5). The difference found between these two was statistically significant (p = 0.006). The 
proportion of unique profiles in summer looks the same for each year except 2010, regardless of 
high or low season. The proportion of unique MLVA profiles during summer seasons was always 
higher during the preceding winter months, progressively decreasing until 2015. In general, during 
high seasons, the proportion of unique profiles tended to decrease year after year; only during 
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summer period 2015, there was a minor increase in their proportion. During low seasons, the 
proportion of unique MLVA profiles presented yearly variations. During winter periods, unique 
patterns were slightly lower than proportions found in spring and summer.  
  
 
 
 
Table 6.2 MLVA profiles uniqueness linked to STM cases presentation, 2010 – 2015 
 
 
 
 
 
 
 Years 2010 2011 2012 2013 2014 2015 
Unique patterns linked to < 10 
cases 
 
399 
(91.5%
) 
367 
(92.2%
) 
266 
(90.2%
) 
330 
(91.7%
) 
309 
(87.5%
) 
352 
(90.3%
)  
Patterns linked to 10 - 50 cases 
 
30 
(6.9%) 
24  
(6%) 
22 
(7.5%) 
25 
(6.9%) 
37 
(10.5%
) 
33 
(8.4%) 
 
Patterns linked to over 50 cases 
 
7 
(1.6%) 
7 
(1.8%) 
7 
(2.3%) 
5 
(1.4%) 
7    
(2%) 
5 
(1.3%) 
Total No. MLVA patterns 
 
436 398 295 360 353 390 
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Figure 6.5 Unique MLVA profiles proportion among STM clades present during high and low season. Blue bars correspond to winter 
months; orange bars correspond to spring months; grey bars correspond to summer months. Middle chart represents difference in 
presence of unique profiles only in terms of high/low season (associated to the number of STM cases presented during summer when 
compared to winter season). Uwi = proportion of unique profiles during winter; Usp = proportion of unique profiles during spring.  
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To examine the relationship between the number of MLVA profiles, presence of singletons 
(MLVA profiles present only once) and the number of MLVA profiles occurring more than once, 
we employed the concept described in 1988 by Marrugan of “richness of the population”. This 
concept is generally used in ecological sciences to estimate the number of different species in an 
ecological community. In this case, it has been used to estimate the relative abundance and 
diversity that MLVA profiles, categorizing them in those present only once and those occurring 
more than once during particular time, within a particular STM population. It appeared that STM 
population in NSW was characterized by a high number of singletons, contributing to the season’s 
peaks distributed through the year. Every year, the highest number of singletons was observed 
during summer months, followed by a progressive decrease through the following autumn-winter 
months, to then finally rise again during the period between spring and summer. Only during 2014, 
which recorded the highest number of STM cases during the study period, was the difference in 
number of singletons present during months related to summer and autumn less visible (Figure 
6.6).  
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Figure 6.6 Trends of STM MLVA profiles richness based on proportion of singletons, patterns observed more than once and total No. 
of observed patterns quarterly, NSW 2010 - 2015 
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6.5 Reduction in newly identified MLVA profiles in winter and spring can 
predict salmonellosis epidemics 
 
In order to quantify the association between the proportion of novel MLVA profiles and 
the total case numbers detected during the preceding winter season as a predictor of “cases 
abundance” for the following summer season, a “Population velocity index” (Pv) was generated. 
The Pv enables quantification of the relationship between the proportion of new MLVA patterns 
during April and September (Quarters 2 and 3 (Q2 and Q3)), and the total number of STM cases 
during the same period as follows: 
 
Pv = (Proportion of new patterns during Q2-Q3 x Total No. of STM cases during Q2-Q3). 
 
  Based on the Pv formula, correlation proved that for a particular preceding winter (Q2-Q3) 
with a low expected number of incident new MLVA profiles, it is likely to expect a lesser number 
of cases as well as new MLVA profiles during the following summer (Q4-Q1). The actual 
correlation can be viewed in Figure 6.7.  
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Figure 6.7 Correlation between number of incident cases (associated with presentation of new 
MLVA profiles) during summer (Q4-Q1 quarters) and the expected number of incident new 
pattern cases during the preceding winter (Q2-Q3), NSW 2010 - 2015 
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When estimating Spearman’s rank correlation coefficient by associating the expected 
number of new profiles in winter and the number of new cases in the following summer, for 5 
years, the indicator resulted in 0.9 (p=0.037), suggesting that whenever the number of cases 
associated to new pattern during winter season quarters increases, the number of cases associated 
to same kind of patterns during summer season quarters will also increase.  
6.6 Discussion 
 
Our results have shown how the severity of seasonal STM epidemics can be predicted from 
small changes in the STM populations recovered from human cases. While we postulated the 
significant role of newly identified STM MLVA profiles and the importance of the time of their 
appearance, it was remarkable that established measures of population diversity remained stable. 
For example, Simpson’s diversity index, which measures the probability that two unrelated isolates 
characterized as being different by MLVA, was consistent over the time of the study. However, it 
didn’t take into account the actual variation of the number of repeat differences at each locus, 
identifying loci, which showed the least or most diversity. Pendergarst et al (2011) calculated 
diversity within each locus showing high diversity associated to STTR6 and 10 (142). The results 
reported in this chapter support the initial hypothesis that polymorphism in STM genomes, 
translated into MLVA profile variations in number of tandem repeats, is a key attribute that, in 
conjunction with epidemiological evidence, can affect the recognition and investigation of STM 
transmission events and community outbreaks.  
We observed a significant increase in the number of STM isolates through the years, with 
an average of over 350 different MLVA profiles individualized through typing. This increase is 
usually related to a relative stable presence of the so called endemic MLVA patterns grouped 
within PT170, which still managed to be associated with majority of confirmed outbreaks in NSW 
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until 2012 (35-37,127-128). The success of clades related to complexes 1 and 2 throughout the 
study period could be explained by constant shedding of new STM infection from environmental 
reservoirs to humans. The average of 372 distinct MLVA profile identified in our study is similar 
to the ones described by Torpdhal et al (2007) in Denmark during a period of 2 years (190) and to 
some degree also similar to the 414 distinct patterns described in Belgium by Wuyts et al (2013). 
This last study, similar to our approach, characterized Typhimurium populations associated with 
seasonal epidemics, showing involvement of specifically predominant MLVA profiles causing 
large numbers of STM cases (122). The descriptions of predominant variants of main persistent 
clonal lineages could lead to the assumption of them as potential parental clades, as described 
through our finding as clonal complexes 1 and 2. Data could suggest as well that the rarely isolated 
variants might represent mutant offsprings, which could potentially spread out through the 
community, enhancing a possible accumulation of them in the environment in particular, and make 
contributions to the permanent circulation and persistence of Salmonella.  
There is a stability of the novel/endemic ratio MLVA profiles to all observed types, which 
supports the assumption of constant seeding from the earlier set STM infections. The continuous 
introduction of new STM variants through latest years through NSW collected isolates must be 
highlighted, most of them not associated with outbreak presentation but with series of individual 
number of STM infection cases. Though numbers still remain low, the introduction of these novel 
variants will directly impact the STM population profile; even more, if particularly successful 
novel patterns raise their incidence, there would be an impact within spread and incidence rates. 
As stated by Tein Ngoi et al (2013), it is expected, when STM is endemic in a region, genetic 
homogeneity of local STM strains will be found (230). The analysis of potential prediction indexes 
adds further insights into the natural history of STM infection, proposing a baseline to delineate 
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cases presentation forthcoming, as well as bringing the need of early warning systems using 
prospective STM typing approaches on public health outcomes. 
These predictors require further analysis incorporating additional years and season. 
Predicting trends in terms of high/ low epidemic for upcoming warmer season, which will present 
higher incidence of STM cases, based on the appearance of new profiles and their relationship 
with total STM cases could be a simple but reliable tool aiming to direct actions as well as higher 
resolution analysis including WGS, for detection of cases and monitoring.  
In conclusion, significant increases in seasonal epidemic of STM can be associated with a 
reduction in newly identified MLVA profiles in the preceding winter and spring, reflecting the 
parallel decrease in population diversity and the emergence of successful STM clades under 
selection pressure. Prospective surveillance of STM based on MLVA-5 can identify the reservoirs 
of diversity from which future epidemics emerge. These findings also draw support for the 
conclusion that, in the analysis of seasonal STM epidemic, both their magnitude in case numbers 
and the diversity of STM subtypes need to be considered for precise public health assessment. 
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Chapter 7: Genomic analysis of successful STM  
7.1 Introduction 
Salmonella Typhimurium (STM) has demonstrated remarkable diversity as a zoonotic 
‘generalist’ serovar from which future epidemics and more ‘specialist’ high virulence strains might 
emerge. Evidence suggests that different serovars of Salmonella have been associated with 
different risks of invasive disease (218, 231) and diverse virulence traits underlie diverse clinical 
outcomes (232). Indeed, significant differences in invasiveness involving small numbers of 
virulence genes have been recently identified within serovars predominant in Europe (233-234) 
and the recent emergence of STM sequence type (ST)313 in Africa has been linked to invasive 
disease. Analysis of the ST313 isolates identified genome degradation concentrated in pathways 
associated with an enteric lifestyle, compared with the most widespread STM ST19 causing 
diarrhoea in humans. It appears that STM ST313 has been adapting towards a more host-restricted 
lifestyle typical of S. Typhi (225). However, the impact of genomic variation among epidemic 
STM isolates remains poorly understood.  Only one recent study has applied WGS analysis and 
associated to MLVA typing in terms of presence of these variations in genes, but to S. Enteritidis 
isolates in the Belgian National Reference Laboratory of Foodborne Outbreaks (122,232).  
Findings from this study, described in previous chapters (Chapters 5 and 6), demonstrated several 
successful clades that have dominated STM populations in NSW. In this chapter we attempted 
comparative genomic analysis between NSW sporadic and epidemic STM clades based on their 
MLVA profile in order to explain their successfulness of particular clades by linking genomic 
variation with epidemic potential in order to support the translation of WGS into public health 
laboratory surveillance of salmonellosis. 
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7.2 Selection of representative STM isolates 
Sixteen isolates representing three high incidence MLVA profiles across NSW throughout 
the years 2010 and 2015 were selected. The 3 MLVA profiles considered within this group were: 
STM-clade 3-9-7-12-523 (PT170), STM-clade 3-10-13-12-496 (PT9) and STM-clade 3-17-9-11-
523 (PT9). For the STM clades 3-9-7-12-523 and 3-10-13-12-496, isolates identified by NSW 
ERL between 2010 and 2015 were included in the study (n=6/clade). For STM clade 3-17-9-11-
523, due to its appearance since mid-2012, only 4 representatives were included (n=4). In addition, 
three strains were selected to contrast the features of successful STM clades. These non-successful 
isolates represented very uncommon MLVA profiles from the same phage types. One such isolate, 
STM MLVA 5-10-12-9-490, was observed very occasionally between February and July 2012 
(n=5). The other two, STM MLVA 3-9-7-15-523 and STM MLVA 3-16-11-11-523, represented 
clades associated with low rates of human infection when compared to the epidemic clades. 
Though they were classified as non-successful due to the limited number of STM cases they were 
associated with in contrast with the successful clades, they presented one or two tandem-repeat 
differences in one or two loci when compared with two of the successful MLVA profiles selected. 
The list of STM isolates selected for this comparative study is summarized in Table 7.1. 
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Table 7.1 STM isolates selected for the comparative study (n=19). Year of collection and 
designation (‘successful’/’non-successful’) have been included. 
 
Isolate Name Year 
collected 
MLVA profile Designation 
STM-01_S46 (STM1) 2010 3-9-7-12-523 Successful 
STM-2_S27 (STM2) 2010 3-10-13-12-496 Successful 
STM-3_S58 (STM3) 2011 3-9-7-12-523 Successful 
STM-4_S48 (STM4) 2011 3-10-13-12-496 Successful 
STM-5_S13 (STM5) 2012 3-9-7-12-523 Successful 
STM-6_S16 (STM6) 2012 3-17-9-11-523 Successful 
STM-7_S35 (STM7) 2012 3-10-13-12-496 Successful 
STM-8_S31 (STM8) 2013 
 
3-9-7-12-523 
 
Successful 
STM-9_S8 (STM9) 2013 3-17-9-11-523 Successful 
STM-10_26 (STM10) 2013 
 
3-10-13-12-496 
 
Successful 
STM-11_50 (STM11) 2014 
 
2014 
3-9-7-12-523 
 
 
Successful 
STM-12_S23 (STM12) 2014 
 
3-17-9-11-523 
 
Successful 
STM-13_S52 (STM13) 2014 3-10-13-12-496 Successful 
STM-14_S19 (STM14) 2015 3-9-7-12-523 Successful 
STM-15_S30 (STM15) 2015 3-17-9-11-523 Successful 
STM-16_S7 (STM16) 2015 3-10-13-12-496 Successful 
SRR2538292 (STM17) 2010 3-9-7-15-523 Non-successful 
SRR2538293 2012 5-10-12-9-490 Non-successful 
SRR2538304 2012 3-16-11-11-523 Non-successful 
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7.3 Main features of the core genome of STM clades  
 
As stated in Chapter 3, the core genome includes mainly genes that are essential for the 
bacterial cell in terms of growth and survival, and are often related to code for enzymes involved 
on the biosynthetic pathway (152). It is highly conserved in terms of sequence identity as well as 
in terms of the presentation order through the genome. The remaining 10% of genes has been 
described as unique to each of the different lineages and has been labelled as accessory genome 
(152). Comparative revision focusing on the accessory genome of all isolates, successful and non-
successful was performed. Preliminary analysis of the accessory genome annotations as well as by 
using graphical representations such as heat maps, indicated there is a stable segment of the 
genome, the core genome, which didn’t present any variations when compared within successful 
clades. There were also no variations when core genome from successful isolates was compared 
against the non-successful ones, regardless the fact that based on number of tandem repeat 
differences from MLVA profile the 3 non- successful clades are genetically distant; core genome 
remained stable for all set of 19 isolates as can be observed in the following heat map generated 
by Roary® (Sanger-Pathogens) (230). (Figure 7.1).  
 
7.4 Variations in accessory genomes 
 
The accessory genome of all isolates demonstrated variations, not only when comparing 
successful group of isolates against non-successful group of isolates but also when comparing each 
isolate against each other. Still, within almost all of the successful isolates (STM 1 – 16) and within 
the 2 non-successful clades, (SRR2538304 and SRR2538292) whose MLVA profile is identifiable 
as member of the two larger successful clonal complexes described in chapters 5 and 6 as clonal 
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complex 1 and clonal complex 2, there is a segment of the accessory genome within all of them, 
where the absence of genes (white colour) and the presence of other (grey) remains similar (Figure 
7.1). 
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Figure 7.1 ROARY heat map displaying core and accessory genomes for 19 STM clades. Grey area displays detectable genes. 
Homogenous grey areas when comparing isolates indicate similarity of genomic composition. White colour corresponds to absence of 
particular genes. Isolates name SRR correspond to ‘non-successful’ ones. The remaining, STM1 to STM16 isolates, correspond to 
‘successful’ isolates (see Table 7.1).   
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We hypothesized that epidemic potential can be associated and explained by the gene loss 
and/or acquisition within genomes of the unsuccessful sporadic clades and successful epidemic 
clades. Our data suggests that no genes were commonly absent in all three sporadic clades when 
compared to epidemic clades. Figure 7.2 illustrates genomic variation within each of the 19 
analysed clades matched against a set of particular genes. Majority of successful clades retained 
their genes throughout the years studied. MLVA profile 3-10-13-12-496 strains (yellow) were 
particularly stable in time. This was observed for genes hin and steC among others. Genes such as 
dinI remained present within clades from the 3-10-13-12-496 complex. While comparing the 
genomic structure of the 3-selected successful MLVA profiles, there were a number of genes in 
common. For instance, profile 3-9-7-12-523 and 3-10-13-12-496 share 37 common genes hence 
profile 3-17-9-11-523 and 3-9-7-12-523 share 12 genes. For MLVA profiles 3-9-7-12-523 and 3-
10-13-12-496 in terms of common genes presented, yfgF related to the bacteria motility, xerD 
related to chromosome stability and ftsK gene, essential for cell division are the relevant to mention 
(Figure 7.2).   
Parallel comparison between non-successful profiles and each of the successful ones 
showed at least 190 genes in common between profiles 5-10-12-9-490 and 3-10-13-12-490. 
Additional comparisons were performed involving successful and non-successful profiles with 
limited number of tandem repeat differences; in both these cases the number of shared genes 
increased in at least 100 genes. Presence of dinI gene, associated with shutting down the response 
that facilitates bacterial replication was the most meaningful finding (Figure 7.3).   
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Figure 7.2. continued 
STM STRAINS 
Genes 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16     17 18 19 Annotation Gene function 
glfT                    Galactoruranosyltransferase GlfT2 Cell wall biogenesis 
gspA 
 
                   General stress protein A Cellular stress response 
lpfD 
 
                   Ong fimbrial protein LpfD Specific adhesion system 
yfgF                    Cyclic di-GMP phosphodiesterase yfgF Bacterial motility (swimming) 
Trg                    Methyl-accepting chemotaxis protein III Regulatory gene 
dinI                    DNA-damage-inducible protein I Shuts off  SOS response when 
overexpressed 
rrrD 
 
                   Lysozyme RrrD Lysozyme activity 
phnT                    Putative 2-aminoethylphosphonate 
import ATP-binding protein PhnT 
Energy coupling to the 
transport system 
ftsK                    DNA translocase FtsK Essential cell division protein 
ybdO                    Putative HTH-type transcriptional 
regulator YbdO 
Involved with virulence-
related phenotypes 
 
oadB 
                   Oxaloacetate decarboxylase beta chain Lyase and sodium transporter 
xerD                    Tyrosine recombinase XerD Chromosome stability in 
bacteria 
Hin                    DNA-invertase hin Flagellar change variation 
promoter 
 
gpfI 
                    
Putative prophage major tail sheath 
protein 
 
DNA packaging of the phage 
genome aldB                    Aldehyde dehydrogenase B Oxidation-reduction process 
 
steC 
 
                    
Secreted effector kinase SteC 
Alters host cell physiology and 
promote bacterial survival in host 
tissue 
dgaE                    D-glucosaminate-6-phosphate ammonia 
lyase 
Catabolism of D-
glucosaminate 
clpP                    ATP-dependent Clp protease proteolytic 
subunit 
Helps growth under stressful 
conditions 
sopE                    Guanine nucleotide exchange factor 
SopE 
Promoting entry into non-
phagocytic cells 
dnaC 
 
                   DNA replication protein DnaC ATP binding 
cfiA                    2-oxoglutarate carboxylase large subunit Lipoyl binding 
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Figure 7.2 Presence or absence of particular allele genes within the 19 analysed STM clades. Presence of gene = coloured box. Absence 
of gene = white box. Also, the 3 particular clonal complexes have been assigned similar coding colour (     = STM complex 3-9-7-12-
523;    = STM complex 3-17-9-11-523;     = STM complex 3-10-13-12-496;     = sporadic clade 5-10-12-9-490;     = sporadic clade 3-9-
7-15-523;     = sporadic clade 3-16-11-11-523).  
 
STM strains 
Genes 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Annotation Gene function 
yihV                    Sulfofructose kinase Ribokinase activity 
brnQ                    Branched-chain amino acid transport 
system 2 carrier protein 
Structural gene 
Dam                    DNA adenine methylase Potential post replication repair 
function 
dpp5                    Dipeptidyl-peptidase-5 Removes dipeptides from larger 
peptides 
Pal                    Peptidoglycan-associated lipoprotein Bacterial survival and pathogenesis 
rspA 
 
                   Putative dehydratase catalytic activity 
rsxC                    Electron transport complex subunit rsxC Electron transport at membrane 
level 
garK 
 
                   Glycerate kinase Organic acid phosphorilation 
ftsK                    DNA translocate FtsK Assembly of cell division 
sspH                    E3 ubiquitin-protein ligase sspH2) Bacterial survival and alters host 
cell physiology 
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Figure 7.3 Venn diagrams summarizing numbers of genes and shared genes between three successful MLVA clades 3-9-7-12-
523, 3-17-9-11-523 and 3-10-13-12-496; also number of genes shared between each of the successful clades compared to each of the 3 
non-successful MLVA profiles. Successful clade 3-9-7-12-523 compared to non-successful 3-9-17-15-523, Successful clade 3-10-13-
12-496 compared to non-successful 5-10-12-9-490 and successful clade 3-17-9-11-523 and non-successful 3-16-11-11-523. 
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Phylogenetic trees based on the accessory genome were used to cluster together the 
different successful and non-successful isolates (Figure 7.4). The tree clustered together isolates 
belonging to MLVA profile 3-10-13-12-496 (STM-2, STM-10, STM-16, STM-13, STM-4 and 
STM-7). Non-successful/sporadic clade 5-10-12-9-490 (SRR2538293), though it is not part of the 
mentioned cluster for profile 3-10-13-12-496, did share a common ancestor.  For these same 
isolates, the ones recovered in 2014 and 2011 were grouped together; similar situation occurred 
for isolates 3-10-13-12-496from 2013 and 2015. 3-10-13-12-496 isolates from 2010 and 2012 
were allocated within the same general cluster but in independent branches. As expected, isolates 
with MLVA profile 3-17-9-11-523 (STM-6, 12, 9 and 15) were clustered together and shared a 
common ancestor. Unsuccessful/sporadic clade 3-16-11-11-523 (SRR2538304), despite being 
close to a most recent ancestor of the successful clades, was positioned separately in the tree 
indicating significant differences between them in accessory genomes. 
For STM MLVA profile 3-9-7-12-523, distribution within the tree was different. Two of 
the isolates (STM-11 and 8) collected in 2013 and 2014 were clustered together. Sporadic clade 3-
9-7-15-523 (SRR2538292) was clustered independently, however with a common ancestor to the 
mentioned MLVA profile. Also, a common ancestor was shown between this sporadic clade and 
other ancestors for MLVA profile 3-17-9-11-523. The rest of the MLVA profile 3-9-7-12-523 
clades (STM-5, 14, 3 and 1) collected in 2010, 2011, 2012 and 2015 were clustered separately. 
Figure 7.4 also showed how unsuccessful clades, i.e 3-16-11-11-523, clustered relative to the 
successful clades profile 3-17-9-11-523. 
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Figure 7.4 Maximum likelihood tree based on accessory genomes. The colours correspond to the identifying colours used for particular 
MLVA profiles in Figure 7.2. MLVA profile 3-9-7-12-523, 3-10-13-12-496 and 3-17-9-11-523 corresponded to the successful clades. 
MLVA profiles 5-10-12-9-490, 3-16-11-11-523 and 3-9-7-15-523 corresponded to the non-successful clades.   
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7.5 Genomic differences between successful and no-successful STM clades 
 
When evaluating genomic differences within non-successful profile 3-9-7-15-523 when 
compared to successful ones, there is a single gene absent from its accessory genome. This one is 
present in all epidemic clades through the years and is gene gspA-2, a general stress protein A.  
It is usually present within the Enterobacteriaceae family and its function is associated with 
lipopolysaccharide 3-alpha-galactosyltransferase activity. Comparison of genomes from sporadic 
clade STM 3-9-7-15-523 with  epidemic STM 3-9-7-12-523 identified three genes which are 
present in the epidemic clade but absent in the sporadic clade: glfT, gspA (previously described in 
general correlation against all successful clades in Figure 7.2) and lpfD. This last gene codes for 
the long polar fimbrial subunit lpfD located within DNA complement strand. It is involved in 
adhesion of Salmonella to either other cells or any extracellular matrix (231). The lpfD-2 gene is 
usually found in serovars Typhimurium and Enteritidis. Its loss could potentially lead to the 
reduction on STM ability to effectively colonize host’s cells. Figure 7.5 displays the lpfD-2 
location on the STM complement strand. 
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Figure 7.5 lpfD gene location on the complement strand of the STM genome (McClelland et al, 
2001). The arrows towards left indicate this gene is located within the reverse strand. Red has been 
used to highlight its location. 
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Gene glfT-2 encodes the enzyme galactofuranose, which plays an important role in cell 
wall biogenesis involving the lipopolysaccharide (LPS) structure in gram-negative bacteria, and 
enabling the “entry to cell” associated activities. The absence of this gene within non-successful 
STM isolate’s genome would translate into limited functionality within the non-successful STM 
clades to actively generate cell infection. Comparing MLVA profile 3-9-7-15-523, sporadic clade, 
with MLVA profile 3-17-9-11-523, classified as successful/epidemic based on case number 
presentation, the sporadic clade presents several missing genes when compared to the particular 
epidemic clade: glfT-2, gspA-2, lpfD-2, yfgF-3 and trg-2. They are located across the whole 
accessory STM genome, with no specific region involved. Two genes, lpfD-2 and yfgF-3 are 
important in STM adhesion to the host cell and the swimming behaviour, respectively (Figure 7.2). 
Comparing non-successful clade 3-9-7-15-523 and successful STM-clade 3-10-13-12-496, 
regardless the year where the successful clade belongs to, results show there are 18 genes missing 
in the accessory genome of the non-successful clade; almost all these gene absences are different 
from the ones recognized when comparing non-successful clade 3-9-7-15-523 to STM-clade 3-17-
9-11-523, with the exception of gspA-2. Five of the missing 18 genes contribute to the capability 
of a particular STM clade to effectively generate infection; these are ptxA, ftsK, dinI-1, hin-1 and 
steC-2. This last one, gene steC-2, is required for the formation of the Salmonella Pathogenicity 
Island (SPI)-2-dependent F-actin meshwork, responsible for the STM replication inside 
mammalian host cells (168) (Table 7.2). 
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Table 7.2 Genes lost in STM MLVA 3-9-7-15-523 in comparison with STM MLVA 3-10-13-12-496 
Lost genes 
  
Annotation Function/Special feature 
gspA General stress protein Bacterial stress response 
dinI DNA-damage-inducible protein I plasmid: pSTM709 
rrrD Lysozyme RrrD Lysozyme activity 
phnT Putative 2-aminoethylphosphonate import ATP-binding 
protein PhnT 
Probably responsible for energy coupling 
to the transport system 
ftsK DNA translocase FtsK Essential cell division protein 
ybdO putative HTH-type transcriptional regulator YbdO Associated with virulence 
oadB Oxaloacetate decarboxylase beta chain Lyase and sodium transporter 
xerD Tyrosine recombinase XerD Stability of circular chromosomes in 
bacteria 
dinI DNA-damage-inducible protein I Decreases replication of damaged DNA 
rrrD Lysozyme RrrD DLP12 Prophage; Lysozyme activity 
Hin DNA-invertase hin Flagellar change variation promoter 
gpfI Putative prophage major tail sheath protein DNA packaging of the phage genome 
aldB Aldehyde dehydrogenase B Oxidation-reduction process 
steC Secreted effector kinase SteC Alters host cell physiology and promote 
bacterial survival in host tissues 
dgaE D-glucosaminate-6-phosphate ammonia lyase Involved in the catabolism of D-
glucosaminate 
oadB Oxaloacetate decarboxylase beta chain Lyase and sodium transporter (sodium ion 
pump) 
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There were three genes missing within non-successful MLVA profile 5-10-12-9-490 
accessory genome: fsr, sspH2-1and gspA-2. The last one was also absent in sporadic clade 3-9-7-
15-523. Gene fsr corresponds to a trans membrane transport protein, which could have a role in 
virulence by activating and repressing multiple genes. Gene sspH-2 (E3 ubiquitin-protein ligase 
SspH2) codes an effector protein on SPI-2 that alters host cell physiology and to promote bacterial 
survival in host tissues. In terms of presence along the sporadic clade’s genome, four genes can be 
identified as present within clade 5-10-12-9-490 only, clcP, dnaC, yihV and sopE. 
All them appeared to be lost from epidemic clades, regardless individual isolate’s year of 
collection. Special mention regarding relevant function for sopE, which has been described as part 
of a protein secretion system that translocate bacterial proteins into the host cell and for clpP, 
which presence would have a role in growth under stressful conditions.   
Gene dinI, which main function has been associated to modulate the switching off of the 
SOS response needed in terms of facilitating bacterial replication, when present in a particular 
Salmonella organism was present in all non-successful clades including 5-10-12-9-490 and absent 
in both most successful MLVA profiles, 3-9-7-12-523 and 3-17-9-11-523. A list of this genes and 
a general summary of their name and function can be found in Table 7.3. 
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Table 7.3 Genes found in STM-clade 5-10-12-9-490, which are absent in epidemic STM clades 
Gene Annotation Function/Special feature 
Group 1091 (dinI) DNA-damage-inducible 
protein I 
Gifsy-1 prophage DinI 
clpP ATP-dependent Clp protease 
proteolytic subunit 
 
Helps bacteria to grow under 
stressful conditions  
gpfI Putative prophage major tail 
sheath protein 
DNA packaging of the phage 
genome 
sopE Guanine nucleotide exchange 
factor SopE 
Promoting bacterial entry into 
non-phagocytic cells 
dnaC DNA replication protein 
DnaC 
 
ATP binding 
Group 176 (cfiA) 2-oxoglutarate carboxylase 
large subunit 
Lipoyl binding 
yihV Sulfofructose kinase Ribokinase activity 
 
 
In terms of gene presence within non-successful clade 3-16-11-11-523 genome but absent 
in all successful profiles, there is a single relevant gene to refer to: dinI. The presence of dinI is 
common within all sporadic clades and it would reduce the STM clades facility to carry on with 
the required intracellular bacterial replication within pathogenesis (236). Additional genes that 
Roary software identifies as present within non-successful 3-16-11-11-523 clade but absent in all 
three successful profiles correspond to: brnQ, xerD-, dam, dpp5, pal and rspA (Table 7.4). 
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Table 7.4 Genes present in STM MLVA 3-16-11-11-523 but absent in any of the three successful 
STM clades 3-9-7-12-523, 3-17-9-11-523 and 3-10-13-12-496. 
 
Gene Annotation Function/Special feature 
dinI (group 1513) DNA damage inducible 
protein I 
Modulates SOS response 
brnQ Branched-chain amino 
acid transport system 2 
carrier protein 
Component of the LIV-II transport system for 
branched-chain amino acids. Structural gene 
xerD Tyrosine recombinase 
xerD 
Catalysing the cutting and re-joining of the 
recombining DNA molecules during cell division 
Dam DNA adenine 
methylase 
Post-replication mismatch repair function 
dpp5 Dipeptidyl-peptidase-5 Removes dipeptides from the C-termini of N-
blocked tripeptides, tetrapeptides and larger 
peptides 
Pal Peptidoglycan-
associated lipoprotein 
Essential for bacterial survival.  
rspA Putative dehydratase Catalytic activity 
 
7.6 Genomic variations within epidemic clades over time 
 
Our findings showed that sspH gene, with a main role in altering host cell physiology and 
promotion of bacterial survival in host tissues, was initially present in the two isolates belonging 
to STM MLVA 3-9-7-12-523 from 2010 and 2011; it appeared lost and was not found in any of 
the four isolates recovered from patients diagnosed with STM disease since 2012. Correlating this 
information with the MLVA profile of associated human cases during each year (Chapter 6), 2012 
was the period where the incidence of this clade was lowest (n=15) compared to 223 cases in 2009 
and 89 identifications within STM cases in 2010.  
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The identification of this particular MLVA profile continued to decrease during 2012 and 
2013, only to present a rise in recognition during 2014 (n=100) to again reduce its identification 
and association to STM cases in 2015 and 2016 (n=43 and 27 respectively). This increase on the 
STM cases in 2014 could not be related to any particular gene finding. For the same profile 3-9-7-
12-523, there were ten genes that remained stable in accessory genome through the 6 years period: 
genes glfT, gspA, lpfD, yfgF, phnT, oadB, xerD, cfiA, garK and ftsK. Genes yfgF and ftsK have 
particular roles in motility and cell division respectively. For epidemic MLVA profile 3-10-13-12-
496, genes remained constant for this particular clade’s accessory genome between 2010 – 2015: 
genes phnT, oadB and steC. These four genes were absent in all 3 sporadic isolates. For epidemic 
clade 3-17-9-11-523, only 3 genes remained present in all isolates belonging to this profile between 
2012 and 2015: yfgF, with a recognized role in suppressing motility defects, trg gene which has 
the ability to sense sugars, as part of its chemotaxis components involved directly into flagellum 
activity and sspH, with an active virulence role previously described for successful MLVA 3-9-7-
12-523. The presence of these genes related to effective motility was related with the peak 
incidence of this clade in terms of STM cases in 2014 (n=200). 
 
7.7 Comparison of present SNPs within the three successful MLVA profiles 
with the reference STM LT2  
  
After performing a variant detection analysis with CLC genomics workbench ® for all the 
three successful clades, in compare to each other, the STM clade which presented the largest 
number of SNPs was clade 3-10-13-12-496, with an average of SNPs presentation of over 1,500 
SNPs per year. Within these, approximately 70% of them, which corresponds to more than 1,000 
SNPs, were related to synonymous SNPs with no evidence of amino acid change as a consequence 
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of the nucleotide mutation.  This proportion remained constant through the 6 years of study. 
MLVA profile 3-9-7-12-523 was the successful clade, regardless the year, with the least 
synonymous SNPs (mean of 301). SNPs observed associated to MLVA profile 3-17-9-11-523 
presented a similar mean of 302. In terms of trend of SNP presence for STM clade 3-9-7-12-523, 
there was a significant drop in numbers, from a total number of SNPs of 1,529 in 2010 to 716 in 
2011; the proportion of synonymous SNPs for year 2010 was 19.3% whereas the following year, 
the proportion of synonymous SNPs increased to 42%. This drastic increase was only visible 
within STM clade 3-9-7-12-523; the other 2 remained constant through all the years, with between 
30 – 40% of the total SNPs corresponding to synonymous (Table 7.5) 
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Table 7.5 Comparative analysis in terms of presence of SNPs within STM successful clades and 
reference strain. There is no data available for profile 3-17-9-11-523 during 2010 – 2011 since this 
clade was not identified as associated to STM infection until 2012.  
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of SNPs (synonymous / non-synonymous) 
MLVA Profiles 2010 2011 2012 2013 2014 2015 
 
3-9-7-12-523 
295/421 
(N=1,529) 
302/414 
(N=716) 
297/443  
(N=730) 
302/434 
(N=736) 
305/431 
(N=736) 
305/429 
(N=734) 
 
3-17-9-11-523 
  302/428  
(N=730) 
303/417 
(N=720) 
305/416 
(N=734) 
302/399 
(N=701) 
 
3-10-13-12-496 
459/1,070 
(N=1,529) 
459/1,052 
(N=1,511) 
458/1,056 
(N=1,514) 
467/1,095 
(N=1,562) 
457/1,049 
(N=1,506) 
470/1,097 
(N=1,567) 
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7.8 Discussion 
 
Our results improve the understanding of dynamic changes in clonal distribution of STM 
over time. All genomic differences within isolates were found in the accessory genome; this 
confers advantage to each particular isolate in a specific niche. Relevant differences involved 
presence of genes associated with pathogenicity and motility within the successful clades and 
absence in the non-successful. Some of these genes were also found strictly in the two more 
successful MLVA profiles when associating them with generation of STM cases. Comparisons of 
STM LT2, S. Enteritidis and S. Gallinarum have proven that genes conserved between serovars 
show approximately 99% identity at the nucleotide level (154). It is not surprising then that when 
we analysed a limited in number however diverse set of STM isolates according to MLVA profile, 
but all belonging to the same serovar, the similarities in terms of genome composition will be even 
greater. 
There was a clear stability of core genome within our isolates, with some variability 
observed at the accessory genome level, particularly when comparing the three successful clades 
against the 3 non-successful ones; Suez et al (2013) mentioned the same conclusion (161). 
Nevertheless, even between members of the same or closely related serovars, between 1 
and 5% of the genes are strain-specific, corresponding mainly to large prophage elements and even 
other mobile genetic elements and plasmids (79). With this assumption in mind, although the 
Salmonella genome can be considered conservative when compared to other organisms such as E. 
coli, it is still highly plastic, which was observed through the analysis of the similar successful 
MLVA profile isolates through time. There was no large number of genes to support the plasticity 
concept based on deletions or insertions; in fact, a majority of the genes remained constant through 
the 4 to 6 years analysis of the 3 selected epidemic clades. Considering that the selection of these 
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isolates was random in terms of representing each year but targeted in terms of not being based on 
any criteria which could increase the chances of genomic adaptability taking place, but only 
focused on having similar MLVA typing result and not belonging to the same patient as published 
by Octavia et al (2015), it seemed that each isolate had not gone through individual adaptive 
changes, resulting on large amount of modifications affecting numerous genes through time (219). 
Particularly for the MLVA profile member of the most successful STM clonal complex in NSW, 
3-9-7-12-523, there are genes whose presence correlated with highly epidemic years. This is the 
case of gene sspH, a phage remnant containing virulence genes commonly associated with type III 
effector proteins that are injected by the bacteria and which are important for virulence, as 
described by Brussow et al, (2004) (237). This gene was found in all of our isolates belonging to 
2 out 3 STM successful MLVA profiles; these two corresponded to the profiles associated with 
the largest number of STM cases in NSW.  
Its presence within the STM genome has been described by Bhavsar et at (2013) as one of 
the secretion systems on SPI-1 and SPI-2 capable of transporting effector proteins directly into the 
host’s cells so they can interfere in particular cellular processes (165). These SPI-2 effectors are 
critical for S. Typhimurium pathogenesis, particularly for systemic infection (Kuhle and Hensen, 
2004) (238). Pang et al (2013) also found this particular gene within their 6 different analysed 
strains, confirming not only its association to SPI-2 secretions but also its role in terms of virulence 
(239). sspH gene remained within the genome of all epidemic clade isolates analysed in this study 
between 2010 and 2011. This period of time is where STM cases associated with this particular 
MLVA profile presented higher incidence. Once the gene disappeared (from 2012 onwards), the 
number of cases associated with this particular profile decreased substantially, according to NSW 
ERL Salmonella dataset.  
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Gene steC, was also found in one of the successful MLVA profiles (3-10-13-12-496); this 
gene has been described by Poh et al (2007) and Imami et al (2013) as responsible for the active 
replication of STM in the host cells as a secreted effector bySPI-2 (240, 165). Thought this gene 
was not a generalized finding within all three successful MLVA profiles, MLVA profile 3-10-13-
12-496 was the one with presence of STM cases which has presented more stability in time when 
compared with the other two successful profiles 3-9-7-12-523 and 3-17-9-11-523; these last two 
have been very successful at their own period of time, as shown in chapters 5 and 6, however their 
association with STM cases has presented fluctuations. 
MLVA successful clade 3-10-13-12-496 has been not been associated with STM cases in 
as elevated numbers but its presence has remained more constant in time, when compared to the 
other two profiles. The disappearance during years 2012 - 2013 and later appearance of genes such 
as rsxC and garK within the accessory genome of successful clade 3-9-7-12-523 could be 
explained as an adaptive measure to respond and regulate growth in a more efficient way, based 
on host and/or environmental characteristics. Lamichhane-Khadka et al (2011) have described the 
presence of gene rsxC, among others, as a tool for metabolic flexibility, allowing STM to survive 
in diverse environmental conditions both outside and within the host, as a way of increasing the 
survival capability of the bacteria either within macrophages and/or animal hosts (241).  
Amongst the STM 3-9-7-12-523 isolates analysed in this study, the garK gene was present 
until 2012, absent in 2013 and 2014 only to reappear in 2015. Perhaps the gene stimulation 
expression by means of a modification of environmental variables (temperature, humidity), 
generated the suppression of this particular gene during those 2 years, where according to NSW 
Health Bulletins relate to lower presentation rate for this particular profile. 
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The presence of gene yfgF only within the three successful STM isolates can be explained 
by the description of the gene’s function as stated by Girgis et al (2007), where this gene’s 
contribution to the bacteria’s capability of generating infection by means of been involved in 
motility-related infective functions is relevant (242). Similarities in terms of its association to the 
flagellum functions are found regarding gene trg. This gene was only present within the successful 
isolates belonging to MLVA profile 3-17-9-11-523, which happens to be an important member of 
the STM clonal complex that since 2012 has been leading the STM cases in NSW. Whenever there 
is a lack of trg presence, a measurable motility defect was present (242).   
In terms of the non-successful-sporadic clades, the presence of gene dinI within their 
genome was a relevant finding. Our results found it within the genome of all non-successful-
sporadic clades and also within successful MLVA profile 3-10-13-12-496. It was not present in 
isolates with successful profiles 3-9-7-12-523 or 317-9-11-523. Erickson et al (2003) and Yasuda 
et al (2001) have described the presence of the dinI gene associated with switching off the SOS 
response mechanism necessary for a successful bacterial DNA replication and repair within host 
cells (243, 236). This statement is easily translated to our results; the 2 MLVA profile, represented 
by a set of 10 isolates that didn’t present it, happen to be the 2 more successful clades within the 
NSW STM cases spectrum. Clearly, for the successful MLVA profiles who did not have dinI, if 
this gene is absent, there will be no interference in terms of the battery of mechanisms involved in 
effectively invading the host cells, which will translate into more effective infection rates, and 
therefore higher number identifying this particular MLVA profiles which lack of the gene 
associated to cases. Regarding the presence of SNPs within the successful-epidemic clades, our 
results showed total number of SNPs of around 1,500 per year for successful MLVA profile 3-10-
13-12-496 and around 700 SNPs for successful profiles 3-9-7-12-523 and 3-17-9-11-523. Phillips 
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et al (2015) referred to a SNP analysis within outbreak associated isolates: a single non-
synonymous SNP was found within all related isolates, reaffirming the fact that increasing number 
of SNPs is associated with genetically distant isolates (45). It would be expected that in case of 
outbreak, the SNPs number should be reduced. Since our isolates don’t belong to a particular 
outbreak, they are simple representatives from each year STM dynamics, it was expected to find 
large number of SNPs. Other studies evaluating STM in Passeriformes birds, humans and domestic 
animals in England described a median pairwise SNP difference of 130 (range of 18 – 406), 
considering the isolates genetically closely related (150).  
The cut-off point in terms of up to how many SNP differences should be considered to state 
genetic relationships seems to vary from author to author. Even though there are large differences 
in terms the number of SNPs described prior to our research, there is one idea that is clear: WGS 
currently provides the highest resolution available to investigate the relatedness and gene content 
of any microorganism. Makendi et al (2016) described SNPs to over 2,600 for S. Weltevreden 
(57). Leekitcharoenphon et al (2016) reported a total of 4,619 SNPs for 315 STM DT104 isolates 
(66). This increase in the detected SNPs could be related to the isolates belonging to different 
countries worldwide. 
Leekitcharoenphon et al (2016), when analysing isolates belonging to a particular MDR 
cluster with isolates belonging to STM DT104 isolates collected from different Danish farms, 
between 1997 – 2011, identified a total of 755 SNPs (66). Interestingly, those farms where direct 
relationship was proven, presented SNPs differences of less than 30, stating the fact that, as 
suspected, the number of mutations within close isolates should be expected to be small. For our 
isolates presenting the lowest number of SNPs (mean 301), belonging to MLVA profile 3-9-7-12-
523 and 3-17-9-11-523, it would be then suggested that this high number of SNPs found within a 
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similar MLVA profile is related to the fact that this reduced set of isolates (n=6 for MLVA profile 
3-9-7-12-523, n=4 for profile 3-17-9-11-523) have no relation with each other in terms of 
geographical location, time of collection or patient where samples came from. The probability that 
these sets of selected successful clades through time could have any genomic relationship is slight, 
which is translated into the large number of SNP difference found through the time follow up for 
each of the MLVA profiles. In terms of the major proportion of SNPs being classified as 
synonymous within our isolates, similar results were described by S. Fu et al (2016), where almost 
70% of SNPs related to STM were synonymous and mostly related to metabolism functions (216). 
Genome of STM has been described as stable, therefore the presence of these SNPs was expected. 
In conclusion,  though we analysed a limited number of isolates belonging to successful 
MLVA profiles, associated with STM cases in a 6 years period, these isolates presented large 
genomic similarities, reflecting the general genomic clonality present within STM isolates. The 
particular genomic variations detected in epidemic clades through time were limited, however 
always related with the increase of the MLVA profile’s ability to infect the host cells, which could 
be associated with the number of STM cases the period of time after the variation took place.  
The limitation of our study due to a relatively small number of STM isolates should be 
acknowledged. This number reflects limited resources for our project. There are many S. 
Typhimurium draft genomes available in public repositories such as the NCBI Genbank and SRA, 
however, the main goal of the study was to examine STM epidemics in the NSW using a 
representative dataset, without any risk of inadequate metadata. In order to perform WGS we had 
to restrict the number of isolates to sequence, however the sample was selected including isolates 
randomly in terms of their representation for the particular period of time they belonged to, but 
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targeted considering that we selected the 2 MLVA successful profiles that really represent the 
epidemics of STM in NSW. 
Chapter 8 intended to relate these genomic findings and translate them into an experimental 
animal model of infection in order to evaluate whether genomic variations taking place in STM 
genome can be associated with more/less effective infections in mice.   
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Chapter 8: Within and between host genomic variations of an acute and 
chronic STM animal model 
8.1 Introduction 
The aim of this study was to explore the variability of STM genomes over the natural course 
of infection. In order to minimize confounding effects that complicate human infection, we used 
established mouse models of experimental salmonellosis. We conducted two separate experiments 
using different mice strains in order to identify within- and between-host variations, and adaptation 
of STM genomes in acute and chronic STM infection (objective number 5). The results of this 
study revealed new insights and enabled better understanding of genomic variations will assist the 
interpretation of STM sequencing results in the context of different transmission pathways. This 
should be relevant for public health surveillance and interpretation of STM genomic variations in 
human cases and, potentially, the variation and adaptability occurring in chronic STM carriers. 
8.2 The transmission pathway  
 
Within-host and between host genome variations of STM were originally examined by 
infecting 6-week-old female BALB/c mice with an epidemic clade MLVA profile 3-9-7-12-523 
isolate (Chapter 4; subchapter 4.7). The initial isolate was obtained from a human infection. Sets 
of five consecutive passages of STM from infected animal to a STM-naïve animal were performed 
in duplicate, using inoculum prepared from stool culture and intra-gastric inoculation. 
Symptomatic infection in mice was confirmed by testing weekly stool cultures. Animals were 
considered recovered when they stopped displaying any symptoms or sign of infection and had 
negative stool cultures for STM. The STM isolate from the recovered mouse was used as inoculum 
(i.e. passaged) to a healthy, STM-naïve mouse in order to reproduce another infection with the 
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same STM.  This approach assured that the main variable in the experiment was the STM strain 
going through sequential animal hosts. The summary of the full transmission pathway network 
used for this described SNPs detection can be seen in Figure 8.1. 
 
8.3 The experimental model of acute Salmonellosis 
 
As described in Chapter 4, we employed an experimental model of acute salmonellosis to 
investigate emergence of polymorphisms in STM genomes. BALB/c mice with STM infection 
displayed systemic symptoms of infection such as ataxia, weight loss and hunched position. The 
addition of all these resulted on displaying severe systemic condition that led to the euthanasia of 
every compromised animal. Post mortem findings at tissue collection stage showed macroscopic 
signs of the infection. An evident splenomegalia was found in every one of the mice with STM-
positive stools (Figure 8.2). Liver, intestine or mesenteric lymph nodes did not display 
macroscopic abnormalities that could have been potentially associated with the disease. The 
duration of culture-confirmed STM excretion in stools in infected animals remained stable at 3 
weeks during passages 1, 2 and 3; passage 4 displayed 2 weeks of culture-confirmed STM 
excretion in stool of its respective group of mice. 
Since this was a model of acute salmonellosis, minimal within-host STM genome variation 
was detected. However, non-synonymous (NS) as well as synonymous (S) single nucleotide 
polymorphisms (SNPs) were identified. Interestingly, the first passages were associated with 
synonymous SNPs but passages 2 and 3 led to non-synonymous mutations (Table 8.1). 
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Figure 8.1 Complete transmission pathways for SNP detection used for the acute STM infection animal experiment. The SNP profiles 
are presented as associated to particular animal and the respective passage (colour blue). SNPs profile codes correspond to: 1= rsxC, 
oadB, ftsK genes; 2 =  rsxC, oadB, ftsK, mukB genes; 3= rsxC, oadB, ftsK, mukB, mobA genes; 4= rsxC, oadB, ftsK, mukB, yjhP genes. 
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Table 8.1 Characteristics of SNPs observed in STM acute infection 
Genes Annotation Synonymous (S)/ 
non-synonymous 
(NS) 
Amino acid 
change 
Function Passage where 
the SNP 
recorded the 
first time 
oadB N-oxaloacetate decarboxylase 
subunit alpha 
S No change Lyase + Sodium transporter 1 
rsxC Electron transport complex 
protein rsxC 
S No change Involved in electron transport 
 
1 
ftsK DNA translocase ftsK S No change Essential cell division protein 1 
mukB Chromosome partition protein 
mukB 
NS AlaThr Central role during cell division 2 
mobA Molybdenum cofactor guanil 
transferase 
NS ValIle Growth – nutrient acquisition 
 
3 
yjhP SAM-dependent methyl-
transferase 
S - Unknown 4 
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Figure 8.2 Spleen enlargement (splenomegalia) in a BALB/c mouse following acute 
infection with STM. An image of the spleen (red/purple structure) in a control healthy 
mouse is on the right. Blue arrows indicate position of the spleen. 
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After inoculation of the initial pair of mice (passage 1) with human STM strain, 4 different 
single SNPs were identified in both animals. The SNPs were located in four genes: genes rsxC 
(electron transport complex subunit RsxC), oadB (oxaloacetate decarboxylase beta chain), ftsK 
(DNA translocase FtsK) and mukB (chromosome partition protein MukB) (Figure 8.1).  
Differences were detected in terms of the type of sample where the SNPs were found. In one 
passage 1 mouse, SNPs were present in faecal samples and spleen tissue, approximately 10 days 
after inoculation took place. The second passage 1 mouse presented the exact same SNP profile in 
faecal samples, spleen and intestinal tissue. After performing 2nd inoculation of a second set of 
animals (passage 2), the same SNP profile present in passage 1 animals was identified in both 
passage 2 animals, remaining only associated to the same genes, rsxC, oadB, ftsK and mukB 
(Figure 8.1). In addition, the SNPs were not detected in intestinal tissue, only in faecal and spleen 
tissue samples.  
Following the 3rd passage in a different pair of mice (passage 3), a different SNP profile 
emerged in one passage 3 mouse, which involved SNPs in genes rsxC, oadB, ftsK, mukB and mobA 
gene (molybdenum cofactor guanylyltransferase: Figure 8.1). A novel SNP profile was also 
detected in the second passage 3 mouse inoculated in parallel, consisting of SNPs in genes rsxC, 
oadB, ftsK, mukB and the yjhP gene. For the animals inoculated with stools with genes rsxC, oadB, 
ftsK, mukB and mobA (passage 3), there was no evidence of change in SNP profile. The STM 
culture from liver tissues obtained from autopsy of both mice at the end of experiment presented 
the mentioned SNP profile. Passage 4 was carried out by inoculation a set of 2 additional animals. 
These two mice were inoculated at passage 4 by using stools samples with SNP profile including 
SNPs in genes rsxC, oadB, ftsK, mukB and yjhP, previously described in passage 3.  
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One passage 4 mouse failed to develop any signs of the infection and her stool cultures 
were negative for STM, even after serial stool samples were collected. The second mouse did 
develop the disease, however, the STM isolate subsequently cultured from her was distinct from 
that in the inoculum. Whole genome sequencing revealed that the isolate recovered from the 
symptomatic passage 4 mouse had lost the SNP in the mukB gene from passage 2 and also gene 
yjhP from passage 3. The final SNP profile for the symptomatic passage 4 animal was associated 
with genes rsxC, oadB and ftsK, similar to the presence of SNPs that was detected within passages 
1 and 2 (Figure 8.1). A final 5th passage was carried out for one mouse using an isolate with SNPs 
present in the rsxC, oadB, ftsK, mukB and mob genes from passage 3, and a second passage 5 
mouse using an isolate with SNPs present in the rsxC, oadB and ftsK genes. For the three remaining 
inoculated mice (passage 5), the culture results were negative for STM. Series of stool samples 
were collected after the additional week, however, none of the collected stools grew STM on 
selective culture media. Genes rsxC, oadB and ftsK presented different SNPs that became fixed 
and carried through all four passages. In terms of amino acid change as a result of the mutation, 2 
SNPs were identified as non-synonymous: mobA and mukB (Table 8.1). The observed 
polymorphisms were evenly distributed across the genome, with no apparent hot spots or 
associations (Figure 8.3).  
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Figure 8.3 The location of genome polymorphisms in comparison to the reference STM LT2 
genome (Artemis DNA Plotter (Sanger Institute)). Light blue colour represents two reverse and 
forward DNA sequence strands of STM LT2 genome with genes containing SNPs (identified in 
acute animal experiment) with their names in red. Grey circle corresponds to the condensed STM 
LT2 reference genome. Purple inner circles represent G-C content through the genome.  
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8.4 The experimental model of chronic Salmonellosis 
 
In order to examine the variations and adaptations within genomes of successful STM 
clades simulating a chronic STM infection, a separate animal experiment using mouse strain 
129X1/SvJ was conducted (Chapter 4; subchapter 4.7). The initial inoculation of two animals was 
performed using a successful STM strain of human origin (MLVA 3-9-7-12-523), similar to the 
one used for acute infection (Passage 1, Week 0). Stool samples from infected animals were 
initially collected on a daily basis, but collection decreased to twice a week following XX number 
of weeks/days. During passage 1, STM infection was confirmed by positive STM cultures of stools 
collected 2 weeks post inoculation from a single mouse, which remained positive until week 17 
when mice were culled. Both passage 1 mice had positive stool cultures by week 5 post-inoculation 
(Figure 8.4). positive STM tissue cultures from spleen, liver and intestines collected at week 17. 
Multiple tissue samples were positive by week 17. 
Passage 2 was carried out at week 4 after beginning the experiment. The incubation period 
for passage 2 mice was longer than that of passage 1 mice. Passage 2 animals continued excreting 
STM in stools for 8 weeks from the initial inoculation. Tissue collection took place during week 
16; STM positive cultures were obtained from the spleen and liver of both passage 2 animals. 
Differences in time to detection of positive cultures were observed during Passage 3, which was 
performed during week 11 of the experiment (Figure 8.4). Positive stool samples were obtained 
one-week post inoculation in both animals (week 12 from initial inoculum). Mice remained stool 
culture positive until week 9 post Passage 3 inoculation (week 20 from initial inoculum), at which 
time tissues were also collected. Systemic infection was confirmed by sampling of spleen and 
intestine tissue that grew STM on selective media. 
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Passage 4 was performed during week 17 of the experiment, and STM positive stool 
samples were also detected 1-week post inoculation in both animals. Stools remained positive until 
week 23 of the experiment (week 6 of passage 4), but only in 1 of the 2 passages 4 mice. The 
second animal excreted STM positive stool for only 4 weeks after inoculation (Figure 8.4). Tissue 
collection occurred during week 6 of passage 4 (week 23 from initial inoculation/passage 1), with 
spleen tissue STM positive for both animals and liver tissue positive for one animal (Figure 8.4). 
No positive cultures were obtained from the intestine tissue cultures. Regardless the passage, 
animal culling took place due to detected weight loss affecting the STM positive animals. No other 
particularly evident clinical sign was observed.  
Passage number 5 was performed using the STM isolate recovered from one of the STM 
positive passage 4 animals. There were no cultures showing confirmed infection in any of the 
inoculated animals within passage 5. Re-inoculation using a fresh preparation of the inoculum was 
performed. After more than 10 days, there were no positive stool samples collected to reflect the 
infectious status of the animals. Mention that for this reason, passage 5 data is not included in 
Figure 8.4. 
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Figure 8.4 STM culture positivity from samples obtained from mice with chronic salmonellosis. Each colour corresponds to particular week and positive cultures 
detected. Black cells = negative culture. * = week where inoculation for that passage occurred. Inoculated mice have been labelled passage number and “a” and “b”.
WEEKS POST 1ST INOCULATION FOR CHRONIC INFECTION MODEL 
 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 
STM (+)  
mice a + b 
                        
 
 
Passage 
1 
 
 
1a stools *                        
1b stools                         
1a spleen                         
1b spleen                         
1a liver 
 
                        
1b liver                         
1aintestine                         
1bintestine                         
 
 
Passage 
2 
 
 
2a stools     *                    
2b stools                         
2a spleen                         
2b spleen                         
2a liver                         
2b liver                         
2aintestine                         
2bintestine                         
 
 
Passage 
3 
3a stools            *             
3b stools                         
3a spleen                         
3b spleen                         
3a liver                         
3b liver                         
3aintestine                         
3bintestine                         
 
 
Passage 
4 
4a stools                  *       
4b stools                         
4a spleen                         
4b spleen                         
4a liver                         
4b liver                         
4aintestine                         
4bintestine                         
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When comparing the duration of STM positivity in weeks, the acute and chronic models 
presented differences. Due to the acute presentation of clinical signs for STM in the balb/c acute 
mice, which displayed progressive deterioration (severe weight loss and general poor condition) 
resulting in euthanasia, positive cultures were obtained no longer than 4 weeks post inoculation. 
Initial passages, one and two, presented a faster appearance of systemic compromise when 
compared with passages three and four. Chronic infection model presented a larger number of 
weeks where STM positive cultures were obtained, confirming the shedding of STM for longer 
period of time as displayed in Figure 8.6. For instance, animals related to passage one, where 
displaying positivity for STM in stool cultures for 14 weeks average. Following passages reduced 
the time frame where positive cultures were obtained at least doubling the weeks recorded for the 
acute infection model. Positivity of culture during all passages can be reviewed in Figure 8.5(a). 
Regarding weight (in grams), acute model mice displayed a progressive decrease during 
the 9 weeks of the experiment. The mean body weight for mice pre-inoculation was around 17 
grams (Figure 8.5). After onset of infection, the weight loss was evident, with over 10 percent 
weight loss recorded for majority of mice. In chronic infection model mice, the mean body weight 
was around 20 gms; though there were weight gain and loss during time, these were minimal These 
findings were related to the general clinical status of the mice; none of them experienced evident 
clinical signs of infection, in contrast with the acute and evident signs displayed by the balb/c mice 
in the acute model. Based on the standard deviation (SD) error bars, there were no significant 
differences between weight gain and loss during each model of infection (Figure 8.5).  
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Figure 8.5 A: Duration of STM cultures positivity for the acute and chronic animal models of 
infection through consecutive passages. Passage 1 showed statistical significance between the 
number of positive STM cultures obtained in acute and chronic models. B:  Mean of weight from 
mice included in both animal models.  
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The allelic differences between STM genomes of the isolate used in Passage 1 for the 
chronic model and the isolates recovered from infected animals during subsequent passages were 
recorded. The first polymorphisms were observed at week 4 of the first passage. The differences 
found involved 2 particular genes and these were single synonymous SNPs involving genes ftsk 
(DNA translocase ftsK) and ssb (Single-stranded DNA-binding protein 1), which play essential 
roles in cell division and DNA replication respectively (see Chapter 7 and Table 8.2 for details 
regarding the genes). Both findings were only present in one of the 2 inoculated animals. Both of 
them were synonymous SNPs with no amino acid changes induced. An interesting finding was 
that gene ftsK and the later to describe oad genes, were also associated with SNPs during the acute 
STM animal experiment. Further SNP was detected on stools from both animals, 2 weeks after 
detection of the previous one (week 6); this one corresponded to gene rrsH that is described as a 
16S ribosomal RNA gene.  
There was a persistent presence of the SNP related to ftsk gene across isolates involved in 
the 4 infective passages (fixed SNP); this was found not only in stool isolates but also among 
tissue, particularly in liver and spleen. The presence of differences within gene oadA (oxaloacetate 
decarboxylase) accompanied by gene ssb (single-stranded DNA-binding protein 1), was detected 
through carriage originated from passage 2, both of them detected in stool samples from the 2 
inoculated animals. This last gene plays an important role in DNA replication, recombination and 
repair. After passage number 3 was performed, there was constant presence of some of the already 
mentioned SNPs such as ftsK. Particular findings involved only one of the 2 inoculated animals at 
this stage, where genes yfdH and phrB were involved, approximately around week 6 post passage 
3 inoculation. Differences related to gene dcoA were also detected exclusively in one of the 
inoculated animals, which also didn’t reflect the 2 previously mentioned genes. Passage 4 was 
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performed based on stools culture from the previously infected generation of mice. The analysis 
of this point in the transmission pathway showed carriage of 2 previously described genes, ftsK 
and oadA, both of them involving both of the inoculated mice. Analysis of the STM positive liver 
tissue from one of the mice inoculated during passage 4, reflected absence of gene dcoB 
(oxalacetate decarboxylase: beta chain) and presence of cysN gene (sulfate adenylyltransferase 
subunit 1).  
In terms of amino acid changes, there were none present in the STM chronic infection 
model. None of the detected SNPs was non-synonymous. Figure 8.6 summarizes the transmission 
pathway utilized for this section of the project as well as presenting the SNP profile detected 
through passages. Table 8.2 summarizes the SNPs in STM chronic model. 
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Table 8.2 Characteristics of the SNPs (all synonymous) observed in STM chronic infection 
Genes Annotation Function Passage where 
the SNP 
recorded the 
first time 
ftsK DNA translocase ftsK Essential cell division protein 1 
Ssb Single-stranded DNA binding 
protein 1 
Role in DNA replication, 
recombination and repair 
1 
rrsH 16S ribosomal RNA Coding gene for RNA 1 
oadA N-oxaloacetate decarboxylase 
subunit alpha 
Lyase + Sodium transporter 2 
phrB deoxyribodipyrimidine photo-
lyase 
Involved in repair of UV 
radiation-induced DNA damage 
3 
yfdH Putative glycosyltransferase Regulatory gene 3 
dcoB Oxaloacetate decarboxylase beta 
chain 
Sodium ion transport 4 
cysN Sulfate adenylyltransferase 
subunit 1 
May be the GTPase, regulating 
ATP sulfurylase activity 
4 
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Figure 8.6 Complete transmission pathways for SNP detection for the chronic STM infection animal experiment. The SNP profiles 
are presented as associated to particular animal and the respective passage (colour blue). 
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8.5 Discussion 
We have reproduced systemic STM infection in two strains of mice in order to measure 
the emergent genomic variation associated with presence of STM polymorphisms during acute 
and chronic disease. This approach was highly novel, and we are aware of one similar study 
(Sondberg and Jelsbak, 2016), which was published after completion of these experiments (244). 
In contrast to the large body of literature describing animal models of typhoid, 
experimental models of non-typhoidal Salmonella have not been extensively studied. A mouse 
model of infection with serovar Typhimurium has been used to investigate enteric fever rather than 
non-typhoidal salmonellosis (11). Microbiologists used these models to examine the mechanisms 
and duration of bacterial excretion. Lam and Monack (2014) studied the changes present in a set 
of isolates in time, where the greater dynamic changes were observed at early time points in 
infection, showing a dramatic decrease in the number of Salmonella strains detected in the faeces 
when reaching the end of the experiment (62). Studies such as that presented here, which are 
focused on exploring the adaptive evolution of Salmonella in association with its host, remain 
uncommon.  
Our observations correlate well with the recent study by Sondberg and Jelsbak (2016), 
which investigated STM adaptation during experimental chronic infection of mice. They 
documented a number of mutations in STM during a short-term experimental chronic infection of 
STM, and analogous to our findings, identified allele differences present in stools and organs such 
as liver, spleen and large intestine (244). The timeliness of these polymorphisms was also similar 
to our study. Once a variant was detected in stools, it was likely to continue being identified over 
time until reaching a particular moment in time, over four weeks, where the gene differences are 
no longer found. Sondberg and Jelsbak (2016) described not only distinct SNPs but also samples 
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from stools and tissues belonging to different animals sharing similar SNPs, which indicated 
transmission between the animals in their study (244). However, no horizontal transmission 
between animals under our care was observed. This may have been due to the in vitro 
characteristics present during the experiments, where cleaning of the housing was constantly 
performed, minimizing an increase on the exposure to excreted STM within the cage.  
The focus of this study was on within-host variations and adaptations in STM genomes. 
Interestingly, we observed polymorphism in the ftsK gene, which became fixed in subsequent 
passages in both the acute and also the chronic transmission pathways. This gene has been 
described as an essential cell division protein, with a confirmed role conferring increased 
resistance to DNA damage (245). Our results suggest that this gene can be important in defining 
virulence phenotype of STM association and in the success of STM clades as human pathogens 
despite the fact that in terms of actual consequence generated from the presence of this SNP, no 
amino acid change took place. Gene ftsK still presents a relevant function in terms of active cell 
division, which could promote the ability of STM to remain actively infectant (Chapter 7). Our 
experiments highlighted the remarkable stability of the STM genome in acute and chronic 
infections. However, at the same time our findings indicate that acute STM infection presents a 
higher likelihood of mutations in STM genomes, including non-synonymous SNPs leading to 
amino acid changes. These were not present through the chronic infection model; all SNPs detected 
were synonymous. Perhaps these changes that took place through longer period of time (23 weeks) 
may be explained mostly in terms of host factor’s influence rather than the infecting organism 
itself. The idea behind selecting  the particular mice strain used for developing a chronic model of 
infection was to effectively mimic the chronic trend in terms of carriage that chronic human 
salmonellosis displays. Other mice strains, even the previously used BALB/c would not have 
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generated the chronicity that we observed. This chronic carriage displayed a number of fixed SNPs 
passing on through generations of mice in time without presenting amino acid changes and 
retaining the SNPs through the passages. A future direction of this work would be to continue to 
elucidate the actual adaptation strategies employed by the pathogen in terms of interactions with 
the host. By approaching an understanding these adaptations within STM genome, contributions 
towards STM infections reduction in human population can be achieved.   
We acknowledge the relatively short duration of our models, particularly the acute one, 
and the effect it could have on the interpretation of our findings. Further studies of STM excretion 
over longer periods of time may warrant reconfirming our conclusions. However, our results are 
supported by genome sequencing experiments of STM strains cultured from human carriers 
showing limited genomic variation (5 SNPs or fewer) associated with short- and long-term carriage 
(173,216,246-248). Though the models encountered issues to extend the analysis in terms of the 
inability of the inoculum to generate more than 5 and 4 passages within acute and chronic model 
respectively, the results were sufficient to address the main objective of the study, which was to 
generate findings applicable to the interpretation of WGS data from human infections, so that 
human STM transmission pathways may be better understood (249-256). 
In conclusion, the results of controlled experimental models of acute and chronic 
salmonellosis suggest acute infection is more likely to lead to genomic polymorphisms than 
chronic infection. Chronic infection model in animals revealed high stability of the genome 
through time, becoming persistently present through time and also through infected individual. 
The difference in genomic polymorphisms may reflect the size of microbial load during acute and 
chronic infections and can be an important factor in the interpretation of possible transmission 
pathways when STM carrier hosts are involved. 
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Chapter 9: Conclusions 
 
9.1. Drawing the findings together 
 
The main aim of this thesis was to investigate the molecular epidemiology of STM in New 
South Wales, Australia in order to gain new insights into the dynamics of seasonal epidemics. This 
region presented a unique setting for this study because of its access to quality pathology services 
and a well-established public health surveillance system. The subtyping techniques routinely 
performed for diagnostic testing in NSW, such as MLVA typing, have performed accurately and 
with sufficient discriminatory power to individualize isolates and, in most cases, associate them 
with particular settings and circumstances. Typing of STM infections in NSW is typically 
uncomplicated as the majority of STM infections in developed countries such as Australia are 
caused by a single strain, in contrast to developing countries where salmonellosis cases are often 
associated with co-infection by multiple strains, which complicates laboratory surveillance and 
deciphering of transmission pathways.   
The emerging fields of genomic epidemiology and genomics-enhanced surveillance bridge 
the fields of microbiology, epidemiology and genomics in order to enhance understanding of the 
dynamics infectious disease epidemics, including STM (257-261). The application of enhanced 
genomic surveillance methods, such as whole genome sequencing, will certainly improve public 
health laboratory surveillance by providing a better understanding of the nature and molecular 
markers of dominant and emerging STM clades (262-265). Our main goal was to present a series 
of analyses to support the implementation of genomic-based surveillance, to improve the 
recognition of transmission pathways, which will ultimately lead to better understanding and 
therefore control of foodborne diseases such as STM. 
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Several countries such as England, US and some states in Australia, have already 
implemented genomic diagnosis and surveillance, transforming the diagnostic practice in clinical 
microbiology and reducing the turnaround time of testing (266-268). Implementation of WGS 
involves a series of modifications to the current laboratory workflows including acquisition of high 
performance computers and up skilling of laboratory personnel involved in the generation and 
analysis of the data produced by molecular subtyping and whole genome sequencing (269-270). 
The results presented in this thesis have added significant body evidence and new insights that 
may improve the quality of surveillance and control of STM disease in developed countries and 
elsewhere. This chapter draws together the findings from each of the thesis’s chapters and 
discusses encountered limitations and the implications for future research in this area. 
 
9.1.1. Objective 1 - To explore the capacity of multi-locus sequence typing to identify and 
differentiate the most common serovars of Salmonella enterica co-circulating in NSW 
We compared the resolution of multi-locus sequence typing (MLST) with conventional 
serotyping to infer Salmonella serovars (271-272). Results generated using conventional 
serotyping of Salmonella and molecular serotypes inferred from MLST were congruent when 
applied to Salmonella strains circulating in NSW and Australia. These observations suggest that 
the use of molecular serotyping to characterize Salmonella in NSW and Australia can minimize 
the considerable challenges of traditional serotyping. Although the number of isolates included in 
the analysis was limited, the results confirmed the ability of the MLST-7 technique to infer 
serotypes. Based on the findings of this study, it is recommended that diagnostic laboratories 
consider implementing MLST-7 as a good and reliable supplement or alternative to serotyping. It 
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is clear that serotyping is still routinely used in many diagnostic laboratories Whilst moving away 
from traditional serotyping would require a change in the workflow of public health microbiology 
laboratories, the routine use of MLST or another similarly high throughput discriminatory 
sequence-based typing method would provide a clearer picture of short-term and long-term 
epidemiology and transmission routes of Salmonella, enabling data comparison and disease 
control in a global context. It is important to mention though, that this recommendation is only 
based upon the comparison between serotyping and MLST, even though as earlier discussed, the 
latter presents serious discriminatory issues. Ideally, all public health reference laboratories should 
be heading towards an organized and systematic whole genome sequence-based analysis. With 
better access to sequencing and bioinformatics resources, the serotype inference and more detail 
analysis using wgMLST for common serotypes should be based upon conduction of WGS. 
 
9.1.2. – Objective 2 – To investigate the structure and mechanisms of seasonal epidemics of 
human STM disease in NSW 
Our findings confirmed that the power and resolution of MLVA characterization was 
sufficient to enable detection of temporal changes in STM populations. This approach can be used 
to identify and quantify the existence and persistence of epidemic clades within specific seasons; 
either associated with large number of individual cases, community outbreaks or for general public 
health surveillance. An increase in STM cases during summer months as well as an increase in the 
number and diversity of MLVA profiles detected in the community during warms months was 
described and measured. There are several possible explanations to these observations. First, 
experts such as Akil et al (2014) have warned about an inevitable rise in STM cases due to global 
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warming. This might even be playing a role on the general decrease in presentation of  typhoid 
related Salmonellas, becoming gradually replaced by a wide host range of non-typhoidal 
Salmonella serovars which, due to their multiple transmission routes, are expected to difficult the 
already highly incident salmonellosis profile. Second, it is the increased selection pressure driven 
by the extensive farming and food production practices which is most probably generating 
different modification, mostly in the environment, generating an impact in the ecological niches 
involved in presentation and sustainability over time of the organisms (275-278). 
Substantial proportions of STM isolates included in clusters showed seasonal fluctuations 
corresponding to changes in STM incidence, with a relatively constant STM population diversity 
over the study period, reassuring the stable profile with predominance of well identified STM 
MLVA profiles. These findings reveal and confirm, as stated in 2016 by Earle et al, that not only 
the stability of the loci within the STM genome targeted by MLVA typing, but also the need to 
consider the existence of permanent links between human infections and animal reservoirs that 
could be involved in the constant dissemination of particular endemic MLVA. There have already 
been several suggestions in terms of the role the animal population has in the dissemination and 
persistence of STM through the food chain. 
Our retrospective sequencing of STM isolates confirmed the high resolution of WGS and 
enhanced genomics surveillance, not only for the accurate identification and subtyping of 
pathogens, but also as a reliable tool for outbreak investigation. It has proven to be the most 
effective technology in order to prospectively identify outbreaks as well as providing information 
in terms of transmission events. Its ability to complement existing epidemiological tools by means 
of reconstructing transmission chains have allowed the identification of otherwise unrecognizable 
epidemiological links. We have managed to prove the added value of genome sequencing in the 
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investigation of point source community outbreaks associated with gastroenteritis caused by STM. 
However, the transition from MLVA based surveillance to genomic surveillance should be 
carefully planned, as the MLVA profiles cannot be inferred from WGS data.  
 
9.1.3. Objective 3 – To characterize attributes of STM populations that are associated with 
seasonal epidemics of human STM disease in NSW 
Despite public health efforts, Salmonella remains the most frequent cause of severe 
foodborne gastroenteritis in Australia and worldwide. We aimed to determine whether 
comparatively high burden seasonal STM epidemics could be predicted by STM activity in the 
preceding months, specifically the total number of STM cases and the appearance of new MLVA 
profiles. The aim of this was to develop a simple but reliable tool to act as an early warning system, 
to inform public health control and prevention efforts ahead of the peak summer months. We were 
able to determine that the severity of STM epidemics in NSW was associated with an increase in 
particular successful STM clades in the cooler months preceding peak summer months. The 
presence of gene variations associated with the tandem repeat numbers appeared concentrated 
within individual MLVA clonal complexes, which are the main characters throughout the 
numerous STM infections yearly. These potentially shedding reservoirs of STM strains in the 
environment, based upon their constant presence as the identified cause linked to several 
salmonellosis infections, might enable STM to become successfully persistent in the environment. 
Endemic/novel STM MLVA profiles remained quite stable until 2012. There was an 
unexplained and sudden increase in the population diversity of STM in 2012, possibly related to 
genomic recombination events as well as environmental conditions. However, the introduction of 
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particularly uncommon profiles has not been seen in relation to specific outbreaks, only with 
individual human cases, where maybe particular circumstances related to either the sociocultural 
background or specific situations that could have increased the risk of exposure for the affected 
patients triggering the appearance of those novel MLVA profiles. Further analysis of host-
pathogen interactions and STM populations in specific environmental reservoirs can explain the 
mechanisms of these shifts in STM population diversity. 
 
9.1.4. Objective 4 – To compare the resolution power of MLST, MLVA and genome 
sequencing for public health laboratory surveillance 
The results presented in Chapters 5 and 6 compared the resolution of three different but 
complimentary approaches to STM genotyping. MLST was found to be capable of inferring 
serovars accurately, supporting recent evidence from studies conducted in other geographical 
locations. Although the number of Salmonella serovars on our data set was not large, it captured 
the diversity of the top 10 most common serovars circulating in NSW. In addition, MLST was 
easy and fast to perform, and MLST results correlated with serotyping without exception, even 
correctly identifying genetic variants of STM, such as the monophasic strains. The reliable 
identification of the latter, often associated with multiple markers of antibiotic resistance, is of 
particular importance. However, the resolution of assigned Sequence Types (ST) appeared to be 
insufficient for public health surveillance purposes as there were numerous MLVA profiles 
identified within the ST19, the most common STM sequence type. In contrast to MLST, the 
MLVA approach was able to identify and define epidemiologically relevant clades of STM 
through the characterization described in the previous objective. Both subtyping methods have 
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become complementary tools with which to study the genetic relatedness of STM strains in routine 
analysis as well as during epidemiological investigations (278-280). Even though MLVA cannot 
be inferred based on WGS, it is still a reasonably fast, reliable and not highly expensive 
surveillance tool, with enough discriminatory power to preliminarily relate cases of Typhimurium 
infection.  
Whole genome sequencing, as the third approach for STM identification and 
characterization, provides superior resolution that can enable precise identification of the 
microorganism down to the ST level, define outbreaks and enable identification of, and linkage to, 
particular source(s) as well as identification of previously unidentified epidemiological links that 
were not detected using conventional epidemiological and laboratory methods. Public health 
investigation of STM related outbreaks using only MLVA typing have underestimated the size and 
duration of the outbreaks in some instances. This situation could be avoided by widespread 
adoption of WGS for outbreak investigation. 
 
9.1.5. Objective 5 – To examine variations in core and accessory genomes of successful STM 
clades 
Results generated from experiments performed to address Objectives 1 to 4 enabled us to 
approach more fundamental questions about genomic differences to explain the epidemic capacity 
of specific STM clades, and to extend recent reports regarding determination of Salmonella 
invasiveness by a small number of virulence genes. We examined the genomic variation among 
epidemic STM isolates using core and accessory genomes established from complete sequences 
of STM isolates, and performed comparative genomic analysis between sporadic and epidemic 
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STM clades based on their MLVA and genomic polymorphisms. The findings emphasized the 
stability of accessory genomes, which was previously underappreciated and requires further in 
vivo validation (281-282). Interestingly, we have also identified gene loss in epidemic clades as a 
potential contributor to the pathogenic success of an STM MLVA profile, evidenced by an increase 
in the number of cases caused by particular profiles following gene loss.  
 
9.1.6. Objective 6 – To identify within- and between-host variation and adaptation in STM 
genomes in models of acute and chronic infection 
The aim of Objective 6 was to improve understanding of the genomic variations associated 
with different transmission pathways in order to accurately interpret STM genomic variations in 
human cases. Furthermore, it would be interesting to focus on the variation and adaptability 
occurring in STM chronic carriers, where the adaptive evolution of Salmonella in association with 
its host can become a critical bottleneck. In our model of chronic salmonellosis, we were able to 
explore STM adaptation strategies evidenced by the appearance of a limited number of mutations 
that did not compromise the ability of STM to maintain infection within the host. Rather, the STM 
isolate was able to successfully generate a persistent infection without severely compromising the 
host, which secured its presence in the experimental environment. The persistence in time of 
particular fixed SNPs related to essential cell functions as well as a conferred resistance to DNA 
damage were clear examples of adaptive genomic modifications. .  
Compared to the chronic infection mode, more genomic changes occurred in the acute 
STM infection model, with the isolate displaying enhanced pathogenicity in terms of compromised 
animal health (283). Furthermore, some of the SNPs detected within the acute infection generated 
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amino acid changes, result that was not observed with the SNPs identified in the chronic infection 
model. There have been recent reports of STM strains cultured from human carriers showing 
similar limited genomic variation associated with short- and long-term carriage. Our results 
demonstrated that the STM core genome is absolutely stable; accessory genome is relatively stable, 
however capable of generating limited number of mutations in order to secure a niche within the 
environment and also as a way of adapting in order to establish chronic infection (285). These 
findings would be of relevance in the study of particular situations in patients classified as chronic 
carriers. It would be interesting to follow the model published by Im et al, (2016) where stools 
were collected randomly from African population. Findings showed presence of NTS in almost 
25% of the stool samples, with none of the participants displaying signs associated with illness. 
Since developing countries are expected to present illness, the idea of taking this concept to 
developing regions with high NTS incidence would be of interest.   
9.2. Study limitations 
Several limitations of our research have to be acknowledged. We studied epidemics of 
STM in one jurisdiction of a large country, with relatively limited number of cases under genomic 
study, a specific laboratory testing and surveillance environment and microbial ecology for 
relatively short period of time. The small number of selected genomes could bias our identification 
of genomic changes within hosts and between hosts. However, we believe that the complexity of 
multi-factorial epidemiology of STM and cost of subtyping made, for this thesis purposes, an 
overarching study of genome dynamics unfeasible and the research of genomic variations under 
controlled conditions of experimental models and defined clusters is the way to tackle the 
relationships between genomic markers and public health outcomes. A larger study is needed to 
verify our observations of STM clonal changes and the relationships between novel MLVA 
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profiles and seasonal epidemics of human infections. If we add to this the fact that the each one of 
these isolates belonged to independent human STM infection cases which might have gone through 
their own individual adaptation processes, our findings might be too limited in terms of their ability 
to be generalized. Future lines should consider increasing the number of analysed genomes per 
years, as well as keeping a larger diversity of profiles considered for the analysis; only that way 
we might be able to, with certainty, extrapolate our results to the larger spectrum of STM illness. 
 
9.3. Concluding remarks: implications for future research 
The findings presented in this thesis have improved the understanding of the dynamics of 
salmonellosis epidemics in NSW, particularly related to STM. Also, we established the key role 
that genomic variability in STM genome presents as a way of interpretation of possible 
transmission pathways when STM carrier hosts are involved. The results have highlighted several 
areas that have practical implications for future research in molecular epidemiology of 
salmonellosis and public health surveillance. These include the complex structure of STM 
epidemics, represented not by actively changing STM populations but quite on the contrary, by 
highly dominant clades, with a limited level of diversity. This characteristic in terms of endemicity 
and genomic stability, makes us wonder whether, as shown through the successful / non-successful 
comparison and by means of the animal models, this region’s local successful clades have become 
adapted to their environment, generating slight modifications within their genome so they can 
ensure a constant presence throughout the years to predominate in NSW, as well as taking 
advantage of beneficial environmental conditions during peak seasons. This adaptation could even 
become, if it hasn’t already occurred, a host-adaptation, which would certainly change the public 
health approach towards the control of foodborne illness associated with STM. Further studies, 
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specifically analysis of a larger and more diverse set of isolates, are required in order to fully 
understand the epidemiological impact of STM genomic variability in NSW and beyond.   
The generalizability of our results to other developed country settings with less endemic 
serovars could be a useful tool to better understand the nature of the MLVA profiles for particular 
regions associated with STM cases. The prediction indexes would become handy for the public 
health authorities’ decision-making processes. 
In conclusion, our research findings provided important insights into the dynamics of 
community epidemics of Salmonella Typhimurium and identified genomic polymorphisms that 
contribute to the establishment of epidemic clades. Our results and analyses have generated 
important evidence to guide the interpretation of Salmonella Typhimurium public health 
laboratory surveillance results and the integration of whole genome sequencing into control of 
foodborne diseases. We anticipate that this research will provide a starting point for future 
experiments, and the collection and analysis of larger genomic datasets in order to fully realize the 
power of genomic surveillance. 
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Appendices 
 
Appendix A. A sample of Roary original data file as output for the successful/non-successful 
MLVA - STM analysis (full file from Roary software is provided as .xls electronic attachment).  
 
 
 
 
 
 
 
 
 
Gene STM-01_S46 3-9-7-12-523 (2010) STM-3S58 3-9-7-12-523 (2011) STM-5S13 3-9-7-12-523 (2012) STM-8S31 3-9-7-12-523 (2013) STM-11_S50 3-9-7-12-523 (2014) STM-14_S19 3-9-7-12-523 (2015)
garK_1 STM-01_S46_00812 STM-3S58_02370 STM-5S13_01334 STM-14_S19_00100
sspH2_2 STM-01_S46_04486 STM-3S58_01290
phnT_1 STM-11_S50_04068
group_28 STM-8S31_04704
group_362 STM-11_S50_03743
oadB_2
group_112 STM-3S58_04038 STM-8S31_03246
group_269 STM-5S13_00094
lpfC STM-5S13_00092
ccmH_1 STM-3S58_01975 STM-14_S19_00860
group_170 STM-5S13_02843
ccmH_2 STM-3S58_03089
group_121 STM-01_S46_01462
atpD_2 STM-14_S19_02538
group_137 STM-8S31_04304
group_139 STM-01_S46_02620
group_140 STM-14_S19_03666
hsrA_1 STM-3S58_00180
pntB_1 STM-3S58_01372
ydiN_1 STM-01_S46_00003
group_1563 STM-01_S46_00166
corA_2 STM-01_S46_02890
group_1590 STM-01_S46_03286
group_1592 STM-01_S46_03363
group_1599 STM-01_S46_04256
mhbT_2 STM-01_S46_04305
argF_2 STM-01_S46_04478
group_169 STM-11_S50_03092
rhaA_1 STM-11_S50_02163
236 
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T^ G C C C G G C C C C C A C G C G G A G G C T A G G G C C G ATTTTAT
5_A4078 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
6_A4103 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
7_A2128 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
8_A2097 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
9_A2096 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
10_A2099 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
11_A2137 A. A . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
14_A1970 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
15_A1974 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
16_A1954 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
17_A1965 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
18_A2474 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
19_A4521 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
20_A2475a A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
21_A2472 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
23_A2465 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
24_A2471 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
25_A4615 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
26_A4611 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
27_A4619 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
28_A4613 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
30_A4318 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (C)
33_S4804 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (SC)
56_E4809 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (E) 
57_E4810 A. . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Outbreak A (E) 
38_M2261 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (C)
39_M2258 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (C)
40_M2268 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (C)
41_M2107 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (C)
42_M5132 . . . . T . . . . . . . A . . . . . ‒ . . A . . . . . A . . ‒ Outbreak M (C)
43_M4657 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (C)
44_M4945 . . . . T . . . . . . . . . . . . . . . . A . . . . . A . . ‒ Outbreak M (C)
45_M4703 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (C)
46_M4704 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (C)
48_M4732 . . . . T . . . . . . . * . . . . . . . . A . . . . . A . . ‒ Outbreak M (C)
50_M2475b . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (C)
51_M5033 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (C)
58_E4692 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (E) 
59_E4696 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (E) 
60_E4720 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (E) 
61_E4721 . . . . T . . . . . . . A . . . . . . . . A . . . T . A . . ‒ Outbreak M (E) 
62_E4742 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (E) 
63_E4743 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (E) 
64_E4499 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (E) 
65_E2330 . . . . T . . . . . . . A . . . . . . . . A . . . . . A . . ‒ Outbreak M (E) 
54_N4956 . . . . . . . . . . . . A . . . . . . . A . . . . . . . . . ‒ Sporadic 
1_N4472 . . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Sporadic 
22_N2054 . . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Sporadic 
31_N4583 . . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Sporadic 
32_N5047 . . . . . . . . . . . . . . . . . . . . . A . . . . . A . . . Sporadic 
2_N4246 . . . . . . . . . . . . . . A . . . . . . A . . . . . A . . . Sporadic 
35_N4800 . . . . . . . . . . . . . . . . . A . . . A . . . . . A . . . Sporadic 
4_N4210 . . . . . . . . . . . A . . . . . . . . . . . . . . . . . . . Sporadic 
37_N4954 . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . . Sporadic 
67_N4799 . . . T . . . . . . . . . . . . . . . . . . . . . . . . . . ‒ Sporadic 
3_N2463 . . . . . . A . T . . . . . . . A . . . . . C . . . . . . A ‒ Sporadic 
29_N4955 . . . . . . A T T . . . . . . . A . . . . . . . . . . . . A ‒ Sporadic 
34_N4802 . . . . . . A T T . . . . . . . A . . . . . . . . . . . . A ‒ Sporadic 
36_N5175 . . . . . . A T T . . . . . . . A . . T . . . . . . . . . A ‒ Sporadic 
52_N5064 . . . . . . . . . . . . . . . A . . . . . . . C . . A . . . . Sporadic 
53_N5139a . . . . . . . . . . . . . . . A . . . . . . . C . . A . . . . Sporadic 
55_N4714 . . A . . T . . . T T . . G . . . . . . . . . . T . . . T . . Sporadic 
Reference nucleotide and genome position in S . Typhimurium LT 2 (GenBank Accession No. NC_003197)
Isolate Epi-confirmed source
